10-Q
0001823466falseQ3--12-31falsehttp://fasb.org/us-gaap/2024#AccountingStandardsUpdate202006Member2024202520262027202831111P1Y1.5http://www.fiscalnote.com/20240930#ChangeInFairValueOfFinancialInstruments0001823466note:EarnoutSharesMember2023-12-310001823466us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembernote:EraConvertivleNoteMember2023-12-310001823466us-gaap:FairValueInputsLevel3Membernote:NewGpoNoteMember2023-12-310001823466note:NewGpoNoteMember2023-01-012023-09-300001823466srt:NorthAmericaMember2024-07-012024-09-300001823466note:AntiDilutiveDragonflySellerConvertibleNotesMember2024-07-012024-09-300001823466note:AdvisoryAdvertisingAndOtherMember2023-07-012023-09-300001823466us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-07-012023-09-300001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMembernote:PerformanceBasedRestrictedStockUnitsMember2024-09-300001823466us-gaap:SellingAndMarketingExpenseMember2023-07-012023-09-300001823466us-gaap:AdditionalPaidInCapitalMember2024-03-310001823466note:DragonflySellerConvertibleNotesMember2024-09-300001823466country:AU2024-07-012024-09-300001823466note:SeniorTermLoanMember2024-03-110001823466note:PublicWarrantsMembernote:ClassACommonStockEqualsOrExceedsDollarSixPointThreeSixMember2022-07-292022-07-290001823466us-gaap:DevelopedTechnologyRightsMember2023-12-310001823466note:DragonflyEyeLimitedMember2023-01-270001823466note:IntangibleAssetsExcludingDevelopedTechnologyMember2024-01-012024-09-300001823466us-gaap:PatentsMember2024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:LiabilityClassifiedWarrantsMember2023-12-3100018234662026-01-012024-09-300001823466us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2023-12-310001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMember2023-07-012023-09-300001823466note:LiabilityClassifiedWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466note:DragonflyEyeLimitedMemberus-gaap:DevelopedTechnologyRightsMember2023-01-272023-01-270001823466note:DragonflySellerConvertibleNotesMember2024-01-012024-09-300001823466srt:EuropeMember2023-07-012023-09-300001823466note:PublicWarrantsMember2022-07-290001823466us-gaap:DevelopedTechnologyRightsMember2024-01-012024-09-300001823466note:PrivatePlacementWarrantsMember2023-07-012023-09-300001823466us-gaap:CommonClassAMember2023-07-012023-09-300001823466srt:MinimumMember2024-09-300001823466us-gaap:CustomerRelationshipsMember2023-12-310001823466us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001823466note:SeniorTermLoanMember2023-01-012023-09-300001823466note:EditorialMember2024-07-012024-09-300001823466note:DragonflySellerConvertibleNotesMember2023-07-012023-09-300001823466note:AntiDilutiveContingentlyIssuableSharesMember2024-07-012024-09-300001823466note:AntiDilutiveAicelConvertibleNotesMember2023-01-012023-09-300001823466us-gaap:RetainedEarningsMember2023-07-012023-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMember2024-09-300001823466note:OtherRevenueMember2024-07-012024-09-300001823466us-gaap:ShortTermInvestmentsMember2024-01-012024-09-300001823466us-gaap:RetainedEarningsMember2023-12-310001823466us-gaap:RetainedEarningsMember2023-01-012023-03-3100018234662023-01-012023-09-300001823466note:OldFiscalNoteWarrantsMember2024-09-300001823466note:BooksMember2024-01-012024-09-300001823466us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001823466us-gaap:DevelopedTechnologyRightsMember2024-07-012024-09-300001823466note:EarnoutAwardsMember2024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001823466us-gaap:CostOfSalesMember2024-01-012024-09-300001823466us-gaap:CommonStockMemberus-gaap:MeasurementInputSharePriceMembernote:LastOutLenderWarrantsMember2023-12-310001823466us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-04-012024-06-300001823466note:EraConvertibleNoteMember2024-04-110001823466us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:ConvertibleNotesPayableMember2024-09-300001823466note:AicelTechnologiesMemberus-gaap:ConvertibleNotesPayableMember2024-09-300001823466note:ConvertiblePromissoryNoteMembernote:NewGpoNoteMember2024-01-012024-09-300001823466us-gaap:RetainedEarningsMember2024-07-012024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001823466note:AntiDilutiveNewGpoNoteMember2024-07-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:ContingentLiabilitiesFromAcquisitionsMember2023-12-310001823466us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMembernote:ShareBasedCompensationAwardTrancheFiveMember2024-09-300001823466us-gaap:RetainedEarningsMember2022-12-310001823466us-gaap:CommonClassAMembernote:DragonflyEyeLimitedMember2023-01-272023-01-270001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001823466us-gaap:DatabasesMember2024-09-300001823466us-gaap:CommonStockMember2023-06-300001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-07-012024-09-300001823466us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembernote:ContingentLiabilitiesFromAcquisitionsMember2024-09-300001823466note:PublicWarrantsMember2023-07-012023-09-300001823466note:ContentLibraryMember2024-09-300001823466note:AntiDilutiveNewGpoNoteMember2024-01-012024-09-300001823466note:PaycheckProtectionProgramMember2024-09-300001823466note:AntiDilutiveEarnoutAwardsMember2024-01-012024-09-300001823466us-gaap:CommonStockMember2024-04-012024-06-300001823466note:SeniorTermLoanMember2024-03-112024-03-110001823466note:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001823466us-gaap:DevelopedTechnologyRightsMember2023-01-012023-09-300001823466us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-09-300001823466note:EraConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2023-12-310001823466note:SubscriptionMember2023-01-012023-09-3000018234662023-01-012023-03-310001823466note:DragonflyEyeLimitedMemberus-gaap:ConvertibleNotesPayableMember2023-12-310001823466note:DSACMember2024-01-012024-09-300001823466srt:MinimumMemberus-gaap:SubsequentEventMember2024-11-122024-11-120001823466note:NoVendorsMemberus-gaap:SupplierConcentrationRiskMembernote:PurchasesMember2024-01-012024-09-300001823466note:SeniorTermLoanMember2024-07-012024-09-300001823466us-gaap:ConvertibleNotesPayableMember2023-07-012023-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:TradeNamesMember2023-01-270001823466us-gaap:AdditionalPaidInCapitalMember2023-06-300001823466note:ExecConnectIntermediateLlcMembernote:BoardOrgBusinessMembernote:PurchaseAgreementMember2024-03-110001823466us-gaap:TradeNamesMember2023-12-3100018234662024-09-300001823466us-gaap:ConvertibleDebtSecuritiesMember2024-07-012024-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2022-12-310001823466us-gaap:MeasurementInputRiskFreeInterestRateMembernote:DragonflySellerConvertibleNotesMember2024-09-300001823466us-gaap:AdvertisingMember2023-01-012023-09-300001823466note:PaycheckProtectionProgramLoanMember2022-02-142022-02-140001823466us-gaap:CommonStockMembernote:EraConvertibleNoteMember2024-04-112024-04-110001823466country:AU2023-07-012023-09-300001823466us-gaap:FairValueMeasurementsRecurringMembernote:EraConvertivleNoteMember2023-12-310001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2023-07-012023-09-300001823466note:AntiDilutiveAicelConvertibleNotesMember2024-07-012024-09-300001823466note:SubscriptionMember2023-07-012023-09-300001823466note:EraConvertibleNoteMember2024-09-300001823466us-gaap:CostOfSalesMember2023-07-012023-09-300001823466us-gaap:ShortTermInvestmentsMember2023-01-012023-09-300001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-01-012024-01-010001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMembernote:ShareBasedCompensationAwardTrancheFiveMember2024-01-012024-09-300001823466note:IntangibleAssetsExcludingDevelopedTechnologyMember2024-07-012024-09-300001823466us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001823466us-gaap:ConvertibleDebtSecuritiesMember2023-01-012023-09-300001823466us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001823466us-gaap:FairValueMeasurementsRecurringMembernote:NewGpoNoteMember2024-09-300001823466note:AntiDilutiveNewGpoNoteMember2023-01-012023-09-300001823466note:PublicWarrantsMembernote:ClassACommonStockEqualsOrExceedsDollarSixPointThreeSixMember2022-07-290001823466note:NewGpoNoteMember2022-01-012022-12-3100018234662023-12-310001823466us-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2024-09-300001823466us-gaap:CommonClassAMembernote:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-09-300001823466us-gaap:SalesRevenueNetMemberus-gaap:GovernmentMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001823466note:SeniorTermLoanMember2024-01-012024-09-300001823466us-gaap:FairValueInputsLevel2Membernote:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466us-gaap:CommonClassAMember2024-01-012024-03-310001823466note:NewFiscalNoteMember2022-07-290001823466us-gaap:FairValueInputsLevel3Membernote:ContingentLiabilitiesFromAcquisitionsMember2024-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2024-01-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:DragonflySellerConvertibleNotesMember2024-01-012024-09-300001823466us-gaap:CommonClassAMember2024-01-012024-09-300001823466srt:AsiaMember2024-01-012024-09-300001823466note:PublicWarrantsMember2024-01-012024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001823466us-gaap:DevelopedTechnologyRightsMembernote:DragonflyEyeLimitedMember2023-01-270001823466us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001823466note:DragonflyEyeLimitedMember2024-01-012024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100018234662023-03-310001823466note:ExecConnectIntermediateLlcMembernote:BoardOrgBusinessMembernote:PurchaseAgreementMember2024-09-300001823466srt:EuropeMember2023-01-012023-09-300001823466us-gaap:CommonClassAMembernote:PublicWarrantsMember2022-07-290001823466note:PrivatePlacementWarrantsMember2023-01-012023-09-300001823466note:MeasurementInputTimeToMaturityMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2023-12-310001823466us-gaap:MeasurementInputRiskFreeInterestRateMembernote:NewGpoNoteMember2023-12-310001823466srt:EuropeMember2024-01-012024-09-300001823466us-gaap:ConvertibleDebtSecuritiesMember2023-07-012023-09-300001823466us-gaap:CostOfSalesMember2023-01-012023-09-300001823466note:IntangibleAssetsExcludingDevelopedTechnologyMember2023-07-012023-09-300001823466us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-04-012023-06-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001823466us-gaap:MeasurementInputRiskFreeInterestRateMembernote:EraConvertibleNoteMember2023-12-310001823466note:OtherRevenueMember2024-01-012024-09-300001823466us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembernote:PublicWarrantsMember2023-12-310001823466note:SeniorTermLoanMember2023-07-012023-09-300001823466note:PaycheckProtectionProgramLoanMember2020-04-132020-04-130001823466us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001823466us-gaap:CommonClassAMember2023-04-012023-06-300001823466note:ExecConnectIntermediateLlcMembernote:BoardOrgBusinessMembernote:PurchaseAgreementMember2024-03-112024-03-110001823466us-gaap:SalesRevenueNetMemberus-gaap:SalesMemberus-gaap:GeographicConcentrationRiskMember2024-07-012024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2024-07-012024-09-300001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2023-01-012023-01-010001823466us-gaap:CashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466note:AdvisoryAdvertisingAndOtherMember2024-07-012024-09-300001823466srt:NorthAmericaMember2023-07-012023-09-300001823466note:PaycheckProtectionProgramLoanMembernote:CARESActMember2020-04-132020-04-130001823466note:DragonflyEyeLimitedMember2023-01-012023-12-310001823466us-gaap:FairValueInputsLevel3Membernote:NewGpoNoteMember2024-01-012024-09-300001823466note:AntiDilutiveNewGpoNoteMember2023-07-012023-09-300001823466note:SubscriptionMember2024-07-012024-09-300001823466us-gaap:CostOfSalesMember2024-07-012024-09-300001823466note:AicelTechnologiesMemberus-gaap:ConvertibleNotesPayableMember2023-01-012023-09-300001823466us-gaap:CommonClassAMember2023-06-272023-06-270001823466us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembernote:ContingentLiabilitiesFromAcquisitionsMember2023-12-310001823466note:WarrantsAssociatedWithAmendment1Member2024-09-300001823466note:DragonflySellerConvertibleNotesMemberus-gaap:MeasurementInputExpectedTermMember2024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001823466us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001823466us-gaap:CashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466us-gaap:ConvertibleNotesPayableMember2023-01-012023-09-300001823466us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001823466srt:AsiaMember2023-01-012023-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:CustomerRelationshipsMember2023-01-270001823466us-gaap:AccountingStandardsUpdate201613Member2023-01-010001823466note:LastOutLenderWarrantsMember2024-01-012024-09-300001823466note:EarlierOfPrepaymentOrJuly292024Member2023-08-030001823466note:DragonflySellerConvertibleNotesMember2023-01-012023-09-300001823466srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2022-12-310001823466country:AU2023-01-012023-09-300001823466us-gaap:AdvertisingMember2024-07-012024-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMembernote:ShareBasedCompensationAwardTrancheFourMember2024-09-300001823466us-gaap:SellingAndMarketingExpenseMember2023-01-012023-09-300001823466note:SeniorTermLoanMembernote:PriorToJuly302024Member2024-09-300001823466note:AicelConvertibleNoteMember2024-09-300001823466note:OtherRevenueMember2023-01-012023-09-300001823466note:AdvisoryMember2023-07-012023-09-300001823466note:EraConvertibleNoteMember2024-06-300001823466us-gaap:FairValueInputsLevel3Membernote:DragonflySellerConvertibleNotesMember2024-09-3000018234662024-10-012024-09-300001823466us-gaap:CommonClassAMembernote:TwoThousandTwentyFourInducementPlanGrantsMember2024-09-300001823466note:EraConvertibleNoteMember2024-03-310001823466us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:CommonClassAMembernote:EarnoutAwardsMember2024-01-012024-09-300001823466us-gaap:CommonClassBMember2024-01-012024-09-300001823466note:AntiDilutiveAicelConvertibleNotesMember2024-01-012024-09-300001823466note:AdvisoryAdvertisingAndOtherMember2023-01-012023-09-300001823466us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembernote:NewGpoNoteMember2023-12-310001823466us-gaap:MeasurementInputDiscountRateMembernote:EraConvertibleNoteMember2023-12-310001823466us-gaap:MeasurementInputPriceVolatilityMembernote:NewGpoNoteMember2023-12-310001823466us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001823466note:SubscriptionMember2024-01-012024-09-300001823466us-gaap:FairValueMeasurementsRecurringMembernote:PublicWarrantsMember2024-09-300001823466us-gaap:CustomerRelationshipsMember2024-09-300001823466us-gaap:CommonStockMember2023-03-310001823466us-gaap:MeasurementInputDiscountRateMembernote:DragonflySellerConvertibleNotesMember2023-12-3100018234662022-12-310001823466us-gaap:CommonClassBMember2024-11-040001823466us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:EquilibriumMember2024-09-300001823466note:EarnoutAwardsMember2024-01-012024-09-300001823466us-gaap:AccountsPayableMembernote:TwoVendorsMemberus-gaap:SupplierConcentrationRiskMember2023-01-012023-12-310001823466us-gaap:CommonClassAMember2024-09-300001823466us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2024-09-300001823466note:EraConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001823466note:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-09-300001823466us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-01-012023-09-300001823466note:MeasurementInputTimeToMaturityMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2024-09-300001823466note:EraConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2024-01-050001823466note:SeniorTermLoanMember2023-12-310001823466us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-07-012024-09-300001823466us-gaap:FairValueInputsLevel3Member2023-12-310001823466note:TwoThousandTwentyFourInducementPlanGrantsMember2024-07-012024-09-300001823466note:BooksMember2023-01-012023-09-300001823466note:SeniorTermLoanAmendmentNo3Member2023-08-022023-08-020001823466us-gaap:SalesRevenueNetMemberus-gaap:SalesMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-09-300001823466us-gaap:MeasurementInputDiscountRateMembernote:DragonflySellerConvertibleNotesMember2024-09-300001823466note:ConvertiblePromissoryNoteMembernote:DragonflyEyeLimitedMember2023-01-270001823466us-gaap:FairValueInputsLevel3Membernote:EraConvertivleNoteMember2023-12-310001823466note:OtherRevenueMember2023-07-012023-09-300001823466us-gaap:FairValueMeasurementsRecurringMembernote:ContingentLiabilitiesFromAcquisitionsMember2023-12-310001823466us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-07-012024-09-300001823466note:TwoThousandTwentyFourInducementPlanGrantsMemberus-gaap:EmployeeStockOptionMember2024-01-012024-09-300001823466note:PriorToJuly302025Membernote:SeniorTermLoanMember2024-09-300001823466note:ConvertiblePromissoryNoteMembernote:NewGpoNoteMemberus-gaap:CommonClassAMember2024-01-012024-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:CustomerRelationshipsMember2023-01-272023-01-270001823466us-gaap:RetainedEarningsMember2024-03-3100018234662024-07-012024-09-300001823466note:DominqueTaylorMember2024-07-012024-09-300001823466note:AdvisoryMember2024-01-012024-09-300001823466us-gaap:RetainedEarningsMember2024-04-012024-06-300001823466us-gaap:SubsequentEventMember2024-11-122024-11-120001823466us-gaap:RetainedEarningsMember2024-06-3000018234662024-01-012024-09-300001823466note:EnvironmentalSustainabilityAndGovernanceMember2023-01-012023-03-310001823466us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMembernote:VendorMember2024-01-012024-09-300001823466note:AicelTechnologiesMemberus-gaap:ConvertibleNotesPayableMember2023-07-012023-09-300001823466note:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001823466us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-09-300001823466us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-09-300001823466us-gaap:SalesRevenueNetMemberus-gaap:SalesMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001823466us-gaap:FairValueInputsLevel3Membernote:EquilibriumMember2023-12-310001823466note:NewGpoNoteMemberus-gaap:MeasurementInputExpectedTermMember2023-12-310001823466us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466note:TermLoanFacilityMembernote:BoardOrgBusinessMember2024-03-112024-03-110001823466note:ConvertiblePromissoryNoteMembernote:NewGpoNoteMember2024-07-012024-09-300001823466note:DragonflySellerConvertibleNotesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466note:PublicWarrantsMember2023-12-310001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMemberus-gaap:EmployeeStockOptionMember2024-09-300001823466us-gaap:ConvertibleNotesPayableMember2024-09-300001823466us-gaap:ConvertibleNotesPayableMember2024-07-012024-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:TradeNamesMember2023-01-272023-01-270001823466us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembernote:PublicWarrantsMember2024-09-300001823466us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-01-012024-03-310001823466note:PublicWarrantsMember2023-01-012023-09-300001823466note:SeniorTermLoanMembernote:EarlierOfPrepaymentOrJuly292024Member2024-09-300001823466us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001823466note:AntiDilutiveEarnoutAwardsMember2024-07-012024-09-300001823466us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-01-012023-03-310001823466note:EraConvertibleNoteMemberus-gaap:MeasurementInputExpectedTermMember2023-12-310001823466note:CurateMember2023-01-012023-03-310001823466note:PrivatePlacementWarrantsMember2024-07-012024-09-300001823466us-gaap:SalesRevenueNetMemberus-gaap:GovernmentMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-09-300001823466note:PublicWarrantsMember2024-07-012024-09-300001823466us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001823466us-gaap:FairValueInputsLevel3Membernote:DragonflySellerConvertibleNotesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466note:NewGpoNoteMemberus-gaap:MeasurementInputDiscountRateMember2024-09-300001823466note:PublicWarrantsMembernote:ClassACommonStockEqualsOrExceedsDollarElevenPointFourFiveMember2022-07-292022-07-290001823466us-gaap:CommonStockMember2023-09-300001823466us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001823466note:SeniorTermLoanMember2024-09-300001823466note:PrivatePlacementWarrantsMember2023-12-310001823466us-gaap:CommonStockMembernote:EraConvertibleNoteMember2024-06-122024-06-1200018234662027-01-012024-09-300001823466us-gaap:FairValueMeasurementsRecurringMembernote:NewGpoNoteMember2023-12-310001823466note:WarrantsAssociatedWithAmendment1Member2023-03-1700018234662024-04-012024-06-300001823466us-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2023-12-310001823466us-gaap:GeneralAndAdministrativeExpenseMember2023-07-012023-09-300001823466note:TwoThousandTwentyFourInducementPlanGrantsMember2024-01-012024-09-300001823466us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:CommonClassAMembernote:EarnoutAwardsMember2024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2023-12-310001823466note:PrivatePlacementWarrantsMember2024-01-012024-09-300001823466us-gaap:TradeNamesMember2024-09-300001823466us-gaap:SubsequentEventMember2024-11-120001823466note:DragonflyEyeLimitedMemberus-gaap:ConvertibleNotesPayableMember2023-01-012023-09-300001823466us-gaap:CommonStockMember2024-06-300001823466note:PublicWarrantsMember2024-09-300001823466note:EraConvertibleNoteMember2023-12-082023-12-080001823466note:NewGpoNoteMemberus-gaap:MeasurementInputSharePriceMember2024-09-300001823466us-gaap:MeasurementInputPriceVolatilityMembernote:DragonflySellerConvertibleNotesMember2023-12-310001823466us-gaap:RestrictedStockUnitsRSUMembernote:TwoThousandTwentyFourInducementPlanGrantsMember2024-01-012024-09-300001823466note:NewGpoNoteMember2023-06-300001823466us-gaap:ConvertibleNotesPayableMember2023-12-310001823466us-gaap:SellingAndMarketingExpenseMember2024-07-012024-09-300001823466note:SeniorTermLoanAmendmentNo3Member2023-08-032023-08-030001823466us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembernote:NewGpoNoteMember2024-09-300001823466us-gaap:MeasurementInputSharePriceMembernote:DragonflySellerConvertibleNotesMember2024-09-300001823466note:AntiDilutiveContingentlyIssuableSharesMember2023-07-012023-09-300001823466note:EarlierOfPrepaymentOrJuly292023Member2023-08-030001823466note:SeniorTermLoanAmendmentMember2023-03-170001823466note:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember2024-01-012024-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001823466us-gaap:SellingAndMarketingExpenseMember2024-01-012024-09-300001823466note:PublicWarrantsMembernote:ClassACommonStockEqualsOrExceedsDollarElevenPointFourFiveMember2022-07-290001823466note:DragonflyEyeLimitedMember2023-01-272023-01-270001823466us-gaap:ConvertibleDebtSecuritiesMember2024-01-012024-09-300001823466note:NewGpoNoteMember2024-09-300001823466note:ConvertiblePromissoryNoteMembernote:NewGpoNoteMemberus-gaap:CommonClassAMember2024-09-300001823466note:NewGpoNoteMember2023-12-310001823466note:EarnoutRSUsMember2024-01-012024-09-300001823466srt:MaximumMember2024-09-300001823466srt:AsiaMember2024-07-012024-09-300001823466us-gaap:CashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466srt:NorthAmericaMember2024-01-012024-09-3000018234662024-01-012024-03-310001823466note:IntangibleAssetsExcludingDevelopedTechnologyMember2023-01-012023-09-300001823466note:PaycheckProtectionProgramMember2023-12-310001823466us-gaap:GeneralAndAdministrativeExpenseMember2024-07-012024-09-300001823466us-gaap:CommonStockMember2024-07-012024-09-300001823466us-gaap:AccountingStandardsUpdate201613Membersrt:ScenarioPreviouslyReportedMember2022-12-310001823466us-gaap:FairValueInputsLevel3Membernote:DragonflySellerConvertibleNotesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466us-gaap:CommonStockMember2023-12-310001823466note:EraConvertibleNoteMember2024-07-012024-09-300001823466note:PublicWarrantsMembernote:ClassACommonStockEqualsOrExceedsDollarSixPointThreeSixMember2024-01-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:NewGpoNoteMember2024-09-300001823466note:SingleCustomerMemberus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMembercountry:US2024-01-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:DtGlobalMember2023-12-310001823466us-gaap:EmployeeStockOptionMembernote:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-01-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:DragonflySellerConvertibleNotesMember2023-12-310001823466us-gaap:FairValueInputsLevel3Membernote:LiabilityClassifiedWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001823466note:EraConvertibleNoteMember2023-12-310001823466note:EraConvertibleNoteMemberus-gaap:MeasurementInputSharePriceMember2023-12-310001823466us-gaap:CommonStockMember2023-04-012023-06-300001823466us-gaap:RetainedEarningsMember2023-04-012023-06-3000018234662023-04-012023-06-300001823466srt:EuropeMember2024-07-012024-09-300001823466note:AicelTechnologiesMemberus-gaap:SubsequentEventMembernote:PurchaseAgreementMember2024-10-312024-10-310001823466note:NewGpoNoteMember2024-01-012024-09-300001823466us-gaap:CommonClassAMember2024-07-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:EraConvertivleNoteMember2024-01-012024-09-300001823466us-gaap:RestrictedStockUnitsRSUMembernote:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-01-012024-09-300001823466srt:NorthAmericaMember2023-01-012023-09-300001823466us-gaap:CashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466us-gaap:AdvertisingMember2023-07-012023-09-300001823466note:EarnoutSharesMember2024-09-300001823466us-gaap:RetainedEarningsMember2023-06-300001823466note:AntiDilutiveEarnoutAwardsMember2023-07-012023-09-300001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMembersrt:MaximumMember2024-01-012024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001823466us-gaap:FairValueInputsLevel3Membernote:CurateMember2023-12-310001823466note:DragonflySellerConvertibleNotesMember2024-07-012024-09-300001823466note:AntiDilutiveContingentlyIssuableSharesMember2023-01-012023-09-300001823466note:DragonflySellerConvertibleNotesMember2023-12-310001823466note:BooksMember2023-07-012023-09-300001823466us-gaap:ResearchAndDevelopmentExpenseMember2024-07-012024-09-300001823466us-gaap:ShortTermInvestmentsMember2024-07-012024-09-300001823466note:ConvertiblePromissoryNoteMembernote:NewGpoNoteMember2024-09-300001823466us-gaap:RetainedEarningsMember2024-01-012024-03-310001823466note:SeniorTermLoanAmendmentMember2023-03-172023-03-170001823466us-gaap:CommonClassAMember2023-01-012023-03-310001823466us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001823466us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001823466us-gaap:AssetsTotalMembernote:SingleCustomerMembercountry:USus-gaap:GeographicConcentrationRiskMember2023-01-012023-12-310001823466note:NewGpoNoteMember2024-07-012024-09-300001823466us-gaap:PrivatePlacementMember2022-07-290001823466us-gaap:DevelopedTechnologyRightsMember2023-07-012023-09-300001823466us-gaap:CommonClassAMember2024-11-040001823466note:SeniorTermLoanMemberus-gaap:PrimeRateMember2024-01-012024-09-300001823466note:DragonflySellerConvertibleNotesMemberus-gaap:MeasurementInputExpectedTermMember2023-12-310001823466note:AdvisoryMember2024-07-012024-09-300001823466us-gaap:MeasurementInputRiskFreeInterestRateMembernote:DragonflySellerConvertibleNotesMember2023-12-310001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMember2023-01-012023-01-010001823466us-gaap:FairValueInputsLevel2Membernote:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466note:EditorialMember2024-01-012024-09-300001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2024-01-012024-09-300001823466note:DragonflySellerConvertibleNotesMember2023-01-270001823466note:EditorialMember2023-01-012023-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001823466note:DragonflyEyeLimitedMemberus-gaap:ConvertibleNotesPayableMember2024-07-012024-09-300001823466srt:AsiaMember2023-07-012023-09-300001823466note:BoardOrgBusinessMember2024-03-112024-03-110001823466us-gaap:DevelopedTechnologyRightsMember2024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2024-09-300001823466note:NewFiscalNoteMemberus-gaap:CommonClassAMembersrt:MaximumMember2022-07-290001823466note:NoVendorsMemberus-gaap:SupplierConcentrationRiskMembernote:PurchasesMember2023-01-012023-09-300001823466note:ExpertNetworkMember2024-09-300001823466us-gaap:FairValueMeasurementsRecurringMembernote:PublicWarrantsMember2023-12-310001823466note:EraConvertibleNoteMember2024-01-012024-09-300001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001823466us-gaap:PrivatePlacementMember2024-01-012024-09-300001823466us-gaap:CommonClassAMembernote:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2024-09-300001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-01-012024-09-300001823466us-gaap:CommonClassAMember2023-12-310001823466us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-01-012024-09-300001823466us-gaap:ShortTermInvestmentsMember2023-07-012023-09-300001823466us-gaap:FairValueInputsLevel3Membernote:ContingentLiabilitiesFromAcquisitionsMember2024-01-012024-09-300001823466note:PaycheckProtectionProgramLoanMembernote:CARESActMember2020-04-130001823466note:PaycheckProtectionProgramLoanMember2022-02-140001823466note:PrivatePlacementWarrantsMember2024-09-300001823466note:AntiDilutiveAicelConvertibleNotesMember2023-07-012023-09-300001823466note:EraConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2024-09-300001823466note:AicelTechnologiesMemberus-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2023-03-310001823466us-gaap:CommonStockMember2022-12-310001823466note:EditorialMember2023-07-012023-09-3000018234662024-03-310001823466note:AntiDilutiveDragonflySellerConvertibleNotesMember2024-01-012024-09-300001823466us-gaap:DatabasesMember2023-12-310001823466us-gaap:CommonClassAMembernote:EarnoutAwardsMembernote:ShareBasedCompensationAwardTrancheFourMember2024-01-012024-09-300001823466note:NorthlandSecuritiesIncMemberus-gaap:SubsequentEventMember2024-11-122024-11-120001823466note:EarnoutSharesMember2024-01-012024-09-300001823466us-gaap:MeasurementInputPriceVolatilityMembernote:DragonflySellerConvertibleNotesMember2024-09-300001823466us-gaap:MeasurementInputSharePriceMemberus-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2024-09-300001823466note:NewGpoNoteMemberus-gaap:MeasurementInputExpectedTermMember2024-09-3000018234662025-01-012024-09-3000018234662024-06-300001823466note:ContentLibraryMember2023-12-310001823466note:EraConvertibleNoteMember2023-12-080001823466note:AicelTechnologiesMemberus-gaap:ConvertibleNotesPayableMember2024-07-012024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001823466us-gaap:RestrictedStockUnitsRSUMembernote:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-09-3000018234662023-09-300001823466us-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2023-12-310001823466note:PaycheckProtectionProgramLoanMember2024-09-300001823466us-gaap:MeasurementInputRiskFreeInterestRateMembernote:NewGpoNoteMember2024-09-3000018234662023-06-300001823466note:SeniorTermLoanAmendmentMemberus-gaap:CommonClassAMember2023-03-172023-03-170001823466note:EraConvertibleNoteMemberus-gaap:ConvertibleNotesPayableMember2023-12-080001823466note:AntiDilutiveEarnoutAwardsMember2023-01-012023-09-300001823466us-gaap:RetainedEarningsMember2024-09-300001823466us-gaap:MeasurementInputPriceVolatilityMembernote:NewGpoNoteMember2024-09-300001823466note:ExpertNetworkMember2023-12-310001823466note:NewGpoNoteMemberus-gaap:MeasurementInputSharePriceMember2023-12-310001823466note:TwoThousandTwentyTwoLongTermIncentivePlanMember2023-01-012023-09-300001823466us-gaap:RetainedEarningsMember2023-03-310001823466us-gaap:AdditionalPaidInCapitalMember2023-09-300001823466us-gaap:PrivatePlacementMember2024-09-300001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2024-01-012024-01-010001823466us-gaap:FairValueInputsLevel3Member2024-09-300001823466us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001823466us-gaap:CommonStockMembernote:LastOutLenderWarrantsMember2024-09-300001823466us-gaap:CommonStockMember2024-09-300001823466note:PerformanceStockOptionsMembernote:TwoThousandTwentyTwoLongTermIncentivePlanMember2024-09-300001823466us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466note:DragonflySellerConvertibleNotesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001823466note:BooksMember2024-07-012024-09-300001823466note:AicelConvertibleNoteMember2023-12-310001823466us-gaap:CommonClassBMember2024-09-300001823466note:DragonflyEyeLimitedMemberus-gaap:ConvertibleNotesPayableMember2023-07-012023-09-300001823466us-gaap:CommonStockMember2024-03-310001823466us-gaap:AdvertisingMember2024-01-012024-09-300001823466note:NewGpoNoteMemberus-gaap:MeasurementInputDiscountRateMember2023-12-3100018234662023-07-012023-09-300001823466note:SeniorTermLoanMembernote:OnOrAfterJuly302025Member2024-09-300001823466country:AU2024-01-012024-09-300001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2024-01-012024-09-300001823466us-gaap:MeasurementInputSharePriceMembernote:DragonflySellerConvertibleNotesMember2023-12-310001823466us-gaap:SalesRevenueNetMemberus-gaap:SalesMemberus-gaap:GeographicConcentrationRiskMember2023-07-012023-09-300001823466srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201613Member2023-01-010001823466srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-12-310001823466us-gaap:CommonClassAMember2024-04-012024-06-300001823466us-gaap:CommonClassBMember2023-12-310001823466us-gaap:ConvertibleNotesPayableMember2024-01-012024-09-300001823466note:AdvisoryMember2023-01-012023-09-300001823466note:NewGpoNoteMember2023-07-012023-09-300001823466us-gaap:FairValueInputsLevel3Membernote:LiabilityClassifiedWarrantsMember2024-01-012024-09-300001823466us-gaap:RetainedEarningsMember2023-09-300001823466us-gaap:PatentsMember2023-12-310001823466us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001823466note:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001823466us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-07-012023-09-300001823466us-gaap:MeasurementInputPriceVolatilityMembernote:EraConvertibleNoteMember2023-12-3100018234662028-01-012024-09-300001823466note:ExecConnectIntermediateLlcMembernote:BoardOrgBusinessMembernote:PurchaseAgreementMember2024-06-060001823466us-gaap:FairValueMeasurementsRecurringMembernote:ContingentLiabilitiesFromAcquisitionsMember2024-09-300001823466note:EraConvertibleNoteMemberus-gaap:SubsequentEventMemberus-gaap:SeniorSubordinatedNotesMember2024-11-120001823466note:TwoThousandTwentyTwoEmployeeStockPurchasePlanMember2023-01-012023-09-300001823466note:AdvisoryAdvertisingAndOtherMember2024-01-012024-09-300001823466us-gaap:CommonClassAMembernote:TwoThousandTwentyTwoLongTermIncentivePlanMember2022-07-270001823466us-gaap:AdditionalPaidInCapitalMember2024-06-300001823466us-gaap:CommonStockMembernote:EraConvertibleNoteMember2024-06-252024-06-250001823466us-gaap:ShortTermInvestmentsMember2024-09-300001823466note:AntiDilutiveContingentlyIssuableSharesMember2024-01-012024-09-30note:TradingDayxbrli:purexbrli:sharesnote:Segmentiso4217:GBPiso4217:USDiso4217:USDxbrli:sharesnote:Acquisitionutr:Y

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

img140592801_0.jpg

FISCALNOTE HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-396972

88-3772307

(State or other jurisdiction of

incorporation or organization)

(Commission File Number)

(I.R.S. Employer
Identification No.)

1201 Pennsylvania Avenue NW, 6th Floor,

Washington, D.C. 20004

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (202) 793-5300

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Class A common stock, par value $0.0001 per share

NOTE

NYSE

Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share

 

NOTE.WS

 

NYSE

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

 

☒

 

Non-accelerated filer

☐

Smaller reporting company

☒

Emerging growth company

☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of November 4, 2024, the registrant had 132,925,259 shares of Class A common stock, $0.0001 par value per share, outstanding, and 8,290,921 shares of Class B common Stock, $0.0001 par value per share, outstanding.

 

 

 


Table of Contents

 

 

FISCALNOTE HOLDINGS, INC.

FORM 10-Q TABLE OF CONTENTS

 

 

 

Page No.

Cautionary Note Regarding Forward-Looking Statements

1

 

 

PART I. Financial Information (Unaudited, except as noted below):

 

Item 1. Financial Statements

 

Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 (Audited)

3

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

4

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)

5

Condensed Consolidated Statements of Cash Flows

6

Notes to Condensed Consolidated Financial Statements

7

 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

27

Item 3. Quantitative and Qualitative Disclosures About Market Risks

42

Item 4. Controls and Procedures

42

 

 

Part II. OTHER INFORMATION

44

 

 

Item 1. Legal Proceedings

44

Item 1A. Risk Factors

44

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

44

Item 3. Defaults upon Senior Securities

44

Item 4. Mine Safety Disclosures

44

Item 5. Other Information

44

Item 6. Exhibits

45

 

 

SIGNATURES

47

 

 

 

 


Table of Contents

 

Forward-Looking Statements

This Quarterly Report on Form 10-Q includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.” These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They may appear in a number of places throughout this Quarterly Report on Form 10-Q, including Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 1A, “Risk Factors,” and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our future results of operations, financial condition and liquidity; our prospects, growth, strategies and the markets in which FiscalNote operates. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting FiscalNote. Factors that may impact such forward-looking statements include:

•
FiscalNote's ability to achieve and sustain organic growth;
•
changes in FiscalNote's strategy, future operations, financial position, estimated revenue and losses, forecasts, projected costs, prospects and plans;
•
FiscalNote's future capital requirements;
•
FiscalNote’s ability to service its repayment obligations and maintain compliance with covenants and restrictions under its existing debt agreements;
•
demand for FiscalNote's services and the drivers of that demand;
•
FiscalNote's ability to provide highly useful, reliable, secure and innovative products and services to its customers;
•
FiscalNote's ability to attract new customers, retain existing customers, expand its products and service offerings with existing customers, expand into geographic markets or identify areas of higher growth;
•
any cost reduction initiatives undertaken by FiscalNote;
•
FiscalNote's ability to successfully integrate acquired businesses and services, and subsequently grow acquired businesses;
•
risks associated with international operations, including compliance complexity and costs, increased exposure to fluctuations in currency exchange rates, political, social and economic instability, and supply chain disruptions;
•
FiscalNote's ability to develop, enhance, and integrate its existing platforms, products, and services;
•
FiscalNote's estimated total addressable market and other industry and performance projections;
•
FiscalNote's reliance on third-party systems and data, its ability to integrate such systems and data with its solutions and its potential inability to continue to support integration;
•
potential technical disruptions, cyberattacks, security, privacy or data breaches or other technical or security incidents that affect FiscalNote's networks or systems or those of its service providers;
•
FiscalNote's ability to obtain and maintain accurate, comprehensive, or reliable data to support its products and services;
•
FiscalNote's ability to introduce new features, integrations, capabilities, and enhancements to its products and services;
•
FiscalNote's ability to maintain and improve its methods and technologies, and anticipate new methods or technologies, for data collection, organization, and analysis to support its products and services;
•
competition and competitive pressures in the markets in which FiscalNote operates; including larger well-funded companies shifting their existing business models to become more competitive with FiscalNote;
•
FiscalNote's ability to protect and maintain its brands;
•
FiscalNote's ability to comply with laws and regulations in connection with selling products and services to U.S. and foreign governments and other highly regulated industries;
•
FiscalNote's ability to retain or recruit key personnel;
•
FiscalNote's ability to effectively maintain and grow its research and development team and conduct research and development;
•
FiscalNote's ability to adapt its products and services for changes in laws and regulations or public perception, or changes in the enforcement of such laws, relating to artificial intelligence, machine learning, data privacy and government contracts;
•
adverse general economic and market conditions reducing spending on our products and services;
•
the outcome of any known and unknown litigation and regulatory proceedings;
•
FiscalNote's ability to successfully establish and maintain public company-quality internal control over financial reporting;

the ability to adequately protect FiscalNote's intellectual property rights; and

•
the possibility that the strategic review undertaken by the Board of Directors does not result in any transaction or other outcome or that any outcome is disruptive to operations and impacts financial performance.

The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of this Quarterly Report on Form 10-Q and the other documents filed by us from

1


Table of Contents

 

time to time with the U.S. Securities and Exchange Commission ("SEC"). The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on current expectations and beliefs concerning future developments and their potential effects on us and our business. There can be no assurance that future developments affecting us will be those that we have anticipated. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

2


Table of Contents

 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

FISCALNOTE HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(in thousands, except shares, and par value)

 

 

 

(Unaudited)

 

 

 

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

25,688

 

 

$

16,451

 

Restricted cash

 

 

683

 

 

 

849

 

Short-term investments

 

 

7,040

 

 

 

7,134

 

Accounts receivable, net

 

 

11,249

 

 

 

16,931

 

Costs capitalized to obtain revenue contracts, net

 

 

3,078

 

 

 

3,326

 

Prepaid expenses

 

 

3,210

 

 

 

2,593

 

Other current assets

 

 

3,414

 

 

 

2,521

 

Total current assets

 

 

54,362

 

 

 

49,805

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

5,444

 

 

 

6,141

 

Capitalized software costs, net

 

 

14,895

 

 

 

13,372

 

Noncurrent costs capitalized to obtain revenue contracts, net

 

 

3,347

 

 

 

4,257

 

Operating lease assets

 

 

17,062

 

 

 

17,782

 

Goodwill

 

 

165,964

 

 

 

187,703

 

Customer relationships, net

 

 

44,164

 

 

 

53,917

 

Database, net

 

 

17,208

 

 

 

18,838

 

Other intangible assets, net

 

 

15,005

 

 

 

18,113

 

Other non-current assets

 

 

498

 

 

 

633

 

Total assets

 

$

337,949

 

 

$

370,561

 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Current maturities of long-term debt

 

$

10,018

 

 

$

105

 

Accounts payable and accrued expenses

 

 

7,635

 

 

 

12,909

 

Deferred revenue, current portion

 

 

40,257

 

 

 

43,530

 

Customer deposits

 

 

1,136

 

 

 

3,032

 

Contingent liabilities from acquisitions, current portion

 

 

114

 

 

 

130

 

Operating lease liabilities, current portion

 

 

3,650

 

 

 

3,066

 

Other current liabilities

 

 

3,976

 

 

 

2,878

 

Total current liabilities

 

 

66,786

 

 

 

65,650

 

 

 

 

 

 

 

 

Long-term debt, net of current maturities

 

 

142,152

 

 

 

222,310

 

Deferred tax liabilities

 

 

1,266

 

 

 

2,178

 

Deferred revenue, net of current portion

 

 

134

 

 

 

875

 

Operating lease liabilities, net of current portion

 

 

23,982

 

 

 

26,162

 

Public and private warrant liabilities

 

 

2,304

 

 

 

4,761

 

Other non-current liabilities

 

 

2,808

 

 

 

5,166

 

Total liabilities

 

 

239,432

 

 

 

327,102

 

Commitment and contingencies (Note 17)

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

Class A Common stock ($0.0001 par value, 1,700,000,000 authorized, 132,584,083 and 121,679,829 issued and outstanding at September 30, 2024 and December 31, 2023, respectively)

 

 

13

 

 

 

11

 

Class B Common stock ($0.0001 par value, 9,000,000 authorized, 8,290,921 issued and outstanding at September 30, 2024 and December 31, 2023, respectively)

 

 

1

 

 

 

1

 

Additional paid-in capital

 

 

885,872

 

 

 

860,485

 

Accumulated other comprehensive income (loss)

 

 

6,147

 

 

 

(622

)

Accumulated deficit

 

 

(793,516

)

 

 

(816,416

)

Total stockholders' equity

 

 

98,517

 

 

 

43,459

 

Total liabilities and stockholders' equity

 

$

337,949

 

 

$

370,561

 

See accompanying notes to unaudited condensed consolidated financial statements.

3


Table of Contents

 

FISCALNOTE HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(in thousands, except shares and per share data)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Subscription

 

$

27,238

 

 

$

30,057

 

 

$

84,015

 

 

$

87,986

 

Advisory, advertising, and other

 

 

2,201

 

 

 

3,952

 

 

 

6,782

 

 

 

10,394

 

Total revenues

 

 

29,439

 

 

 

34,009

 

 

 

90,797

 

 

 

98,380

 

Operating expenses: (1)

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues, including amortization

 

 

6,235

 

 

 

10,441

 

 

 

20,342

 

 

 

28,863

 

Research and development

 

 

3,250

 

 

 

4,540

 

 

 

9,935

 

 

 

14,170

 

Sales and marketing

 

 

9,068

 

 

 

11,235

 

 

 

27,484

 

 

 

35,222

 

Editorial

 

 

4,639

 

 

 

4,516

 

 

 

13,752

 

 

 

13,533

 

General and administrative

 

 

10,622

 

 

 

14,418

 

 

 

37,958

 

 

 

48,813

 

Amortization of intangible assets

 

 

2,436

 

 

 

2,899

 

 

 

7,541

 

 

 

8,614

 

Impairment of goodwill

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,837

 

Transaction (gains) costs, net

 

 

-

 

 

 

(579

)

 

 

(4

)

 

 

1,138

 

Total operating expenses

 

 

36,250

 

 

 

47,470

 

 

 

117,008

 

 

 

156,190

 

Operating loss

 

 

(6,811

)

 

 

(13,461

)

 

 

(26,211

)

 

 

(57,810

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of business (Note 4)

 

 

-

 

 

 

-

 

 

 

(71,599

)

 

 

-

 

Interest expense, net

 

 

5,585

 

 

 

8,018

 

 

 

18,267

 

 

 

21,853

 

Change in fair value of financial instruments

 

 

3,501

 

 

 

(7,157

)

 

 

3,174

 

 

 

(18,850

)

Loss on settlement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,474

 

Other (income) expense, net

 

 

(341

)

 

 

207

 

 

 

(82

)

 

 

245

 

Net (loss) income before income taxes

 

 

(15,556

)

 

 

(14,529

)

 

 

24,029

 

 

 

(64,532

)

(Benefit) provision from income taxes

 

 

(621

)

 

 

(62

)

 

 

1,129

 

 

 

181

 

Net (loss) income

 

 

(14,935

)

 

 

(14,467

)

 

 

22,900

 

 

 

(64,713

)

Other comprehensive income (loss)

 

 

1,123

 

 

 

(1,006

)

 

 

1,062

 

 

 

(1,037

)

Total comprehensive (loss) income

 

$

(13,812

)

 

$

(15,473

)

 

$

23,962

 

 

$

(65,750

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share attributable to common shareholders (Note 14):

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

$

(0.11

)

 

$

(0.11

)

 

$

0.17

 

 

$

(0.49

)

Weighted average shares used in computing earnings (loss) per share attributable to common shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

 

135,050,093

 

 

 

128,832,502

 

 

 

135,160,124

 

 

 

131,994,563

 

 

(1) Amounts include stock-based compensation expenses, as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenues, including amortization

 

$

116

 

 

$

45

 

 

$

324

 

 

$

185

 

Research and development

 

 

454

 

 

 

328

 

 

 

1,138

 

 

 

1,080

 

Sales and marketing

 

 

486

 

 

 

1,041

 

 

 

1,182

 

 

 

1,718

 

Editorial

 

 

200

 

 

 

120

 

 

 

465

 

 

 

292

 

General and administrative

 

 

2,925

 

 

 

4,690

 

 

 

10,776

 

 

 

14,937

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

4


Table of Contents

 

FISCALNOTE HOLDINGS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

(in thousands, except share data)

(Unaudited)

 

 

Equity (Deficit)

 

 

Common Stock

 

Additional paid-in capital

 

Accumulated other comprehensive loss

 

Accumulated deficit

 

Total stockholders' equity (deficit)

 

 

Shares

 

Amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2022

 

131,416,516

 

 

13

 

 

846,205

 

 

(785

)

 

(700,743

)

 

144,690

 

Adoption of new accounting standard

 

-

 

 

-

 

 

-

 

 

-

 

 

(212

)

 

(212

)

Issuance of Class A common stock in connection with business acquisitions

 

1,885,149

 

 

-

 

 

9,539

 

 

-

 

 

-

 

 

9,539

 

Issuance of Class A common stock upon vesting of restricted share units

 

287,157

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Issuance of Class A common stock upon exercise of stock options

 

194,775

 

 

-

 

 

264

 

 

-

 

 

-

 

 

264

 

Issuance of Class A common stock upon settlement of contingent consideration

 

83,393

 

 

-

 

 

196

 

 

-

 

 

-

 

 

196

 

Stock-based compensation expense

 

-

 

 

-

 

 

6,506

 

 

-

 

 

-

 

 

6,506

 

Withholding taxes on net share settlement of stock-based compensation and option exercises

 

-

 

 

-

 

 

(917

)

 

-

 

 

-

 

 

(917

)

Net loss

 

-

 

 

-

 

 

-

 

 

-

 

 

(19,273

)

 

(19,273

)

Foreign currency translation loss

 

-

 

 

-

 

 

-

 

 

(359

)

 

-

 

 

(359

)

Balance at March 31, 2023

 

133,866,990

 

$

13

 

$

861,793

 

$

(1,144

)

$

(720,228

)

$

140,434

 

Issuance of Class A common stock upon vesting of restricted share units

 

478,619

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Issuance of Class A common stock upon employee stock purchase plan

 

102,807

 

 

-

 

 

318

 

 

 

 

 

 

318

 

Issuance of Class A common stock upon exercise of stock options

 

8,437

 

 

-

 

 

35

 

 

-

 

 

-

 

 

35

 

Stock-based compensation expense

 

-

 

 

-

 

 

5,482

 

 

-

 

 

-

 

 

5,482

 

Withholding taxes on net share settlement of stock-based compensation and option exercises

 

-

 

 

-

 

 

(494

)

 

-

 

 

-

 

 

(494

)

Return of common stock (Note 17)

 

(5,881,723

)

 

(1

)

 

(21,409

)

 

-

 

 

-

 

 

(21,410

)

Net loss

 

-

 

 

-

 

 

-

 

 

-

 

 

(30,973

)

 

(30,973

)

Foreign currency translation gain

 

-

 

 

-

 

 

-

 

 

328

 

 

-

 

 

328

 

Balance at June 30, 2023

 

128,575,130

 

$

12

 

$

845,725

 

$

(816

)

$

(751,201

)

$

93,720

 

Issuance of Class A common stock upon vesting of restricted share units

 

313,090

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Issuance of Class A common stock upon exercise of stock options

 

7,529

 

 

-

 

 

33

 

 

-

 

 

-

 

 

33

 

Stock-based compensation expense

 

-

 

 

-

 

 

5,590

 

 

-

 

 

-

 

 

5,590

 

Withholding taxes on net share settlement of stock-based compensation and option exercises

 

-

 

 

-

 

 

(301

)

 

-

 

 

-

 

 

(301

)

Net loss

 

-

 

 

-

 

 

-

 

 

-

 

 

(14,467

)

 

(14,467

)

Foreign currency translation gain

 

-

 

 

-

 

 

-

 

 

(1,006

)

 

-

 

 

(1,006

)

Balance at September 30, 2023

 

128,895,749

 

$

12

 

$

851,047

 

$

(1,822

)

$

(765,668

)

$

83,569

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2023

 

129,970,750

 

 

12

 

 

860,485

 

 

(622

)

 

(816,416

)

 

43,459

 

Issuance of Class A common stock upon vesting of restricted share units

 

867,341

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Issuance of Class A common stock upon exercise of employee stock purchase plan

 

202,327

 

 

-

 

 

196

 

 

-

 

 

-

 

 

196

 

Stock-based compensation expense

 

-

 

 

-

 

 

6,175

 

 

-

 

 

-

 

 

6,175

 

Withholding taxes on net share settlement of stock-based compensation and option exercises

 

-

 

 

-

 

 

76

 

 

-

 

 

-

 

 

76

 

Change in fair value of debt instruments (Note 16)

 

-

 

 

-

 

 

-

 

 

5,707

 

 

-

 

 

5,707

 

Net income

 

-

 

 

-

 

 

-

 

 

-

 

 

50,599

 

 

50,599

 

Foreign currency translation loss

 

-

 

 

-

 

 

-

 

 

(116

)

 

-

 

 

(116

)

Balance at March 31, 2024

 

131,040,418

 

$

12

 

$

866,932

 

$

4,969

 

$

(765,817

)

$

106,096

 

Issuance of Class A common stock upon vesting of restricted share units

 

1,292,237

 

 

1

 

 

-

 

 

-

 

 

-

 

 

1

 

Note conversion

 

6,852,099

 

 

1

 

 

9,966

 

 

 

 

-

 

 

9,967

 

Stock-based compensation expense

 

-

 

 

-

 

 

3,529

 

 

-

 

 

-

 

 

3,529

 

Withholding taxes on net share settlement of stock-based compensation and option exercises

 

-

 

 

-

 

 

8

 

 

-

 

 

-

 

 

8

 

Net loss

 

-

 

 

-

 

 

 

 

-

 

 

(12,764

)

 

(12,764

)

Foreign currency translation gain

 

-

 

 

-

 

 

 

 

55

 

 

-

 

 

55

 

Balance at June 30, 2024

 

139,184,754

 

$

14

 

$

880,435

 

$

5,024

 

$

(778,581

)

$

106,892

 

Issuance of Class A common stock upon vesting of restricted share units

 

597,575

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Issuance of Class A common stock upon exercise of employee stock purchase plan

 

307,538

 

 

-

 

 

275

 

 

-

 

 

-

 

 

275

 

Issuance of Class A common stock upon exercise of stock options

 

-

 

 

-

 

 

3

 

 

-

 

 

-

 

 

3

 

Shares issued to satisfy interest on GPO Note

 

785,137

 

 

-

 

 

967

 

 

-

 

 

-

 

 

967

 

Stock-based compensation expense

 

-

 

 

-

 

 

4,181

 

 

-

 

 

-

 

 

4,181

 

Withholding taxes on net share settlement of stock-based compensation and option exercises

 

-

 

 

-

 

 

11

 

 

-

 

 

-

 

 

11

 

Net loss

 

-

 

 

-

 

 

-

 

 

-

 

 

(14,935

)

 

(14,935

)

Foreign currency translation gain

 

-

 

 

-

 

 

-

 

 

1,123

 

 

-

 

 

1,123

 

Balance at September 30, 2024

 

140,875,004

 

$

14

 

$

885,872

 

$

6,147

 

$

(793,516

)

$

98,517

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

5


Table of Contents

 

FISCALNOTE HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

Operating Activities:

 

 

 

 

 

 

Net income (loss)

 

$

22,900

 

 

$

(64,713

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

Depreciation

 

 

905

 

 

 

1,007

 

Amortization of intangible assets and capitalized software development costs

 

 

14,699

 

 

 

19,068

 

Amortization of deferred costs to obtain revenue contracts

 

 

2,795

 

 

 

2,602

 

Gain on sale of business (Note 4)

 

 

(71,599

)

 

 

-

 

Impairment of goodwill

 

 

-

 

 

 

5,837

 

Non-cash operating lease expense

 

 

1,567

 

 

 

2,885

 

Stock-based compensation

 

 

13,885

 

 

 

18,212

 

Loss on settlement

 

 

-

 

 

 

3,474

 

Other non-cash expenses

 

 

4

 

 

 

(688

)

Bad debt expense

 

 

201

 

 

 

267

 

Change in fair value of acquisition contingent consideration

 

 

(4

)

 

 

(138

)

Unrealized loss on securities

 

 

95

 

 

 

115

 

Change in fair value of financial instruments

 

 

3,174

 

 

 

(18,850

)

Deferred income taxes

 

 

(838

)

 

 

(80

)

Paid-in-kind interest, net

 

 

5,995

 

 

 

3,987

 

Non-cash interest expense

 

 

2,244

 

 

 

3,035

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable, net

 

 

4,149

 

 

 

2,560

 

Prepaid expenses and other current assets

 

 

(1,429

)

 

 

1,935

 

Costs capitalized to obtain revenue contracts, net

 

 

(2,155

)

 

 

(3,263

)

Other non-current assets

 

 

163

 

 

 

(119

)

Accounts payable and accrued expenses

 

 

(3,047

)

 

 

(6,389

)

Deferred revenue

 

 

4,796

 

 

 

6,141

 

Customer deposits

 

 

(928

)

 

 

(2,182

)

Other current liabilities

 

 

1,082

 

 

 

(754

)

Contingent liabilities from acquisitions, net of current portion

 

 

(13

)

 

 

(39

)

Operating lease liabilities

 

 

(2,538

)

 

 

(5,844

)

Other non-current liabilities

 

 

(53

)

 

 

(6

)

Net cash used in operating activities

 

 

(3,950

)

 

 

(31,940

)

 

 

 

 

 

 

 

Investing Activities:

 

 

 

 

 

 

Capital expenditures

 

 

(6,875

)

 

 

(5,957

)

Purchases of short-term investments

 

 

-

 

 

 

(7,369

)

Cash proceeds from the sale of business, net (Note 4)

 

 

91,384

 

 

 

-

 

Cash paid for business acquisitions, net of cash acquired

 

 

-

 

 

 

(5,010

)

Net cash provided by (used in) investing activities

 

 

84,509

 

 

 

(18,336

)

 

 

 

 

 

 

 

Financing Activities:

 

 

 

 

 

 

Proceeds from long-term debt, net of issuance costs

 

 

801

 

 

 

6,000

 

Principal payments of long-term debt

 

 

(65,781

)

 

 

(80

)

Payment of deferred financing costs

 

 

(7,068

)

 

 

-

 

Proceeds from exercise of stock options and employee stock purchase plan purchases

 

 

474

 

 

 

650

 

Net cash (used in) provided by financing activities

 

 

(71,574

)

 

 

6,570

 

 

 

 

 

 

 

 

Effects of exchange rates on cash

 

 

86

 

 

 

(184

)

 

 

 

 

 

 

 

Net change in cash, cash equivalents, and restricted cash

 

 

9,071

 

 

 

(43,890

)

Cash, cash equivalents, and restricted cash, beginning of period

 

 

17,300

 

 

 

61,223

 

Cash, cash equivalents, and restricted cash, end of period

 

$

26,371

 

 

$

17,333

 

 

 

 

 

 

 

 

Supplemental Noncash Investing and Financing Activities:

 

 

 

 

 

 

Issuance of common stock for conversion of debt and interest

 

$

10,934

 

 

$

-

 

Warrants issued in conjunction with long-term debt issuance

 

$

-

 

 

$

178

 

Amounts held in escrow related to the sale of Board.org

 

$

285

 

 

$

-

 

Property and equipment purchases included in accounts payable

 

$

74

 

 

$

323

 

 

 

 

 

 

 

 

Supplemental Cash Flow Activities:

 

 

 

 

 

 

Cash paid for interest

 

$

11,723

 

 

$

15,290

 

Cash paid for taxes

 

$

277

 

 

$

16

 

See accompanying notes to unaudited condensed consolidated financial statements.

6


 

FISCALNOTE HOLDINGS, INC.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except shares, par value, per share amounts, or as otherwise noted)

(Unaudited)

Note 1. Summary of Business and Significant Accounting Policies

Description of Business

FiscalNote Holdings, Inc. (“FiscalNote,” or the “Company”) is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political, regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups, and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products. The Company is headquartered in Washington, D.C.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances have been eliminated in consolidation.

These condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s balance sheet and its results of operations, including its comprehensive loss, temporary equity, stockholders' equity (deficit), and cash flows. All adjustments are of a normal recurring nature. The results for the nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for any subsequent quarter or for the fiscal year ending December 31, 2024. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.

Liquidity and Going Concern

In accordance with Accounting Standards Codification Topic 205-40, Going Concern, the Company evaluates whether there are certain conditions and events, considered in the aggregate, which raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s cash, cash equivalents, restricted cash, and short-term investments were $33.4 million at September 30, 2024, compared with $24.4 million at December 31, 2023. Further, the Company had a negative working capital balance of $45.8 million (excluding cash and short-term investments) at September 30, 2024 and had an accumulated deficit of $793.5 million and $816.4 million as of September 30, 2024 and December 31, 2023, respectively, and has incurred net losses of $48.7 million (excluding the effect of the gain on sale of business) and $64.7 million for the nine months ended September 30, 2024 and 2023, respectively. Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, future acquisitions, and infrastructure and product development. Historically, the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt and selling assets, including the receipt of approximately $18.1 million of net cash proceeds that were retained by the Company for operating matters from the sale of Board.org, see Note 4, Acquisitions and Dispositions.

The Company has implemented various cost saving measures throughout 2023 and during 2024 to rationalize its cost structure and is actively evaluating additional cost saving opportunities and sources of capital. As there can be no assurance that cost saving measures and necessary financing will be available, the Company may execute other strategic alternatives to maximize stakeholder value, including further expense reductions, sale of all or portions of the business, corporate capital restructuring or formal reorganization, or liquidation of assets.

As disclosed in Note 8, “Debt”, the Company is subject to certain financial covenants. The Company’s ability to maintain compliance with these financial covenants is based on the Company’s current expectations regarding revenues, collections, cost structure, current cash burn rate and other operating assumptions, which in part, depend on general economic, financial, competitive, legislative, regulatory, and other conditions. Within one year from the date of this filing, without any actions taken by management and lenders, it is probable that the Company may not be compliant with one, or all, of its financial covenants. At the time that the Company does not maintain compliance with all of its financial covenants, the lenders may declare the amounts outstanding due and payable at which time the Company would not be able to satisfy the lenders rights. Accordingly, the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year from the date of this filing.

There can be no assurance that any necessary additional financing in the future will be available on terms acceptable to the Company, or at all. If the Company raises funds in the future by issuing equity securities, dilution to stockholders will occur and may be substantial. Any equity securities issued may also provide for rights, preferences, or privileges senior to those of holders of common stock. If the Company raises funds in the future by issuing additional debt securities, these debt securities could have rights, preferences, and privileges senior to those of preferred and common stockholders. The terms of any additional debt securities or borrowings could impose significant restrictions on the Company’s operations. The capital markets have experienced in the past, and may experience in the future, periods of upheaval that could impact the availability and cost of equity and debt financing.

7

 


Table of Contents

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

Segments

The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. Over the past several years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence, and reach in various market segments. While the Company has offerings in multiple market segments and operates in multiple countries, the Company’s business operates in one operating segment because the Company’s CODM evaluates the Company’s financial information and resources, and assesses the performance of these resources, on a consolidated basis.

Earnings per Share

Basic earnings per share (EPS) is calculated by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period without consideration for common stock equivalents. Diluted EPS is computed by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period and the weighted average number of dilutive common stock equivalents outstanding for the period determined using the if-converted method (convertible debt instruments) or treasury-stock method (warrants and share-based payment arrangements). For purposes of this calculation, common stock issuable upon conversion of debt, options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share when their effect is dilutive.

Fair Value of Financial Instruments

The Company has elected the fair value option on the subordinated convertible promissory notes issued as part of the Dragonfly acquisition, refer to Note 4, "Acquisitions and Dispositions" and Note 8, "Debt" for further details, and for the New GPO Note and Era Convertible Notes, refer to Note 8, "Debt" for further details. The Company records changes in fair value through the condensed consolidated statement of operations where the portion of the change that results from a change in the instrument-specific credit risk is recorded separately in accumulated other comprehensive income, if applicable. Additionally, under the fair value option, all issuance costs are expensed in the period that the debt is incurred.

Investments

The Company has invested in highly liquid investments that have investment-grade ratings. These investments are accounted for at fair value through the condensed consolidated statement of operations. The Company is able to easily liquidate these into cash; accordingly, the Company has presented these investments as available for current operations and are presented as short-term investments within current assets in the condensed consolidated balance sheets. Purchases and sales of short-term investments are classified in the investing section of our consolidated statement of cash flows.

Concentrations of Risks

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company generally maintains its cash and cash equivalents with various nationally recognized financial institutions. The Company’s cash and cash equivalents at times exceed amounts guaranteed by the Federal Deposit Insurance Corporation. The Company considers cash on deposit and all highly liquid investments with original maturities of three months or less to be cash and cash equivalents. At September 30, 2024, approximately 47% of the Company’s cash and cash equivalents were held at JPMorgan Chase Bank, N.A.

The Company does not require collateral for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days billings are past due, collection history of each customer, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the condensed consolidated statements of operations, included in sales and marketing expense, up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to deferred revenue on the condensed consolidated balance sheets. Receivables are written off and charged against the recorded allowance when the Company has exhausted collection efforts without success. As of September 30, 2024 and December 31, 2023, allowance for credit losses of $1,479 and $1,252, respectively, was included in the accounts receivable, net balance.

No single customer accounted for more than 10% of the Company's accounts receivable balance as of September 30, 2024 and December 31, 2023. Revenue derived from the U.S. Federal Government was 17% and 15% of revenue for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024 and December 31, 2023, assets located in the United States were approximately 83% and 85% percent of total assets, respectively.

As of September 30, 2024 two vendors accounted for more than 10% of the Company's accounts payable balance. No vendors individually accounted for more than 10% of the Company’s accounts payable as of December 31, 2023. During the nine months ended September 30, 2024 and 2023, no vendor and one vendor represented more than 10% of the total purchases made.

8


Table of Contents

 

Recently Adopted Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") ASU 2016-13 Financial Instruments – Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") guidance with respect to measuring credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate now reflects an entity's current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company adopted ASC 2016-13 on January 1, 2023 using the modified retrospective transition method. Upon adoption, the Company recorded a $212 cumulative-effect adjustment to accumulated deficit on the condensed consolidated balance sheets, our allowance for doubtful accounts receivable changed from $468 at December 31, 2022 to $680 at January 1, 2023.

In August 2020, the FASB issued ASU 2020-06 Debt – Debt with Conversion and Other Options (ASC 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASC 815-40) ("ASU 2020-06") guidance modifying the requirements for the accounting for convertible instruments and contracts in an entity’s own equity. The modifications eliminate certain accounting models for convertible debt instruments, eliminate certain requirements for equity classification of embedded derivatives and align earnings per share calculations for convertible instruments. The Company adopted ASC 2020-06 on January 1, 2023 using the modified retrospective approach. The adoption of ASC 2020-06 did not have a material impact on the Company's condensed consolidated financial statements.

Recent Accounting Pronouncements Not Yet Effective

In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280) guidance for segment reporting. The new guidance amends segment reporting to include significant segment expenses. The guidance is effective for the Company beginning with our annual report for the year ended December 31, 2024, and the subsequent interim periods and is required to be disclosed retrospectively to all prior periods presented. The Company does not expect that this guidance will have a significant impact on our disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in the ASU enhance income tax disclosures, primarily through standardization, disaggregation of rate reconciliation categories, and income taxes paid by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption allowed. We are currently evaluating the impact of adoption on our financial disclosures.

Note 2. Business Combination with DSAC

On July 29, 2022, the Company consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2021, and as amended on May 9, 2022, (the “Merger Agreement”), by and among FiscalNote Holdings, Inc., a Delaware corporation (“Old FiscalNote”), Duddell Street Acquisition Corp., a Cayman Islands exempted company (“DSAC”), and Grassroots Merger Sub, Inc., a Delaware Corporation and a wholly owned direct subsidiary of DSAC (“Merger Sub” and, together with DSAC, the “DSAC Parties”). Pursuant to these transactions, Merger Sub merged with and into Old FiscalNote, with Old FiscalNote becoming a wholly owned subsidiary of DSAC (the “Business Combination” and, collectively with the other transactions described in the Business Combination Agreement, the “Transactions”). In connection with the closing of the Transactions, DSAC domesticated and continued as a Delaware corporation under the name of “FiscalNote Holdings, Inc.” (“New FiscalNote”). Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the closing on July 29, 2022. Subsequent to the closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE.WS,” respectively. The Company accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded.

In connection with the closing of the Business Combination Agreement, FiscalNote also entered into the Credit Agreement with Runway Growth Finance Corp., ORIX Growth Capital, LLC, Clover Orochi LLC, and ACM ASOF VIII SaaS FinCo LLC (together the “New Senior Lenders”), pursuant to which a new senior term loan was consummated simultaneously with the Closing (the "Senior Term Loan").

 

Note 3. Revenues

Disaggregation of Revenue

The following table depicts the Company's disaggregated revenue for the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Subscription

 

$

27,238

 

 

$

30,057

 

 

$

84,015

 

 

$

87,986

 

Advisory

 

 

1,123

 

 

 

1,555

 

 

 

3,345

 

 

 

3,906

 

Advertising

 

 

437

 

 

 

428

 

 

 

1,259

 

 

 

1,204

 

Books

 

 

39

 

 

 

27

 

 

 

220

 

 

 

1,151

 

Other revenue

 

 

602

 

 

 

1,942

 

 

 

1,958

 

 

 

4,133

 

Total

 

$

29,439

 

 

$

34,009

 

 

$

90,797

 

 

$

98,380

 

 

9


Table of Contents

 

Revenue by Geographic Locations

The following table depicts the Company’s revenue by geographic operations for the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

North America

 

$

23,073

 

 

$

27,025

 

 

$

72,134

 

 

$

79,921

 

Europe

 

 

5,527

 

 

 

5,015

 

 

 

16,178

 

 

 

14,192

 

Australia

 

 

328

 

 

 

298

 

 

 

950

 

 

 

875

 

Asia

 

 

511

 

 

 

1,671

 

 

 

1,535

 

 

 

3,392

 

Total

 

$

29,439

 

 

$

34,009

 

 

$

90,797

 

 

$

98,380

 

Revenues by geography are determined based on the region of the Company's contracting entity, which may be different than the region of the customer. North America revenue consists solely of revenue attributed to the United States. For the three months ended September 30, 2024 and 2023, revenue attributed to the United Kingdom represented approximately 15% and 12% of total revenues, respectively. For the nine months ended September 30, 2024 and 2023, revenue attributed to the United Kingdom represented approximately 14% and 11% of total revenues, respectively. No other foreign country represented more than five percent of total revenue during the three and nine months ended September 30, 2024 and 2023.

Contract Assets

The Company had contract assets of $1,171, $1,183, and $1,464 as of September 30, 2024, December 31, 2023, and December 31, 2022, respectively. Contract assets are generated when contractual billing schedules differ from the timing of revenue recognition or cash collections. They represent a conditional right to consideration for satisfied performance obligations that becomes a receivable when the conditions are satisfied. They are recorded as part of other current assets on the condensed consolidated balance sheets.

Deferred Revenue

Details of the Company’s deferred revenue for the periods presented are as follows:

Balance at December 31, 2022

 

$

36,487

 

Acquired deferred revenue

 

 

3,941

 

Revenue recognized in the current period from amounts in the prior balance

 

 

(33,226

)

New deferrals, net of amounts recognized in the current period

 

 

39,551

 

Effects of foreign currency

 

 

(47

)

Balance at September 30, 2023

 

$

46,706

 

 

 

 

 

Balance at December 31, 2023

 

$

44,405

 

Sale of Board.org

 

 

(9,117

)

Revenue recognized in the current period from amounts in the prior balance

 

 

(35,869

)

New deferrals, net of amounts recognized in the current period

 

 

40,594

 

Effects of foreign currency

 

 

378

 

Balance at September 30, 2024

 

$

40,391

 

Costs Capitalized to Obtain Revenue Contracts

During the nine months ended September 30, 2024 and 2023, the Company capitalized $2,155 and $3,286 of costs to obtain revenue contracts. The Company amortized costs capitalized to obtain revenue contracts in the amount of $910 and $954 to sales and marketing expense during the three months ended September 30, 2024 and 2023, respectively, and $2,795 and $2,602 during the nine months ended September 30, 2024 and 2023, respectively. There were no impairments of costs capitalized to obtain revenue contracts for the three and nine months ended September 30, 2024 and 2023.

Unsatisfied Performance Obligations

At September 30, 2024, the Company had $81,746 of remaining contract consideration for which revenue has not been recognized due to unsatisfied performance obligations. The Company expects to recognize this over the next five years.

Note 4. Acquisitions and Dispositions

2024 Disposition

On March 11, 2024, the Company entered into an agreement (the "Purchase Agreement") to sell the equity of the Company's subsidiary owning and operating its Board.org business ("Board.org") with Exec Connect Intermediate LLC (the “Buyer”). On March 11, 2024, after adjustments based on Board.org’s working capital, indebtedness and transaction expenses, as well as retention payments payable to certain employees of Board.org, the Company received $90,905 in cash (excluding $785 of the purchase price that was deposited into escrow to satisfy certain potential post-closing purchase price adjustments and indemnification claims and including $21 of cash acquired by the Buyer). The Company is entitled to receive an earn-out payment of up to $8,000, less the amount of certain retention payments potentially owing to the former Board.org employees, if the Board.org business achieves specified revenue targets for fiscal year 2024. The Purchase Agreement contains representations, warranties and indemnification obligations of the parties customary for transactions similar to those contemplated by the Purchase Agreement. As a result of the sale of Board.org, the Company recorded a pre-tax gain on disposal of $71,599, inclusive of the $785 of funds placed in escrow that the Company anticipates receiving and $50 of estimated post-closing purchase price adjustment which are included in other current assets. On June 6, 2024, the Company received $500 of the $785 placed in escrow and

10


Table of Contents

 

finalized the post-closing purchase price adjustment. At September 30, 2024 the Company has $285 included in other current assets representing the remaining balance held in escrow pursuant to the Purchase Agreement.

The proceeds from the sale of Board.org were used in part to prepay $65,700 of term loans under the Company’s Credit Agreement, and pay $7,068 of related prepayment and exit fees associated with the retired amount. The remaining $18,137 of net proceeds were retained by the Company for general corporate purposes. As part of the sale the Company recorded a current tax liability for federal and state income tax of $2,004 and a non-cash deferred tax charge of $300.

The Company determined that Board.org was not a significant subsidiary, and the disposition of Board.org did not constitute a strategic shift that would have a major effect on the Company’s operations or financial results. As a result, the results of operations for Board.org were not reported as discontinued operations under the guidance of ASC 205 “Presentation of Financial Statements."

Pursuant to the Employee Lease Agreement entered into in connection with the closing of the sale of Board.org, the Company was the employer of record for the Board.org employees until June 30, 2024. Under the terms of the Employee Lease agreement, the Company was responsible for the payment of salaries and benefits to the Board.org employees at the direction of the Buyer, until the Buyer legally assumed those employees. On July 1, 2024 the Buyer became the employer of record for the Board.org employees and all services under the Employee Lease Agreement ceased.

Additionally, the Company entered into a Transition Services Agreement in connection with the closing of the sale of Board.org whereby the Company will provide certain transitional support services for a period of time following the closing and the buyer will reimburse FiscalNote for certain direct costs of those services. No material costs were incurred under the Transition Services Agreement during the period from March 11, 2024 to June 30, 2024.

2023 Acquisition

Dragonfly Acquisition

On January 27, 2023, the Company entered into a Sale and Purchase Agreement for all of the issued and outstanding share capital of Dragonfly Eye Limited ("Dragonfly"), a UK- based SaaS-based geopolitical and security intelligence provider of actionable data and analysis delivered through Dragonfly's SaaS-based, proprietary Security Intelligence and Analysis Service subscription platform and API.

The aggregate purchase price consisted of (i) $5.6 million in cash (£4.5 million pounds sterling), (ii) 1,885,149 shares of the Company’s Class A Common Stock, and (iii) $11.1 million (£8.9 million pounds sterling) in aggregate principal amount of subordinated convertible promissory notes (“Seller Convertible Notes”). The Company incurred expenses of $1,272 in connection with the transaction during the year ended December 31, 2023 (inclusive of $446 of amounts paid on January 27, 2023 that were recognized as expense during the three months ended March 31, 2023).

The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following:

 Cash

 

$

5,617

 

 Fair value of Class A common stock

 

 

9,539

 

 Fair value of Seller Convertible Notes

 

 

8,635

 

 Fair value of contingent consideration

 

 

1,445

 

      Total

 

$

25,236

 

The Class A common stock issued as consideration as part of the acquisition of Dragonfly represents non-cash activity on the condensed consolidated statement of stockholders equity and condensed consolidated statement of cash flows.

Certain employees of Dragonfly are eligible for employee earnout bonus awards ("Employee Earnout Awards") based on 2024 revenue targets. The Employee Earnout Awards are subject to forfeiture in the event that Dragonfly does not achieve its revenue target or these employees terminate their employment. Any Employee Earnout Awards that are forfeited are reallocated to the other eligible employees.

The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition:

Cash and cash equivalents

 

$

607

 

Current assets, net

 

 

3,690

 

Property and equipment, net

 

 

18

 

Intangible assets

 

 

9,600

 

Deferred revenues

 

 

(3,933

)

Current liabilities

 

 

(1,764

)

Deferred tax liabilities

 

 

(1,517

)

Total net assets acquired

 

 

6,701

 

Goodwill

 

 

18,535

 

Total purchase price

 

$

25,236

 

 

11


Table of Contents

 

The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition:

 

 

Estimated Fair Value

 

 

Estimated Useful Life (Years)

 

 

Customer relationships

 

$

7,300

 

 

6,10

 

(a)

Developed technology

 

 

1,750

 

 

 

10

 

 

Tradename

 

 

550

 

 

 

3

 

 

Total intangible assets acquired

 

$

9,600

 

 

 

 

 

(a) Includes two separate customer relationships with two different useful lives

 

 

The fair values of the customer relationships, developed technology and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates.

The purchase price allocation includes UK deferred income tax assets and liabilities for acquired book and tax basis differences. Goodwill recorded for this acquisition is not tax deductible.

Note 5. Leases

The Company has operating leases, principally for corporate offices under non-cancelable operating leases that expire at various dates through 2031. The non-cancellable base terms of these leases typically range from one to nine years. Certain lease agreements include options to renew or terminate the lease, which are not factored into the determination of lease payments if they are not reasonably certain to be exercised.

The following table details the composition of lease expense for the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Operating lease cost

 

$

1,170

 

 

$

1,200

 

 

$

3,614

 

 

$

5,000

 

Variable lease cost

 

 

70

 

 

 

304

 

 

 

220

 

 

 

701

 

Short-term lease cost

 

 

77

 

 

 

123

 

 

 

167

 

 

 

462

 

Total lease costs

 

$

1,317

 

 

$

1,627

 

 

$

4,001

 

 

$

6,163

 

Sublease income

 

$

(26

)

 

$

(26

)

 

$

(77

)

 

$

(1,416

)

 

Cash payments related to operating lease liabilities were $4,442 and $7,959 (inclusive of $1,682 lease termination fee) for the nine months ended September 30, 2024 and 2023, respectively.

Note 6. Intangible Assets

The following table summarizes the gross carrying amounts and accumulated amortization of the Company’s intangible assets by major class:

 

 

September 30, 2024

 

 

December 31, 2023

 

 

Weighted Average

 

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Accumulated Impairment

 

 

Net
Carrying Amount

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Impairment

 

 

Net
Carrying Amount

 

 

Remaining Useful Life (Years) September 30, 2024

 

Customer relationships

 

$

80,128

 

 

$

(33,729

)

 

$

(2,235

)

 

$

44,164

 

 

$

88,544

 

 

$

(32,392

)

 

$

(2,235

)

 

$

53,917

 

 

 

8.0

 

Developed technology

 

 

37,453

 

 

 

(28,982

)

 

 

(1,909

)

 

 

6,562

 

 

 

37,205

 

 

 

(26,743

)

 

 

(1,909

)

 

 

8,553

 

 

 

7.0

 

Databases

 

 

29,887

 

 

 

(12,679

)

 

 

-

 

 

 

17,208

 

 

 

29,895

 

 

 

(11,057

)

 

 

-

 

 

 

18,838

 

 

 

8.1

 

Tradenames

 

 

11,879

 

 

 

(5,015

)

 

 

(579

)

 

 

6,285

 

 

 

12,077

 

 

 

(4,367

)

 

 

(579

)

 

 

7,131

 

 

 

7.8

 

Expert network

 

 

2,832

 

 

 

(1,712

)

 

 

-

 

 

 

1,120

 

 

 

2,692

 

 

 

(1,291

)

 

 

-

 

 

 

1,401

 

 

 

2.4

 

Patents

 

 

850

 

 

 

(229

)

 

 

(8

)

 

 

613

 

 

 

784

 

 

 

(217

)

 

 

(8

)

 

 

559

 

 

 

17.4

 

Content library

 

 

592

 

 

 

(167

)

 

 

-

 

 

 

425

 

 

 

592

 

 

 

(123

)

 

 

-

 

 

 

469

 

 

 

7.2

 

Total

 

$

163,621

 

 

$

(82,513

)

 

$

(4,731

)

 

$

76,377

 

 

$

171,789

 

 

$

(76,190

)

 

$

(4,731

)

 

$

90,868

 

 

 

 

Finite-lived intangible assets are stated at cost, net of amortization, generally using the straight-line method over the expected useful lives of the intangible assets. Amortization of intangible assets, excluding developed technology, was $2,435 and $2,899 for the three months ended September 30, 2024 and 2023, respectively, and $7,540 and $8,614 for the nine months ended September 30, 2024 and 2023, respectively.

Amortization of developed technology was recorded as part of cost of revenues, including amortization in the amount of $531 and $3,140 for the three months ended September 30, 2024 and 2023, respectively, and $2,059 and $5,783 for the nine months ended September 30, 2024 and 2023, respectively.

12


Table of Contents

 

The expected future amortization expense for intangible assets as of September 30, 2024 is as follows:

2024 (remainder)

 

$

2,692

 

2025

 

 

10,565

 

2026

 

 

10,294

 

2027

 

 

9,860

 

2028

 

 

9,505

 

Thereafter

 

 

33,461

 

Total

 

$

76,377

 

The Company regularly reviews the remaining useful lives of its intangible assets. In the second quarter of 2023, the Company revised the remaining useful life of certain of its developed technology. Accordingly, the Company recognized $1,935 of amortization expense during the three months ended September 30, 2023.

Capitalized software development costs

Capitalized software development costs are as follows:

 

 

September 30, 2024

 

 

December 31, 2023

 

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Accumulated Impairment

 

 

Net
Carrying Amount

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Impairment

 

 

Net
Carrying Amount

 

Capitalized software development costs

 

$

33,738

 

 

$

(17,351

)

 

$

(1,492

)

 

$

14,895

 

 

$

27,659

 

 

$

(12,795

)

 

$

(1,492

)

 

$

13,372

 

During the nine months ended September 30, 2024 and 2023, the Company capitalized interest on capitalized software development costs in the amount of $393 and $313, respectively. Amortization of capitalized software development costs was recorded as part of cost of revenues, including amortization in the amount of $1,693 and $1,656 for the three months ended September 30, 2024 and 2023, respectively, and $5,100 and $4,671 for the nine months ended September 30, 2024 and 2023, respectively. The estimated useful life is determined at the time each project is placed in service.

Note 7. Goodwill

Goodwill represents the excess of the purchase price in a business combination over the fair value of net assets acquired. Goodwill amounts are not amortized, but are rather tested for impairment at least annually as of October 1 of each year.

The changes in the carrying amounts of goodwill, which are generally not deductible for tax purposes, are as follows:

Balance at December 31, 2023

 

$

187,703

 

Sale of Board.org

 

 

(23,022

)

Impact of foreign currency fluctuations

 

 

1,283

 

Balance at September 30, 2024

 

$

165,964

 

Due to the decline in the Company’s stock price and market capitalization in the first quarter of 2023, and the underperformance of the Company’s ESG reporting unit compared to internal projections, the Company performed a quantitative goodwill impairment assessment as of March 31, 2023. This quantitative assessment resulted in all the goodwill in our ESG reporting unit being impaired; accordingly, an impairment charge of $5,837 was recognized during the three months ended March 31, 2023. Prior to the quantitative goodwill impairment the Company tested the recoverability of its long-lived assets, and concluded that such assets were not impaired.

The fair value estimate of the Company's reporting units was derived based on an income approach. Under the income approach, the Company estimated the fair value of reporting units based on the present value of estimated future cash flows, which the Company considers to be a Level 3 unobservable input in the fair value hierarchy. The Company prepared cash flow projections based on management's estimates of revenue growth rates and operating margins, taking into consideration the historical performance and the current macroeconomic, industry, and market conditions. The Company based the discount rate on the weighted-average cost of capital considering Company-specific characteristics and the uncertainty related to our reporting unit's ability to execute on the projected cash flows.

Potential indicators of impairment include significant changes in performance relative to expected operating results, significant negative industry or economic trends, or a significant decline in the Company's stock price and/or market capitalization for a sustained period of time. It is reasonably possible that one or more of these impairment indicators could occur or intensify in the near term, which may result in an impairment of long-lived assets or further impairment of goodwill.

 

 

13


Table of Contents

 

Note 8. Debt

The following presents the carrying value of the Company’s debt as of the respective period ends:

 

 

September 30, 2024

 

 

December 31, 2023

 

Senior Term Loan

 

$

93,365

 

 

$

158,228

 

New GPO Note

 

 

36,487

 

 

 

36,954

 

Convertible Notes

 

 

15,595

 

 

 

14,052

 

Dragonfly Seller Convertible Notes

 

 

9,226

 

 

 

9,002

 

Era Convertible Note

 

 

-

 

 

 

5,977

 

Aicel Convertible Note

 

 

1,150

 

 

 

1,156

 

PPP loan

 

 

63

 

 

 

144

 

Total gross debt

 

 

155,886

 

 

 

225,513

 

Debt issuance costs

 

 

(3,716

)

 

 

(3,098

)

Total

 

 

152,170

 

 

 

222,415

 

Less: Current maturities

 

 

(10,018

)

 

 

(105

)

Total Long-term debt

 

$

142,152

 

 

$

222,310

 

 

Senior Term Loan

On July 29, 2022, concurrent with the closing of the Company's Business Combination, FiscalNote, Inc., a wholly owned indirect subsidiary of FiscalNote Holdings, Inc., entered into a senior credit agreement (the "Credit Agreement") providing for a Senior Term Loan consisting of a fully funded principal amount of $150,000 and an uncommitted incremental loan facility totaling $100,000 available upon notice if the Company meets certain financial growth criteria and other customary requirements (the “Incremental Term Facility”) (collectively the “Senior Credit Facility”). The annual interest of the Senior Term Loan consists of two components: a cash interest component of (a) the greater of (i) Prime Rate plus 5.0% per annum or (ii) 9.0% payable monthly, and (b) interest payable in kind component of 1.00% per annum, payable in kind monthly. The Senior Credit Facility will mature on July 29, 2027.

On March 17, 2023, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 1 provided for the extension of an incremental term loan by one of the lenders under the facility in the principal amount of $6,000 which was received by the Company on March 31, 2023, on the same terms as the existing term loans (the “Incremental Facility”). In connection with the funding of the Incremental Facility, the Company issued the lender warrants expiring July 15, 2027, to purchase up to 80,000 Class A Common Stock at an exercise price of $0.01 per share, in a transaction exempt from registration under the Securities Act of 1933, as amended, in reliance on Regulation D promulgated thereunder. The lender warrants represented a non-cash financing activity.

On May 16, 2023, the Company entered into Amendment No. 2 ("Amendment No. 2") to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 2 joined Dragonfly Eye Limited and Oxford Analytica Limited (“Oxford Analytica”), each a wholly owned subsidiary of the Company, as Guarantors under the Credit Agreement.

On August 3, 2023, the Company entered into Amendment No. 3 ("Amendment No. 3") to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 3 provided for: (a) the extension of the July 2023 Deferred Fee from July 29, 2023 to July 29, 2024, (b) the increase of the July 2023 Deferred Fee from $1,734 to $2,034, (c) an increase of the Restatement Date Final Agreement from $7,410 to $8,970 and (d) the revision to the minimum annual recurring revenue ("ARR") and adjusted EBITDA covenants (as both are defined in the Credit Agreement).

In connection with the completion of the sale of Board.org on March 11, 2024, the Company also entered into Amendment No. 4 to the Credit Agreement (the “Amendment No. 4”), pursuant to which, among other things, the lenders consented to the release of the liens on Board.org’s assets and permitted the consummation of the sale in exchange for the permanent prepayment of $65,700 of term loans under the Credit Agreement. The Company also made a payment of $1,314 and $5,754 of related prepayment and exit fees, respectively. Amendment No. 4 also requires that upon receipt of any earn-out payment pursuant to the equity purchase agreement underlying the sale of Board.org, the Company will prepay outstanding obligations under the Credit Agreement in an amount equal to 70% of the net proceeds received from such earn-out payment, together with a prepayment fee and an exit fee, equal to 5.75% of the amount of such prepayment.

In addition, Amendment No. 4 extended the commencement of amortization payments under the Credit Agreement from August 15, 2025 to August 15, 2026, with such payments to fully amortize the term loans by the maturity date of July 15, 2027. Amendment No. 4 also increased the Company’s minimum liquidity covenant to $22,500 and modified the Company’s minimum ARR and adjusted EBITDA (as defined in the Credit Agreement, as amended) in order to appropriately reflect the sale of Board.org and the absence of its future contributions to the Company’s overall financial performance and position.

The Prime Rate in effect for the Senior Term Loan was 8.50% at September 30, 2024. For the nine months ended September 30, 2024 and 2023, the Company incurred $11,165 and $15,341 and $837 and $1,177 of cash interest and paid-in-kind interest, respectively, on the Senior Term Loan. Paid-in-kind interest is reflected as a component of the carrying value of the Senior Term Loan as the payment of such interest will occur upon the settlement of the Senior Term Loan.

The Company may prepay the Senior Term Loan in whole, subject to a 2.0% prepayment fee if prepaid prior to July 30, 2024, 1.0% prepayment fee if prepaid after July 30, 2024 but prior to July 30, 2025, and no prepayment fee if prepaid on or after July 30, 2025. The July 2023 Deferred Fee, as previously amended, of $2,034 was paid as part of Amendment No. 4. Accordingly, the Company recognized the accretion of the July 2023 Deferred Fee as interest expense through March 11, 2024. Prior to Amendment No. 4, the Company had $8,970 of deferred fees due at the earlier of prepayment or maturity of the Senior Term Loan which were amortized over the term of the Senior

14


Table of Contents

 

Term Loan using the effective interest method. On March 11, 2024, and as a result of Amendment No. 4, the Company had $5,250 of deferred fees outstanding which the Company recognized the accretion of these deferred fees as interest expense. The $1,134 of prepayment fee paid on March 11, 2024 was treated as a debt discount. The amortization recorded for the three months ended September 30, 2024 and September 30, 2023 was $675 and $180, respectively, and for the nine months ended September 30, 2024 and September 30, 2023 was $1,487 and $490, respectively, and is included within interest expense in the condensed consolidated statements of operations and comprehensive income (loss). The remaining unamortized debt discount at September 30, 2024 is $3,317, excluding any deferred fees, and is reflected net against debt on the condensed consolidated balance sheets.

The Senior Term Loan is senior to all other debt and has a first priority lien on substantially all of the Company’s assets. The Senior Term Loan contains customary negative covenants related to borrowing, events of default and covenants, including certain non-financial covenants and covenants limiting the Company’s ability to dispose of assets, undergo a change in control, merge with or acquire stock, and make investments, in each case subject to certain exceptions. In addition to the negative covenants, there were four financial covenants in place at September 30, 2024: a minimum cash balance requirement, minimum ARR requirement, an adjusted EBITDA requirement and a capital expenditure limitation. As of, and for the three and nine months ended September 30, 2024, the Company was in compliance with all required financial covenants. Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Senior Term Loan due and payable the lenders can elect to increase the interest rate by 5.0% per annum.

New GPO Note

On June 30, 2023 (the “Subscription Date”), the Company entered into an Exchange and Settlement Agreement (the “Exchange and Settlement Agreement”) with GPO FN Noteholder LLC (the “Investor”) pursuant to which (i) the Investor returned 5,881,723 shares of Class A Common Stock held by the Investor to the Company for cancellation, (ii) the Company issued to the Investor a subordinated convertible promissory note in an initial principal amount of $46,794 (the “New GPO Note”), and (iii) the parties agreed to a mutual settlement and release of all claims including, but not limited to, any claims by the Investor for additional shares or money damages resulting from the entry into the Merger Agreement, relating to or arising from the conversion of the Amended and Restated Senior Secured Subordinated Promissory Note, dated December 29, 2020, previously issued by a subsidiary of the pre-business combination FiscalNote Holdings, Inc. to the Investor. The exchange and settlement are non-cash exchanges in the condensed consolidated statement of cash flows. The before mentioned transactions closed on July 3, 2023.

The New GPO Note will mature on July 3, 2028, unless earlier redeemed or repurchased by the Company or converted in accordance with the terms thereof. The New GPO Note bears interest at a rate of 7.50% per annum payable quarterly in arrears, as follows: (i) for the first year following the date of issuance, interest will be payable in kind by adding interest to the principal amount of the New GPO Note; and (ii) for any period thereafter, interest will be payable in cash or freely tradeable shares of Class A Common Stock, at the Company’s option, with the value per share determined with reference to the trailing 30-day volume weighted average trading price prior to the interest payment date, subject to certain exceptions under which the Company will be permitted to pay PIK Interest.

The New GPO Note is subordinate to the Company’s obligations under its Senior Term Loan which limits certain actions that the Company and the Investor may take under the New GPO Note. At any time prior to the July 3, 2028 maturity date, the Investor is entitled to convert all or any portion of the principal amount of the New GPO Note and accrued interest thereon into shares of Class A Common Stock at $7.92 per share. The New GPO Note is subject to customary anti-dilution adjustments for stock splits and similar transactions and, subject to standard exceptions, weighted average anti-dilution protection. The principal amount, together with accrued interest thereon, of the New GPO Note is redeemable by the Company in whole or in part based on certain conditions as defined in the New GPO Note. Pursuant to the terms of the New GPO Note, paid-in-kind interest accrued from the date of issuance through June 30, 2024. Beginning on July 1, 2024 the Company was required to pay interest with either cash or shares, solely at the discretion of the Company. Accordingly, on September 30, 2024, the Company issued 785,137 Class A Common Shares in satisfaction of the third quarter interest of $967. The Company expects to satisfy future quarterly interest payments in shares.

The Company elected to account for the New GPO Note using the fair value option. The New GPO Note was recorded at its June 30, 2023 acquisition date fair value of $36,583. The Company initially recorded a loss contingency of $11,700 in its fiscal year 2022 financial statements representing the difference between the fair value of the shares returned by the Investor and the fair value of the New GPO Note on the date of exchange. With the execution of the Exchange and Settlement Agreement and New GPO Note, the Company recorded an additional non-cash loss on settlement with GPO of $3,474 in the condensed consolidated statement of operations for the nine months ended September 30, 2023. The fair market value at September 30, 2024 and December 31, 2023 was $36,487 and $36,954, respectively. The unrealized change in the fair value of the New GPO Note of $4,443 is recorded in accumulated other comprehensive income for the period ended September 30, 2024 and the non-cash loss was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) in the amount of a loss of $3,234 and $2,117 for the three and nine months ended September 30, 2024, respectively. The Company incurred total interest expense related to the new GPO note of $967 and $868 for the three months ended September 30, 2024 and 2023 and $2,826 and $868 for the nine months ended September 30, 2024 and 2023, respectively.

Convertible Notes

At September 30, 2024, the holders of four convertible notes that were previously issued by Old FiscalNote (the “Convertible Notes”) with a principal and accrued PIK balance of $15,595, remained outstanding. The Company incurred total interest expense related to the Convertible Notes, including the amortization of the various discounts, of $630 and $548 during the three months ended September 30, 2024 and 2023, respectively, and $1,829 and $1,585 for the nine months ended September 30, 2024 and 2023, respectively. These notes mature in July 2025 and November 2025. The notes that mature in July 2025 are recorded in the current maturities of long-term debt.

15


Table of Contents

 

Dragonfly Seller Convertible Notes

In connection with the Company's acquisition of Dragonfly, the Company financed part of the purchase with the issuance of convertible notes. The Dragonfly Convertible Notes were issued in a principal amount of £8.9 million pounds sterling (approximately $11,050 on the closing date of the acquisition), with interest at an annual rate of 8%, which can be paid in cash or paid-in-kind. The paid-in-kind interest will be annually credited to the principal amount. All principal and accrued interest are due upon maturity on January 27, 2028.

At any time after August 2, 2023, the Company can convert any portion of the principal and accrued interest at the volume weighted-average price for the five consecutive trading day period ending on the last trading day of the calendar month preceding the date the Company provides notice of conversion to the Sellers.

At any time after the 18 month anniversary of the Dragonfly acquisition closing date, the lender has the right to convert the outstanding principal and accrued interest for FiscalNote common stock at $10.00 per share, subject to adjustment in the event of any stock dividend, stock split, reverse stock split, combination or other similar recapitalization with respect to common stock.

The Company elected to account for the Dragonfly Seller Convertible Notes using the fair value option. The Dragonfly Seller Convertible Notes were recorded at their acquisition date fair value of $8,635. The fair market value at September 30, 2024 and at December 31, 2023 was $9,226 and $9,002. The unrealized change in the fair value of the Dragonfly Seller Convertible Note of $0 and $1,264 is recorded in accumulated other comprehensive income for the three and nine months ended September 30, 2024 and the non-cash loss of $743 and $339 was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three and nine months ended September 30, 2024. The non-cash gain was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive loss in the amount of a gain of $401 and a loss of $6 for the three and nine months ended September 30, 2023, respectively. The Company incurred total interest expense related to the Dragonfly Seller Convertible Notes of $259 and $230 during the three months ended September 30, 2024 and 2023, respectively, and $747 and $609 for the nine months ended September 30, 2024 and 2023, respectively.

Era Convertible Notes

In connection with a Company’s strategic commercial partnership, the Company issued a convertible note to EGT-East, LLC ("Era"), a third-party lender, for $5,500 on December 8, 2023 and a second convertible note for $801 on January 5, 2024 (collectively, the "Era Convertible Notes"). The Era Convertible Notes were issued in aggregate principal amount of $6,301, with cash interest at a rate equal to the applicable federal rate published by the Internal Revenue Service beginning on June 8, 2024. All principal and unpaid interest were to mature on December 8, 2027.

Pursuant to the copilot agreement (the "Co-Pilot Agreement") entered into by and among the Company, FiscalNote Inc., a subsidiary of the Company, and Era on December 8, 2023, the Company agreed to issue Era up to an additional $3,150 in the form of shares of the Company's Class A Common Stock no later than June 2024 (the "Partnership Shares"). The Co-Pilot Agreement requires the Company to issue additional shares of Common Stock (“Additional Shares”) to Era if Era’s sales of the Partnership Shares and the shares of Class A Common Stock underlying the Era Convertible Notes (the "Underlying Shares") do not generate aggregate cash proceeds to Era that equal or exceed approximately $9,452 during the sell-off period set forth in the Co-Pilot Agreement. Any such Additional Shares would be valued based on the volume weighted average price of the trailing 30 trading day period, calculated prior to the date of any such issuance.

On April 11, 2024, the Company entered into a letter agreement (the “Letter Agreement”) with Era modifying certain provisions of the Era Convertible Notes and the Co-Pilot Agreement. The Letter Agreement permitted and required the Company to convert approximately $1,599 in aggregate principal amount of the Era Convertible Notes (the “Early Converted Notes”) into a portion of the Underlying Shares. Pursuant to the Letter Agreement, the Company was also required to issue to Era the Partnership Shares. Pursuant to the Letter Agreement, Era has the right to convert the aggregate principal amount of the remaining Era Convertible Notes (the “Remaining Notes”), but only on or after June 30, 2024, if such conversion right is not cancelled by the terms of the Letter Agreement. In addition, the Letter Agreement terminated the Company’s obligation to issue the Additional Shares under the circumstances specified therein. On April 11, 2024 and pursuant to the Letter Agreement, the Company issued the Investor an aggregate of 3,003,268 shares of Common Stock to satisfy its obligations with respect to the Partnership Shares and a portion of the Underlying Shares.

The Company elected to account for the Era Convertible Notes using the fair value option. The Era Convertible Note dated December 8, 2023 was recorded at its acquisition date fair value of $5,500. The Era Convertible Note dated January 5, 2024 was recorded at its acquisition date fair value of $801. The fair market value of the Era Convertible Note dated December 8, 2023 was $5,977 at December 31, 2023. The non-cash change in fair value of financial instruments recorded in the condensed consolidated statements of operations and comprehensive income (loss) was a loss $3,189 for the nine months ended September 30, 2024, respectively.

On June 12, 2024 and June 25, 2024 the Company issued the Investor an aggregate amount of 3,848,831 shares of Common Stock to satisfy its remaining obligations with regards to the Era Convertible Notes and Co-Pilot Agreement, including the obligation to issue Additional Shares. Accordingly, the Company has no obligations outstanding related to the Era Convertible Note.

Aicel Convertible Note

In connection with the Company’s acquisition of Aicel, the Company assumed a convertible note (“Aicel Convertible Note”) issued by Aicel in a private placement to a third-party lender dated July 27, 2022. The Aicel Convertible Note was issued in a principal amount of $1,131, with paid-in-kind interest at an annual rate of 1%. All principal and accrued and unpaid interest are due on maturity at July 27, 2027. The Aicel Convertible Note provides for no prepayments until maturity without written consent of the lender.

The Aicel Convertible Note can be converted upon the occurrence of certain events, including (i) Aicel initial public offering (“IPO”), (ii) change in control of Aicel (the acquisition of Aicel by FiscalNote did not constitute a change in control as defined in the purchase

16


Table of Contents

 

agreement), or (iii) sale of substantially all of Aicel’s assets (collectively, a “Conversion Event”). The Company has the right to convert the Aicel Convertible Note into shares of common stock issued in an IPO, if (a) the Conversion Event is an IPO and (b) the price per share paid in an IPO is greater than the stipulated initial conversion price. The lender has the right to elect to convert the Aicel Convertible Note into shares of common stock upon the occurrence of a Conversion Event.

At any time after the second anniversary of the Aicel acquisition closing date until the earlier of (a) the Aicel Convertible Note maturity date, or (b) the occurrence of any liquidity event, the lender has the right to require FiscalNote to repurchase the outstanding principal in exchange for FiscalNote common stock. The lender will receive a number of shares of FiscalNote equal to the outstanding principal plus accrued interest divided by the FiscalNote common stock price and rounded to the nearest whole share.

Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Aicel Convertible Note due and payable the lenders can elect to increase the paid-in-kind interest rate to 12.0% per annum.

The Company concluded that the contingent default interest provision was required to be bifurcated and treated as an embedded derivative liability. The associated value was immaterial and required no initial amount to be recorded and continues to be immaterial as of the reporting date. The Company determined that the remaining embedded features were clearly and closely related to the debt host and did not require bifurcation from the debt host.

The Aicel Convertible Note was recorded at its acquisition fair value of $1,131. The Company incurred total interest expense related to the Aicel Convertible Note of $3 and $2 during the three months ended September 30, 2024 and 2023, and $8 and $8 during the nine months ended September 30, 2024 and 2023, respectively. On October 31, 2024, the Aicel convertible note was assumed by the buyer with the sale of the Aicel entity as discussed in Note 18, Subsequent events.

PPP Loan

On April 13, 2020, the Company received funding in the principal amount of $8,000 under the CARES Act to be repaid over five years. Interest accrues annually at 1%. On February 14, 2022, the SBA forgave $7,667 of the PPP Loan with the remaining balance of $333. The Company recognized the forgiveness of PPP Loan as a gain on debt extinguishment in the condensed consolidated statements of operations and comprehensive income (loss) in 2022. As of September 30, 2024, the Company recorded the remaining PPP Loan balance of $63 as short-term debt.

Total Debt

The following table summarizes the total estimated fair value of the Company's debt as of September 30, 2024 and December 31, 2023, respectively. These fair values are deemed Level 3 liabilities within the fair value measurement framework.

 

 

September 30, 2024

 

 

December 31, 2023

 

Senior Term Loan

 

$

92,576

 

 

$

168,702

 

New GPO Note

 

 

36,487

 

 

 

36,954

 

Convertible Notes

 

 

15,102

 

 

 

13,992

 

Dragonfly Seller Convertible Notes

 

 

9,226

 

 

 

10,407

 

Era Convertible Notes

 

 

-

 

 

 

5,977

 

Total

 

$

153,391

 

 

$

236,032

 

 

Warrants

 

Old FiscalNote Warrants

At September 30, 2024, 118,700 warrants (previously issued by Old FiscalNote to lenders prior to the Senior Term Loan) with an exercise price of $8.56, remain outstanding. These warrants are accounted for as a liability with a fair value of $68 at September 30, 2024, and are included as part of the other non-current liabilities within the condensed consolidated balance sheets.

Warrants associated with Amendment No. 1

On March 17, 2023, in connection with Amendment No. 1 discussed above, the Company issued 80,000 warrants with an exercise price of $0.01. These warrants are accounted for as a liability with a fair value of $102 at September 30, 2024, and are included as part of the other non-current liabilities within the condensed consolidated balance sheets.

Note 9. Stockholders’ Equity

Authorized Capital Stock

The Company’s charter authorizes the issuance of 1,809,000,000 shares, which includes Class A common stock, Class B common stock, and preferred stock.

Class A Common Stock

Subsequent to the Closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE.WS,” respectively. Pursuant to the Company’s charter,

17


Table of Contents

 

the Company is authorized to issue 1,700,000,000 shares of Class A common stock, par value $0.0001 per share. As of September 30, 2024, the Company had 132,584,083 shares of Class A common stock issued and outstanding.

Additionally, the Company has outstanding warrants to purchase shares of New FiscalNote Class A common stock that became exercisable upon the Closing of the Business Combination. Refer to Note 11, "Warrant Liabilities."

Class B Common Stock

Pursuant to the Company’s charter, the Company is authorized to issue 9,000,000 shares of Class B common stock, par value $0.0001 per share.

In connection with the Closing of the Business Combination, the Co-Founders, or entities controlled by the Co-Founders, received Class B shares of New FiscalNote common stock as consideration (see further details in Note 2, "Business Combination with DSAC").

As of September 30, 2024, the Company had 8,290,921 shares of Class B common stock issued and outstanding.

Preferred Stock

Pursuant to the Company’s charter, the Company is authorized to issue 100,000,000 shares of preferred stock, par value $0.0001 per share. Our board of directors has the authority without action by the stockholders, to designate and issue shares of preferred stock in one or more classes or series, and the number of shares constituting any such class or series, and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights of each class or series of preferred stock, including, without limitation, dividend rights, conversion rights, redemption privileges and liquidation preferences, which rights may be greater than the rights of the holders of the common stock. As of September 30, 2024, there were no shares of preferred stock issued and outstanding.

Dividends

The Company's Class A and Class B common stock are entitled to dividends if and when any dividend is declared by the Company's board of directors, subject to the rights of all classes of stock outstanding having priority rights to dividends. The Company has not paid any cash dividends on common stock to date. The Company may retain future earnings, if any, for the further development and expansion of the Company's business and have no current plans to pay cash dividends for the foreseeable future. Any future determination to pay dividends will be made at the discretion of the Company's board of directors and will depend on, among other things, the Company's financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as the Company's board of directors may deem relevant.

Note 10. Earnout Shares and RSUs

The shareholders and other equity holders of Old FiscalNote as described below are entitled to receive up to 19,195,100 additional shares of Class A common stock of New FiscalNote (the “Earnout Awards”) in the form of Earnout Shares or as shares reserved for issuances upon settlement of Earnout RSUs, as described below. The Earnout Awards are split into five tranches each consisting of 3,839,020 shares of Class A common stock in New FiscalNote. Certain Old FiscalNote equity holders will receive Earnout Restricted Stock Units (the “Earnout RSUs”), which are settled in Class A common stock. The right to receive Earnout Awards will expire five years after the Closing Date (the “Earnout Period”). Each tranche of the Earnout Awards will be issued only when the dollar volume-weighted average price of one share of New FiscalNote Class A common stock is greater than or equal to $10.50, $12.50, $15.00, $20.00, or $25.00, respectively, for any 10 trading days within any period of 20 consecutive trading days during the Earnout Period (collectively, the “Triggering Events”).

Pursuant to the terms of the Business Combination Agreement, the holders of Old FiscalNote common stock, Old FiscalNote warrants, vested Old FiscalNote options and vested Old FiscalNote RSUs outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of Earnout Shares subject to achievement of the Triggering Event. Holders of unvested Old FiscalNote options and unvested Old FiscalNote RSUs outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of Earnout Shares in the form of Earnout RSUs subject to achievement of the Triggering Event. To the extent the equity award issued upon New FiscalNote's assumption of such any Old FiscalNote Option or Old FiscalNote RSU (each a “Converted Award”) is outstanding and has vested as of the occurrence of a Triggering Event, the holder thereof will receive a proportionate allocation of Earnout Shares in lieu of Earnout RSUs.

If a Converted Award is forfeited after the Closing Date but prior to the Triggering Event, no Earnout RSUs will be issued for such Converted Award. The right to receive Earnout RSUs that have been forfeited shall be reallocated pro-rata to the remaining holders of vested Converted Awards in the form of Earnout Shares and unvested Converted Awards in the form of Earnout RSUs in the manner described above. Reallocated Earnout RSUs are subject to the remaining vesting schedule and conditions of the Converted Award held by such equity holder. The forfeiture and subsequent reallocation of the Earnout RSUs are accounted for as the forfeiture of the original award and the grant of a new award.

A portion of the Earnout Shares that may be issued to Old FiscalNote common stockholders, Old FiscalNote vested option holders and Old FiscalNote warrant holders and all of the Earnout RSUs were determined to represent additional compensation for accounting purposes pursuant to ASC 718, “Compensation-Stock Compensation”. The Company recognizes stock-compensation expense based on the fair value of the Earnout Awards over the requisite service period for each tranche. Upon Closing, the Company recognized $17,712 of share-based compensation expense for vested Earnout Awards. The Company recognized $106 and $278 of share-based compensation expense during the three and nine months ended September 30, 2024, respectively. The Company recognized $237 and $1,618 of share-based compensation expense during the three and nine months ended September 30, 2023, respectively. The remaining Earnout Shares were determined to represent an equity transaction in conjunction with the reverse recapitalization and were evaluated pursuant to ASC 480, “Distinguishing Liabilities from Equity” and ASC 815, “Derivatives and Hedging”. These remaining Earnout Shares will be accounted for as a liability as

18


Table of Contents

 

the arrangement is indexed to something other than the Company’s stock. The liability is revalued at each reporting period with changes being recorded as a non-operating gain or loss in the condensed consolidated statements of operations and comprehensive income (loss). The liability of $68 was recorded in other non-current liabilities on the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023.

As of September 30, 2024, there was $263 of unrecognized compensation expense related to the Earnout Awards to be recognized over a weighted-average period of approximately one and a half years. As of September 30, 2024, no Earnout Shares and no Earnout RSUs have been issued as no Triggering Events have occurred.

Note 11. Warrant Liabilities

Upon the Closing of the Business Combination, the Company assumed 8,750,000 public warrants and 7,000,000 private placement warrants that were previously issued by Old DSAC. Each public warrant and private placement warrant is exercisable for 1.571428 shares of New FiscalNote Class A common stock (or an aggregate of up to 24,750,000 shares of New FiscalNote Class A common stock).

During the nine months ended September 30, 2024, no public warrants were exercised into shares of Class A common stock. No private placement warrants have been exercised to date. Accordingly, as of September 30, 2024, the Company had 8,358,964 public warrants and 7,000,000 private placement warrants outstanding with a per share fair value of $0.44. These warrants are accounted for as a liability and have a fair value of $2,304 at September 30, 2024.

Public Warrants

Each public warrant entitles the registered holder to acquire 1.571428 shares of the Company’s Class A common stock at a price of $7.32 per share, subject to adjustment as discussed below. The warrants became exercisable on August 29, 2022. Warrants may only be exercised for a whole number of shares of Class A common stock. The public warrants will expire on July 29, 2027, or earlier upon redemption or liquidation.

Redemption of warrants for cash

The Company may call the public warrants for redemption for cash:

•
in whole and not in part;
•
at a price of $0.01 per warrant;
•
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
•
if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $11.45 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of the Company’s Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company for cash, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of warrants for shares of Class A common stock

The Company may redeem the outstanding warrants for shares of Class A common stock:

•
in whole and not in part;
•
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined by reference to an agreed table, based on the redemption date and the “fair market value” of Class A common stock (as defined below) except as otherwise described below;
•
if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $6.36 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of the Company’s Class A common stock and equity-linked securities) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and
•
if and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of shares of our Class A common stock) as the outstanding public warrants, as described above.
•
The “fair market value” of the Class A common stock shall mean the average of the last reported sales price for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.567 shares of Class A common stock per warrant (subject to adjustment).

Private Placement Warrants

The private placement warrants are not redeemable by the Company so long as they are held by the sponsor of DSAC or its permitted transferees, except in certain limited circumstances. The DSAC Sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis and the DSAC Sponsor and its permitted transferees has certain registration rights related to the private placement warrants (including the shares of Class A common stock issuable upon exercise of the private placement warrants). Except as described in this section, the private placement warrants have terms and provisions that are identical to those of the public warrants. If

19


Table of Contents

 

the private placement warrants are held by holders other than the DSAC Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the public warrants.

Note 12. Stock-Based Compensation

2022 Long-Term Incentive Plan

In connection with the Business Combination, the Company's board of directors adopted, and its stockholders approved, the 2022 Long-Term Incentive Plan (the “2022 Plan”) under which 20,285,600 shares of Class A common stock were initially reserved for issuance. The 2022 Plan allows for the issuance of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, other stock-based awards and cash-based awards. The number of shares of the Company’s Class A common stock available for issuance under the 2022 Plan increases on the first day of each calendar year, starting on January 1, 2023 and continuing through and including January 1, 2027, by the lesser of (a) 13,523,734, (b) three percent (3%) of the total number of shares of Class A Common Stock outstanding on December 31st of the immediately preceding fiscal year or (c) a lesser number determined by the Company’s board of directors prior to January 1 of a given year. In accordance with this provision, on each of January 1, 2023 and January 1, 2024, the number of shares authorized for issuance under the 2022 Plan increased by 3,693,767 and 3,650,394, respectively.

During the nine months ended September 30, 2024, the Company issued 2,365,285 stock options and 7,362,404 restricted stock units. At September 30, 2024, 8,687,689 stock options, 2,556,550 performance stock options, 10,240,288 restricted stock units, and 75,000 performance based restricted stock units remain outstanding. As of September 30, 2024, the Company had 830,211 shares of Class A common stock available for issuance under the 2022 Plan.

The Company recognized $3,853 and $5,709 of stock-based compensation expense for all long term incentive plans in effect during the three months ended September 30, 2024 and 2023, respectively, and $13,092 and $15,772 during the nine months ended September 30, 2024 and 2023, respectively. The Company recognized an expense of $138 and an expense of $169 of stock-based compensation expense related to acquisition earnouts during the three months ended September 30, 2024 and 2023, respectively. The Company recognized $238 and $507 of stock-based compensation expense related to acquisition earnouts during the nine months ended September 30, 2024 and 2023, respectively.

2022 Employee Stock Purchase Plan

In connection with the Business Combination, the Company’s board of directors adopted, and its stockholders approved, the 2022 Employee Stock Purchase Plan (the “ESPP”) whereby eligible employees may authorize payroll deductions of up to 15% of their regular base salary to purchase shares at the lower of 85% of the fair market value of the common stock on the date of commencement of the offering period or on the last day of the six-month offering period. The plan is defined as compensatory, and accordingly, a stock-based compensation charge of $46 and $110 was recorded as the difference between the fair market value and the discounted purchase price of the Company's common stock for the three months ended September 30, 2024 and 2023 and $239 and $315 for the nine months ended September 30, 2024 and 2023, respectively. The number of shares of Common Stock reserved for issuance under the ESPP will automatically increase on January 1st each year, starting on January 1, 2023 and continuing through and including January 1, 2027, by the lesser of (a) 3,267,760, (b) one percent (1%) of the total number of shares of all classes of Common Stock outstanding on December 31st of the preceding fiscal year, or (c) a lesser number determined by the Board prior to January 1 of a given year. Pursuant to this provision, on each of January 1, 2023 and January 1, 2024, the number of shares authorized for issuance under the ESPP increased by 1,231,255 and 1,299,707, respectively. As of September 30, 2024, 509,865 shares have been issued under the ESPP and the Company had 5,186,050 shares of Class A common stock available for issuance under the ESPP.

2024 Inducement Plan Grants

The Company's board of directors adopted the 2024 Inducement Equity Incentive Plan (the “Plan”). The plan allows for the issuance of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights, other stock-based awards and cash-based awards. Under the Plan, 500,000 shares of Class A common stock were initially reserved for issuance.

During the nine months ended September 30, 2024, the Company issued 200,000 stock options and 300,000 restricted stock units. At September 30, 2024, all of the awards remain outstanding. The Company recognized $38 and $38 of stock-based compensation expense for this plan in effect during the three months and nine months ended September 30, 2024, respectively.

Withholding Taxes on Equity Awards

In connection with the settlement of equity awards, the Company records a non-cash liability and corresponding APIC adjustment for the withholding taxes on net share settlement of stock-based compensation and option exercises until such time as those taxes have been remitted to the respective taxing authorities.

20


Table of Contents

 

Note 13. Transaction (Gains) Costs, net

The Company incurred the following transaction costs related to businesses acquired and the consummation of the Business Combination during the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Transaction costs related to acquired businesses

 

$

-

 

 

$

12

 

 

$

-

 

 

$

1,391

 

Non-capitalizable Business Combination costs

 

 

-

 

 

 

81

 

 

 

-

 

 

 

415

 

Change in contingent consideration liabilities

 

 

-

 

 

 

195

 

 

 

(4

)

 

 

(138

)

Contingent compensation (gain) expense

 

 

-

 

 

 

(867

)

 

 

-

 

 

 

(530

)

Total transaction (gains) costs, net

 

$

-

 

 

$

(579

)

 

$

(4

)

 

$

1,138

 

 

Note 14. Earnings (Loss) Per Share

The Company has two classes of common stock authorized: Class A common stock and Class B common stock. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to twenty-five votes per share. The Company allocates undistributed earnings attributable to common stock between the common stock classes on a one‑to‑one basis when computing net loss per share. As a result, basic and diluted net income (loss) per share of Class A common stock and Class B common stock are equivalent.

The following is a calculation of the basic and diluted earnings per share for the Company's common stock, including a reconciliation between net income attributable to common stockholders used for Basic EPS and Diluted EPS for the three and nine months ended September 30, 2024 and 2023:

(in thousands, except share and per share data)

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Basic Earnings Per Share

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income used to compute basic and diluted EPS

 

$

(14,935

)

 

$

(14,467

)

 

$

22,900

 

 

$

(64,713

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding, basic and diluted

 

 

135,050,093

 

 

 

128,832,502

 

 

 

135,160,124

 

 

 

131,994,563

 

Earnings Per Share, basic and diluted

 

$

(0.11

)

 

$

(0.11

)

 

$

0.17

 

 

$

(0.49

)

Since the Company was in a net loss position during the three and nine months ended September 30, 2023 and the three months ended September 30, 2024, basic net loss per share attributable to common stockholders is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive.

Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

Anti-dilutive securities excluded from diluted loss per share:

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Anti-dilutive Earnout Awards

 

 

19,195,100

 

 

 

19,195,100

 

 

 

19,195,100

 

 

 

19,195,100

 

Anti-dilutive stock options

 

 

170,494

 

 

 

1,435,384

 

 

 

170,494

 

 

 

1,446,013

 

Anti-dilutive Convertible Notes

 

 

2,560,717

 

 

 

2,225,858

 

 

 

2,560,717

 

 

 

2,225,858

 

Anti-dilutive contingently issuable shares

 

 

66,220

 

 

 

976,953

 

 

 

66,220

 

 

 

976,953

 

Anti-dilutive restricted stock units

 

 

10,615,288

 

 

 

6,779,610

 

 

 

10,615,288

 

 

 

6,779,610

 

Anti-dilutive New GPO Note

 

 

6,011,159

 

 

 

5,686,757

 

 

 

6,011,159

 

 

 

5,686,757

 

Anti-dilutive Dragonfly Seller Convertible Notes

 

 

1,147,033

 

 

 

-

 

 

 

1,147,033

 

 

 

-

 

Anti-dilutive Aicel Convertible Notes

 

 

112,038

 

 

 

109,023

 

 

 

112,038

 

 

 

109,023

 

Total anti-dilutive securities excluded from diluted loss per share

 

 

39,878,049

 

 

 

36,408,685

 

 

 

39,878,049

 

 

 

36,419,314

 

 

Note 15. Provision (Benefit) from Income Taxes

Effective Tax Rate

The Company computes its quarterly and year-to-date provisions for income taxes by applying the estimated effective tax rates to the quarterly and year-to-date pre-tax income or losses and adjusting the provisions for discrete tax items recorded in the periods. For the three months ended September 30, 2024 the Company reported a tax provision of $621 on a pre-tax loss of $15,556, which resulted in an effective tax rate of (3.99) percent. For the nine months ended September 30, 2024, the Company reported a tax provision of $1,129 on a pre-tax income of $24,029, which resulted in an effective tax rate of (4.70) percent. The Company’s effective tax rate differed from the U.S. statutory rate of 21 percent primarily due to the impact of a valuation allowance on the Company’s deferred tax assets. During the nine months ended September 30, 2024, the Company recorded a discrete tax charge for the impact of the sale of Board.org of $2,301.

For the three months ended September 30, 2023, the Company reported a tax benefit of $62 on a pre-tax loss of $14,529, which resulted in an effective tax rate of 42.67% percent. For the nine months ended September 30, 2023, the Company reported a tax provision of $181 on a pre-tax loss of $64,532, which resulted in an effective tax rate of 0.28 percent. The Company’s effective tax rate differed from the U.S. statutory rate of 21 percent primarily due to state taxes, the impact of a valuation allowance on the Company’s deferred tax assets, and other

21


Table of Contents

 

nondeductible expenses such as stock option deductions and non-deductible officer's compensation. During the nine months ended September 30, 2023, the Company had discrete items relating to goodwill impairment, unrecognized tax benefits and the tax impact of interest expense on unrecognized tax benefits.

Unrecognized Tax Benefits and Other Considerations

The Company records liabilities related to its uncertain tax positions. Tax positions for the Company and its subsidiaries are subject to income tax audits by multiple tax jurisdictions throughout the world. The Company believes that it has provided adequate reserves for its income tax uncertainties in all open tax years. As the outcome of the tax audits cannot be predicted with certainty, if any issues arising in the Company's tax audits progress in a manner inconsistent with management's expectations, the Company could adjust its provision for income taxes in the future. For the nine months ended September 30, 2024, the Company reported an uncertain tax position totaling $639 relating to a state tax filing position. The Company has the no activity relating to unrecognized tax benefits for the three and nine months ended September 30, 2024 and 2023.

Note 16. Fair Value Measurements and Disclosures

Fair value is defined as the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels, which are described below:

•
Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets
•
Level 2 – Observable inputs other than quoted prices that are either directly or indirectly observable for the asset or

liability

•
Level 3 – Unobservable inputs that are supported by little or no market activity

The carrying value of cash and cash equivalents (including investments with an original maturity of three months or less at the date of purchase), restricted cash, accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments.

The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of September 30, 2024 by level within the fair value hierarchy:

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

$

3,518

 

 

$

-

 

 

$

-

 

 

$

3,518

 

Short-term investments

 

 

-

 

 

 

7,040

 

 

 

-

 

 

 

7,040

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Public warrants

 

$

1,254

 

 

$

-

 

 

$

-

 

 

$

1,254

 

Private placement warrants

 

 

-

 

 

 

1,050

 

 

 

-

 

 

 

1,050

 

Contingent liabilities from acquisitions

 

 

-

 

 

 

-

 

 

 

113

 

 

 

113

 

New GPO Note

 

 

-

 

 

 

-

 

 

 

36,487

 

 

 

36,487

 

Dragonfly Seller Convertible Notes

 

 

-

 

 

 

-

 

 

 

9,226

 

 

 

9,226

 

The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2023 by level within the fair value hierarchy:

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

$

3,044

 

 

$

-

 

 

$

-

 

 

$

3,044

 

Short-term investments

 

 

-

 

 

 

7,134

 

 

 

-

 

 

 

7,134

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Public warrants

 

$

2,591

 

 

$

-

 

 

$

-

 

 

$

2,591

 

Private placement warrants

 

 

-

 

 

 

2,170

 

 

 

-

 

 

 

2,170

 

Contingent liabilities from acquisitions

 

 

-

 

 

 

-

 

 

 

130

 

 

 

130

 

Liability classified warrants (a)

 

 

-

 

 

 

-

 

 

 

23

 

 

 

23

 

New GPO Note

 

 

-

 

 

 

-

 

 

 

36,954

 

 

 

36,954

 

Dragonfly Seller Convertible Notes

 

 

-

 

 

 

-

 

 

 

9,002

 

 

 

9,002

 

Era Convertible Note

 

 

-

 

 

 

-

 

 

 

5,977

 

 

 

5,977

 

(a) - Included in other non-current liabilities on the condensed consolidated balance sheets

 

 

22


Table of Contents

 

The following table summarizes changes in fair value of the Company’s level 3 liabilities during the periods presented:

 

 

Contingent
Liabilities from Acquisitions

 

 

Liability Classified Warrants

 

 

New GPO Note

 

 

Dragonfly Seller Convertible Notes

 

 

Era Convertible Note

 

Balance at December 31, 2023

 

$

130

 

 

$

23

 

 

$

36,954

 

 

$

9,002

 

 

$

5,977

 

Fair value at issuance date

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

801

 

Change in fair value included in the determination of net (income) loss(a)

 

 

(3

)

 

 

(23

)

 

 

2,117

 

 

 

339

 

 

 

3,189

 

Change in fair value included in accumulated other comprehensive income

 

 

-

 

 

 

-

 

 

 

(4,443

)

 

 

(1,264

)

 

 

-

 

Cash contingent consideration earned and subsequently settled

 

 

(14

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Paid in kind interest

 

 

-

 

 

 

-

 

 

 

2,826

 

 

 

747

 

 

 

-

 

Note and interest conversion

 

 

-

 

 

 

-

 

 

 

(967

)

 

 

-

 

 

 

(9,967

)

Foreign exchange

 

 

-

 

 

 

-

 

 

 

-

 

 

 

402

 

 

 

-

 

Balance at September 30, 2024

 

$

113

 

 

$

-

 

 

$

36,487

 

 

$

9,226

 

 

$

-

 

(a)
The change in contingent liabilities from acquisitions is recorded as transaction costs on the condensed consolidated statements of operations and comprehensive income (loss).

 

Short-Term Investments

The fair value of the short-term investments is based on the quoted market price of the securities on the valuation date. As of September 30, 2024, the estimated fair value of the short-term investments was $7,040. The Company recognized a non-cash loss of $15 and $115 and $94 and $115 for the three and nine months ended September 30, 2024 and 2023, respectively, resulting from the change in fair value of the short-term investments. The change in fair value is recorded in the condensed consolidated statements of operations and comprehensive income (loss).

Public Warrants

The fair value of the public warrants is based on the quoted market price of such warrants on the valuation date. As of September 30, 2024 and December 31, 2023, the estimated fair value of the public warrants was $1,254 and $2,591, respectively. The Company recognized a non-cash gain of $251 and a non-cash gain of $2,173 during the three months ended September 30, 2024 and 2023, respectively, and a non-cash gain of $1,337 and $8,777 during the nine months ended September 30, 2024 and 2023 resulting from the change in fair value of the public warrants, respectively. The change in fair value is recorded in change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss).

Private Placement Warrants

As of September 30, 2024 and December 31, 2023, the estimated fair value of the private warrants was $1,050 and $2,170, respectively. The Company recognized a non-cash gain of $210 and a non-cash gain of $1,820 during the three months ended September 30, 2024 and 2023, respectively, and a non-cash gain of $1,120 and $7,350 during the nine months ended September 30, 2024 and 2023, respectively, resulting from the change in fair value of the private warrants. The change in fair value is recorded in change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss).

New GPO Note

The New GPO Note was recognized as a liability in connection with the settlement of litigation on the Subscription Date at its estimated fair value of $36,583. The estimated fair value of the New GPO Note was determined based on a trinomial lattice model. The following table presents the assumptions used to determine the fair value of the New GPO Note at September 30, 2024 and at December 31, 2023:

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Common stock share price

 

$

1.28

 

 

$

1.14

 

Risk free rate

 

 

3.6

%

 

 

3.9

%

Yield

 

 

17.5

%

 

 

14.5

%

Expected volatility

 

 

49.0

%

 

 

50.0

%

Expected term (years)

 

 

3.8

 

 

 

4.5

 

Dragonfly Seller Convertible Notes

The Dragonfly Seller Convertible Notes were recognized as a liability in connection with the acquisition on January 27, 2023 at a fair value of $8,635. As of September 30, 2024 and December 31, 2023, the estimated fair value of the Dragonfly Seller Convertible Notes were $9,926 and $9,002. The unrealized change in the fair value of the Dragonfly Seller Convertible Note of $0 and $1,264 is recorded in accumulated other comprehensive income for the three and nine months ended September 30, 2024 and the non-cash loss of $743 and non-cash loss of $339 was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three and nine months ended September 30, 2024. The non-cash gain was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive loss in the amount

23


Table of Contents

 

of a gain of $401 and a loss of $6 for the three and nine months ended September 30, 2023, respectively. The following table presents the assumptions used to determine the fair value of the Dragonfly Seller Convertible Notes at September 30, 2024 and January 27, 2023:

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Common stock share price

 

$

1.28

 

 

$

1.14

 

Risk free rate

 

 

3.6

%

 

 

3.9

%

Yield

 

 

19.0

%

 

 

15.5

%

Expected volatility

 

 

50.0

%

 

 

50.0

%

Expected term (years)

 

 

3.3

 

 

 

4.1

 

As of September 30, 2024, the difference between the aggregate fair value and the unpaid principal balance of the Dragonfly Seller Convertible Notes is $4,415.

Era Convertible Note

The Era Convertible Note was recognized as a liability associated with the Company’s strategic commercial partnership on December 8, 2023 at a fair value of $5,500. During the first quarter of 2024, the Company issued $801 of new debt related to the new Era Convertible Note. During the second quarter of 2024, the Company satisfied all of its obligations underlying the Era Convertible Note by issuing 6,852,099 shares of Common Stock. At December 31, 2023 the fair value of the Era Convertible Note was $5,977. The non-cash change in fair value of financial instruments recorded in the condensed consolidated statements of operations and comprehensive income (loss) was a loss of $0 and $3,189 for the three and nine months ended September 30, 2024, respectively. The following table presents the assumptions used to determine the fair value of the Era Convertible Note at December 31, 2023:

 

 

December 31, 2023

 

Common stock share price

 

$

1.14

 

Risk free rate

 

 

4.17

%

Yield

 

 

153.24

%

Expected volatility

 

 

63.00

%

Expected term (years)

 

 

3.9

 

Contingent Liabilities from acquisitions

The contingent liabilities from acquisitions are classified as Level 3 in the fair value hierarchy. At September 30, 2024 and December 31, 2023, the contingent consideration and compensation relates to the following acquisitions:

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Curate

 

$

-

 

 

$

4

 

Equilibrium

 

 

113

 

 

 

112

 

DT Global

 

 

-

 

 

 

14

 

Total contingent liabilities from acquisitions

 

$

113

 

 

$

130

 

The Company settled part of the Curate contingent consideration and compensation through an issuance of 83,393 additional shares in a non-cash transaction during the first quarter of 2023.

Liability classified warrants

The Last Out Lender Warrants are classified as Level 3 in the fair value hierarchy. The fair value of the Last Out Lender Warrants is calculated using the Black-Scholes calculation with the following inputs:

 

 

September 30, 2024

 

 

December 31, 2023

 

Common stock fair value

 

$

1.28

 

 

$

1.14

 

Time to maturity (years)

 

 

0.8

 

 

 

1.6

 

Risk free rate

 

 

4.10

%

 

 

4.45

%

Volatility

 

 

62

%

 

 

122

%

Exercise price

 

$

8.56

 

 

$

8.56

 

Non-Financial Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

The Company’s long-lived assets, including property and equipment, intangible assets and goodwill are measured at fair value on a non-recurring basis when an impairment has occurred. The Company has recognized an impairment of goodwill as disclosed in Note 7, "Goodwill" during the three months ended March 31, 2023. The Company has not identified any additional impairments to be recorded during the three and nine months ended September 30, 2024 and 2023.

There were no transfers of assets or liabilities between levels during the nine months ended September 30, 2024 and 2023.

Changes to fair value are recognized as income or expense in the condensed consolidated statements of operations and comprehensive loss.

24


Table of Contents

 

Note 17. Commitments and Contingencies

Legal Proceedings

From time to time the Company is a party to various disputes, claims, lawsuits and other regulatory and legal matters, including both asserted and unasserted legal claims, in the ordinary course of business. The status of each such matter, referred to herein as a loss contingency, is reviewed and assessed in accordance with applicable accounting rules regarding the nature of the matter, the likelihood that a loss will be incurred, and the amounts involved.

As discussed in Note 8, "Debt", on June 30, 2023, the Company entered into the Exchange and Settlement Agreement and New GPO Note. Pursuant thereto, on July 3, 2023, (i) the Disputing Lender returned 5,881,723 shares of Class A Common Stock, which the Company subsequently cancelled, (ii) the Company issued the New GPO Note, and (iii) the parties agreed to a mutual settlement and release of all claims (including, but not limited to, any claims by the Investor for additional shares or money damages resulting from the entry into the Merger Agreement), relating to or arising from the conversion of the Amended and Restated Senior Secured Subordinated Promissory Note, dated December 29, 2020, previously issued by a subsidiary of the pre-business combination FiscalNote Holdings, Inc. to the Investor.

Legal fees are recognized as incurred when the legal services are provided, and therefore are not recognized as part of the loss contingency.


 

25


Table of Contents

 

Note 18. Subsequent Events

The Company has evaluated subsequent events through November 12, 2024, the date that the financial statements were available to be issued.

Sale of Aicel

On October 31, 2024, the Company entered into an agreement (the "Purchase Agreement") to sell the equity of the Company's subsidiary owning and operating its Aicel Technologies business ("Aicel") to a South Korean based-group (the “Buyer”). Total consideration was $9,650 comprised of a cash payment to the Company of $8,500 and the assumption of an existing convertible note previously issued by Aicel in 2022, with an outstanding total principal and accrued paid-in-kind interest amount of $1,150. The net proceeds, after paying transaction fees, expenses, and taxes were used to repay $5,000 of principal and accrued paid-in-kind interest of the Company's Senior Term Loan.

Era Convertible Note

On November 12, 2024, the Company issued a $5,500 senior subordinated convertible note (the "Note") to a subsidiary of Era Global Technologies, LLC (the "Investor") with cash interest equal to the applicable federal rate published by the Internal Revenue Service beginning on the six-month anniversary of the Issuance Date. The Note is contractually subordinated to the Company’s obligations under its senior secured indebtedness, and accordingly the Company’s right to make certain cash payments in connection therewith is limited by the terms of such subordination agreement (the “Subordination Agreement”). The Investor may convert the Note into shares (the “Underlying Shares”) of the Company’s class A common stock beginning on the six-month anniversary of the Issuance Date (the “Initial Conversion Date”) based on the volume weighted average price of the trailing 30 trading day period prior to the conversion. In addition, the Company may elect to convert all or a portion of the Note into the Underlying Shares (the “Optional Conversion Right”) if the Underlying Shares are registered for resale under the Securities Act of 1933, as amended (the “Securities Act”). The note matures on November 12, 2027.

The Company also issued, as a success fee, 2,549,129 shares of Common Stock to the Investor (the “Success Fee Shares”). The Investor is not permitted to sell the Success Fee Shares before the six-month anniversary of the Issuance Date; provided, however, that if the Company elects to convert any portion of the Note into Underlying Shares pursuant to its Optional Conversion Right, then the Investor may sell a pro-rata portion of the Success Fee Shares. The Company also issued 650,000 shares of Common Stock to Northland Securities, Inc. to cover brokerage fees incurred by the Investor in connection with its sales of Common Stock over time.

The Note also requires the Company to issue additional shares of Common Stock (“Additional Shares”) to the Investor if the Investor sells the Success Fee Shares and Underlying Shares within 12 months after the earlier of (i) issuance of all Underlying Shares issued pursuant to the Optional Conversion Right or (ii) the Initial Conversion Date (the “Sell-Off Period”), to the extent such sales of the Success Fee Shares and the Underlying Shares during the Sell-Off Period do not generate aggregate cash proceeds to the Investor that equal or exceed $8,250. Any such Additional Shares would be valued based on the volume weighted average price of the trailing 30 trading day period, calculated prior to the date of any such issuance. In the event the Investor sells the Underlying Shares, Success Fee Shares and/or any Additional Shares for an amount equal to the sum of $8,250, the Investor shall be required to return any remaining Underlying Shares, Success Fee Shares and/or Additional Shares, as applicable, and cancel any remaining amount of the Principal Amount owed by the Company.

 

26


Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion provides information that FiscalNote’s management believes is relevant to an assessment and understanding of FiscalNote’s condensed consolidated results of operations and financial condition. The discussion should be read together with the unaudited interim condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Certain monetary amounts, percentages and other figures included below have been subject to rounding adjustments as amounts are presented in thousands or millions, as the context describes. Percentage amounts included below have not in all cases been calculated on the basis of such rounded figures, but on the basis of such amounts prior to rounding. For this reason, percentage amounts may vary from those obtained by performing the same calculations using the figures in our condensed consolidated financial statements included elsewhere herein. Certain other amounts that appear below may not sum due to rounding.

This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in Part II, Item 1A, “Risk Factors” and other factors set forth in other parts of this Quarterly Report on Form 10-Q. Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the Closing.

Overview

FiscalNote is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political, regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products, coupled with expert research and analysis of markets and geopolitical events, as well as powerful tools to manage workflows, advocacy campaigns and constituent relationships.

Business Combination

On July 29, 2022, the Company consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2021, and as amended on May 9, 2022, (the “Merger Agreement”), by and among FiscalNote Holdings, Inc., a Delaware corporation (“Old FiscalNote”), Duddell Street Acquisition Corp., a Cayman Islands exempted company (“DSAC”), and Grassroots Merger Sub, Inc., a Delaware Corporation and a wholly owned direct subsidiary of DSAC (“Merger Sub” and, together with DSAC, the “DSAC Parties”). Pursuant to these transactions, Merger Sub merged with and into Old FiscalNote, with Old FiscalNote becoming a wholly owned subsidiary of DSAC (the “Business Combination” and, collectively with the other transactions described in the Business Combination Agreement, the “Transactions”). In connection with the closing of the Transactions, DSAC domesticated and continued as a Delaware corporation under the name of “FiscalNote Holdings, Inc.” (“New FiscalNote”). Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the closing on July 29, 2022. Subsequent to the closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE.WS,” respectively. The Company accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded.

Factors Impacting the Comparability of Our Operating Results

Acquisitions / Disposals

On March 11, 2024, we completed the sale of Board.org for a total value of up to $103.0 million, consisting of $95.0 million in cash at closing and a potential earnout opportunity of up to $8.0 million. The Company recorded a gain on sale of business of $71.6 million during the three months ended March 31, 2024.

On January 27, 2023, we completed the acquisition of Dragonfly for up to $25.2 million (the "2023 Acquisition"), which included a combination of cash, stock, convertible notes and contingent payments.

As a result of our acquisitions, we have, and will continue to incur, significant non-cash amortization expense related to the amortization of purchased intangibles, which have reduced our operating income by approximately $0.8 million and $1.3 million during the three months ended September 30, 2024 and 2023, respectively, and $2.6 million and $3.7 million during the nine months ended September 30, 2024 and 2023, respectively.

 

27


Table of Contents

 

Product rationalization

From time to time, management reviews the Company’s existing products and services based on their financial profile and other strategic factors. In connection with such reviews, management decided to cease actively selling and therefore sunset certain non-core products, representing, in aggregate:

•
Subscription revenue of approximately $0.1 million and $0.2 million during the three months ended September 30, 2024 and 2023 and approximately $0.4 million and $0.5 million during the nine months ended September 30, 2024 and 2023; and
•
Non-subscription advisory revenue of approximately $1.1 million and $2.4 million during the three and nine months ended September 30, 2023.

On March 11, 2024, we sold Board.org. Board.org’s contributions to FiscalNote through March 11, 2024 were as follows:

•
Subscription revenue of approximately $3.4 million during the three months ended September 30, 2023 and approximately $2.8 million and $9.6 million during the nine months ended September 30, 2024 and 2023;
•
Non-subscription event revenue of approximately $0.2 million and $0.5 million during the three and nine months ended September 30, 2023;
•
Run-rate revenue of approximately $15.2 million at December 31, 2023 and $14.3 million at September 30, 2023; and
•
Annual Recurring Revenue ("ARR") of approximately $14.7 million at December 31, 2023 and $13.7 million at September 30, 2023.

At the beginning of the third quarter of 2023 the Company had approximately 760 employees. In conjunction with the Company's product rationalization, business simplification, and cost takeout actions, the Company's full-time equivalent headcount reduced by approximately 175 from the beginning of the third quarter of 2023 through September 30, 2024. As a result, the Company has seen a reduction in overall costs across all operating expenses. Management will continue evaluating the Company's product portfolio for additional rationalization opportunities, both to further reduce the complexity of the business and ongoing operating expenses and to raise capital through opportunistic divestitures where appropriate. For example, as discussed in Note 18, Subsequent Events, the Company sold the Aicel business on October 31, 2024.

Future Growth Initiatives

The Company has observed slower than anticipated client decision-making on new logo sales, cross-sells and upsells, together with softer than expected renewal rates among existing clients, due to several factors including macroeconomic headwinds, competitive pressures and delays in the launch of certain product enhancements. These issues have led to slower growth in ARR, which in turn is expected to impact revenue in the coming fiscal year. In response and subject to the Company's review of strategic alternatives as previously disclosed, the Company is expecting to implement a number of actions to accelerate growth into 2025, including:

•
product enhancements and new product launches to drive improvement in user experience, client engagement and retention;
•
improvements to our client success and support; and
•
cross-selling and upselling opportunities at existing clients.

 

Several of these initiatives require focused investment in our core product offerings and refinement of our go-to-market approach. We may continue to incur additional costs upfront to implement product enhancements, launch new products and features, obtain new customers and expand our relationships with existing customers, including additional sales and marketing expenses specific to subscription revenue. In addition, we will continue to assess opportunities to acquire complementary businesses that supplement our existing platform or enable us to enter adjacent markets.

Key Performance Indicators

In addition to our GAAP results further described and discussed below in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” we monitor the following key performance indicators to evaluate growth trends, prepare financial projections, make strategic decisions, and measure the effectiveness of our sales and marketing efforts. Our management team assesses our performance based on these key performance indicators because it believes they reflect the underlying trends of our business and serve as meaningful measures of our ongoing operational performance.

Annual Recurring Revenue (“ARR”)

Approximately 90% of our revenues are subscription based. Our ability to retain existing subscription customers is a key performance indicator that helps explain the evolution of our historical results and is a leading indicator of our revenues and cash flows for subsequent periods. We use ARR as a measure of our revenue trend and an indicator of our future revenue opportunity from existing recurring subscription customer contracts. We calculate ARR on a parent account level by annualizing the contracted subscription revenue, and our total ARR as of the end of a period is the aggregate thereof. ARR is not adjusted for the impact of any known or projected future customer cancellations, upgrades or downgrades, or price increases or decreases. The amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to timing of the revenue bookings during the period, cancellations, upgrades, or downgrades and pending renewals. ARR should be viewed independently of revenue as it is an operating metric and is not intended to be a replacement or forecast of revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

28


Table of Contents

 

Our ARR at September 30, 2024 and December 31, 2023, was $109.5 million and $126.1 million, respectively. Excluding Board.org, our ARR at December 31, 2023 and September 30, 2023 was $111.4 million and $109.3 million, respectively.

Run-Rate Revenue

Management also monitors Run-Rate Revenue, which we define as ARR plus non-subscription revenue earned during the last twelve months. We believe Run-Rate Revenue is an instructive indicator of our total revenue growth, incorporating the non-subscription revenue that we believe is a meaningful contribution to our business as a whole. Although our non-subscription business is non-recurring, we regularly sell different advisory services to repeat customers. The amount of actual subscription and non-subscription revenue that we recognize over any 12-month period is likely to differ from Run-Rate Revenue at the beginning of that period, sometimes significantly. Our Run-Rate Revenue at September 30, 2024 and December 31, 2023, was approximately $119.4 million and $139.7 million, respectively. Excluding Board.org, our Run-Rate Revenue at December 31, 2023 and September 30, 2023 was $124.5 million and $123.9 million, respectively.

Net Revenue Retention (“NRR”)

Our NRR, which we use to measure our success in retaining and growing recurring revenue from our existing customers, compares our recognized recurring revenue from a set of customers across comparable periods. We calculate our NRR for a given period as ARR at the end of the period minus ARR contracted from new clients for which there is no historical revenue booked during the period, divided by the beginning ARR for the period. We calculate NRR at our parent account level. Customers from acquisitions are not included in NRR until they have been part of our condensed consolidated results for 12 months. Accordingly, the 2023 and 2022 Acquisitions are not included in our NRR for the three months ended September 30, 2023. Our calculation of NRR for any fiscal period includes the positive recurring revenue impacts of selling additional licenses and services to existing customers and the negative recognized recurring revenue impacts of contraction and attrition among this set of customers. Our NRR may fluctuate as a result of a number of factors, including the level of our revenue base, the level of penetration within our customer base, expansion of products and features, the timing of renewals, and our ability to retain our customers. Our calculation of NRR may differ from similarly titled metrics presented by other companies. NRR was 99% and 100% for the three months ended September 30, 2024 and 2023, respectively.

Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with GAAP, we use certain non-GAAP financial measures to clarify and enhance our understanding, and aid in the period-to-period comparison, of our performance. Where applicable, we provide reconciliations of these non-GAAP measures to the corresponding most closely related GAAP measure. Investors are encouraged to review the reconciliation of each of these non-GAAP financial measures to its most comparable GAAP financial measure. While we believe that these non-GAAP financial measures provide useful supplemental information, non-GAAP financial measures have limitations and should not be considered in isolation from, or as a substitute for, their most comparable GAAP measures. These non-GAAP financial measures are not prepared in accordance with GAAP, do not reflect a comprehensive system of accounting and may not be comparable to similarly titled measures of other companies due to potential differences in their financing and accounting methods, the book value of their assets, their capital structures, the method by which their assets were acquired and the manner in which they define non-GAAP measures.

Adjusted Gross Profit and Adjusted Gross Profit Margin

We define Adjusted Gross Profit as Total revenues minus cost of revenues, including amortization of capitalized software development costs and acquired developed technology, before amortization of intangible assets that are included in costs of revenues. We define Adjusted Gross Profit Margin as Adjusted Gross Profit divided by Total revenues.

We use Adjusted Gross Profit and Adjusted Gross Profit Margin to understand and evaluate our core operating performance and trends. We believe these metrics are useful measures to us and to our investors to assist in evaluating our core operating performance because they provide consistency and direct comparability with our past financial performance and between fiscal periods, as the metrics eliminate the non-cash effects of amortization of intangible assets that may fluctuate for reasons unrelated to overall operating performance.

Adjusted Gross Profit and Adjusted Gross Profit Margin have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of our results as reported under GAAP. They should not be considered as replacements for gross profit and gross profit margin, as determined by GAAP, or as measures of our profitability. We compensate for these limitations by relying primarily on our GAAP results and using non-GAAP measures only for supplemental purposes. Adjusted Gross Profit and Adjusted Gross Profit Margin as presented herein are not necessarily comparable to similarly titled measures presented by other companies.

EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin

EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. EBITDA represents earnings before interest expense, income taxes, depreciation and amortization. Adjusted EBITDA reflects further adjustments to EBITDA to exclude certain non-cash items and other items that management believes are not indicative of ongoing operations. We define Adjusted EBITDA Margin as Adjusted EBITDA divided by Total revenues.

We disclose EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin in this Quarterly Report on Form 10-Q because these non-GAAP measures are key measures used by management to evaluate our business, measure our operating performance and make strategic decisions. We believe that EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin are useful for investors and others in understanding and evaluating our operating results in the same manner as management. EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin are not financial measures calculated in accordance with GAAP and should not be considered as substitutes for net income (loss), net income (loss) before income taxes, or any other operating performance measure calculated in accordance with GAAP. Using these non-GAAP financial measures to analyze our business would have material limitations because the calculations are based on the subjective determination

29


Table of Contents

 

of management regarding the nature and classification of events and circumstances that investors may otherwise find significant. In addition, although other companies in our industry may report measures titled EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin or similar measures, such non-GAAP financial measures may be calculated differently from how we calculate non-GAAP financial measures, which reduces their comparability. Because of these limitations, you should consider EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin alongside other financial performance measures, including net income and our other financial results presented in accordance with GAAP.

Key Components of Results of Operations

Revenues

We derive our revenues from subscription revenue arrangements and advisory, advertising and other revenues. Subscription revenues accounted for approximately 93% and 90% of our total revenues for the nine months ended September 30, 2024 and 2023.

Subscription revenue

Subscription revenues consist of revenue earned from subscription-based arrangements that provide customers the right to use the Company’s software and products in a cloud-based infrastructure. Subscription revenues are driven primarily by the number of active licenses, the types of products and the price of the subscriptions. The Company also earns subscription revenues by licensing to customers its digital content, including transcripts, news and analysis, images, video and podcast data.

Our subscription arrangements generally have contractual terms of 12 months or more and are non-refundable regardless of the actual use of the service. Subscription revenues are recognized ratably over the non-cancellable contract terms beginning on the commencement date of each contract, which is the date our service is first made available to customers.

Advisory, advertising, and other revenue

Advisory revenue is typically earned under contracts for specific deliverables and are non-recurring in nature, although we regularly sell different advisory services to repeat customers. One-time advisory revenues are invoiced according to the terms of the contract, usually delivered to the customer over a short period of time, during which revenues are recognized.

Advertising revenue is primarily generated by delivering advertising in our own publications (Roll Call and CQ) in both print and digital formats. Revenue for print advertising is recognized upon publication of the advertisement. Revenue for digital advertising is recognized over the period of the advertisement or, if the contract contains impression guarantees, based on delivered impressions.

Books revenue is recognized when the product is shipped to the customer, which is when control of the product transfers to the customer. Shipping and handling costs are treated as a fulfillment activity and are expensed as incurred.

Events revenue is deferred and only recognized when the event has taken place and is included in other revenues.

Cost of revenues, including amortization

Cost of revenues, including amortization primarily consists of expenses related to hosting our service, the costs of data center capacity, amortization of developed technology and capitalized software development costs, certain fees paid to various third parties for the use of their technology, services, or data, costs of compensation, including bonuses, stock compensation, benefits and other expenses for employees associated with providing professional services and other direct costs of production. Also included in cost of revenues, including amortization are our costs related to the preparation of contracted advisory deliverables, as well as costs to develop, publish, print and deliver our publications underlying our books revenue.

Research and development

Research and development expenses include the costs of compensation, including bonuses, stock compensation, benefits and other expenses for employees associated with the creation and testing of the products we offer, related software subscriptions, consulting and contractor fees and allocated overhead.

Sales and marketing

Sales and marketing expenses consist primarily of salaries and related expenses, including bonuses, stock compensation, benefits and other expenses for our sales and marketing staff, including commissions, related software subscriptions, consulting fees, marketing programs and allocated overhead. Marketing programs consist of advertising, events, corporate communications, brand building and product marketing activities.

Editorial

Editorial expenses consist of salaries and related expenses, including bonuses, stock compensation, benefits and other expenses for the editorial team involved in acquiring, creating, and distributing content and allocated overhead.

General and administrative

General and administrative expenses are primarily related to our executive offices, finance and accounting, human resources, legal, internal operations and other corporate functions. These expenses consist of salaries and related expenses, including bonuses, stock compensation, benefits and other expenses, along with professional fees, depreciation and other allocated overhead.

30


Table of Contents

 

Amortization of intangible assets

Amortization expense relates to our finite-lived intangible assets, including developed technology, customer relationship, databases and tradenames. These assets are amortized over periods of between three and twenty years. Finite-lived intangible assets are tested for impairment when indicators are present, and, if impaired, are written down to fair value. No impairment of intangible assets has been identified during any financial period included in our accompanying condensed consolidated financial statements.

Impairment of goodwill

Goodwill is tested for impairment when indicators are present, and if impaired are written down to fair value. An impairment of goodwill was identified during the three months ended March 31, 2023 and is included in our accompanying condensed consolidated financial statements.

Transaction costs, net

Transaction costs consist of acquisition related costs (including due diligence, accounting, legal, and other professional fees, incurred from acquisition activity), fair value adjustments to contingent consideration due to sellers, and non-capitalizable costs.

Interest expense, net

Interest expense, net, consists of expense related to interest on our borrowings, the amortization and write off of debt issuance costs and original discount, and interest related to certain derivative instruments.

Fair value of financial instruments

The fair value of warrants, debt accounted for under the fair value option, and derivative liabilities are accounted for in accordance with ASC 815, ASC 825, and ASC 480. These financial instruments are marked to market each reporting period in accordance with ASC 820 with all gains and losses being recorded within the condensed consolidated statement of operations and comprehensive loss, with the exception of any gains or losses recorded due to changes in the fair value of instrument-specific credit risk being recorded as a component of accumulated other comprehensive income in the condensed consolidated balance sheets.

Income taxes

We use the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on temporary differences between the condensed consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.

The effect on deferred tax assets and liabilities of a change in tax laws is recognized in the condensed consolidated statements of operations and comprehensive income (loss) in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are expected to be realized based on the weighting of positive and negative evidence.

Results of Operations

The period-to-period comparisons of our results of operations have been prepared using the historical periods included in our condensed consolidated financial statements. The following discussion should be read in conjunction with those condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q.

31


Table of Contents

 

Comparison of the Consolidated Results for the Three and Nine Months Ended September 30, 2024 and September 30, 2023

The following table presents our results of operations for the periods indicated:

 

 

Three Months Ended
September 30,

 

 

Change

 

 

Nine Months Ended
September 30,

 

 

Change

 

(In thousands)

 

2024

 

 

2023

 

 

$

 

 

%

 

 

2024

 

 

2023

 

 

$

 

 

%

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subscription

 

$

27,238

 

 

$

30,057

 

 

$

(2,819

)

 

 

(9.4

)%

 

$

84,015

 

 

$

87,986

 

 

$

(3,971

)

 

 

(4.5

)%

Advisory, advertising, and other

 

 

2,201

 

 

 

3,952

 

 

 

(1,751

)

 

 

(44.3

)%

 

 

6,782

 

 

 

10,394

 

 

 

(3,612

)

 

 

(34.8

)%

Total revenues

 

 

29,439

 

 

 

34,009

 

 

 

(4,570

)

 

 

(13.4

)%

 

 

90,797

 

 

 

98,380

 

 

 

(7,583

)

 

 

(7.7

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues, including amortization

 

 

6,235

 

 

 

10,441

 

 

 

(4,206

)

 

 

(40.3

)%

 

 

20,342

 

 

 

28,863

 

 

 

(8,521

)

 

 

(29.5

)%

Research and development

 

 

3,250

 

 

 

4,540

 

 

 

(1,290

)

 

 

(28.4

)%

 

 

9,935

 

 

 

14,170

 

 

 

(4,235

)

 

 

(29.9

)%

Sales and marketing

 

 

9,068

 

 

 

11,235

 

 

 

(2,167

)

 

 

(19.3

)%

 

 

27,484

 

 

 

35,222

 

 

 

(7,738

)

 

 

(22.0

)%

Editorial

 

 

4,639

 

 

 

4,516

 

 

 

123

 

 

 

2.7

%

 

 

13,752

 

 

 

13,533

 

 

 

219

 

 

 

1.6

%

General and administrative

 

 

10,622

 

 

 

14,418

 

 

 

(3,796

)

 

 

(26.3

)%

 

 

37,958

 

 

 

48,813

 

 

 

(10,855

)

 

 

(22.2

)%

Amortization of intangible assets

 

 

2,436

 

 

 

2,899

 

 

 

(463

)

 

 

(16.0

)%

 

 

7,541

 

 

 

8,614

 

 

 

(1,073

)

 

 

(12.5

)%

Impairment of goodwill

 

 

-

 

 

 

-

 

 

 

-

 

 

NM

 

 

 

-

 

 

 

5,837

 

 

 

(5,837

)

 

 

(100.0

)%

Transaction (gains) costs, net

 

 

-

 

 

 

(579

)

 

 

579

 

 

NM

 

 

 

(4

)

 

 

1,138

 

 

 

(1,142

)

 

NM

 

Total operating expenses

 

 

36,250

 

 

 

47,470

 

 

 

(11,220

)

 

 

(23.6

)%

 

 

117,008

 

 

 

156,190

 

 

 

(39,182

)

 

 

(25.1

)%

Operating loss

 

 

(6,811

)

 

 

(13,461

)

 

 

6,650

 

 

 

(49.4

)%

 

 

(26,211

)

 

 

(57,810

)

 

 

31,599

 

 

 

(54.7

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of business

 

 

-

 

 

 

-

 

 

 

-

 

 

NM

 

 

 

(71,599

)

 

 

-

 

 

 

(71,599

)

 

 

100.0

%

Interest expense, net

 

 

5,585

 

 

 

8,018

 

 

 

(2,433

)

 

 

(30.3

)%

 

 

18,267

 

 

 

21,853

 

 

 

(3,586

)

 

 

(16.4

)%

Change in fair value of financial instruments

 

 

3,501

 

 

 

(7,157

)

 

 

10,658

 

 

 

(148.9

)%

 

 

3,174

 

 

 

(18,850

)

 

 

22,024

 

 

 

(116.8

)%

Loss on settlement

 

 

-

 

 

 

-

 

 

 

-

 

 

NM

 

 

 

-

 

 

 

3,474

 

 

 

(3,474

)

 

NM

 

Other (income) expense, net

 

 

(341

)

 

 

207

 

 

 

(548

)

 

NM

 

 

 

(82

)

 

 

245

 

 

 

(327

)

 

NM

 

Net (loss) income before income taxes

 

 

(15,556

)

 

 

(14,529

)

 

 

(1,027

)

 

 

7.1

%

 

 

24,029

 

 

 

(64,532

)

 

 

88,561

 

 

NM

 

(Benefit) provision from income taxes

 

 

(621

)

 

 

(62

)

 

 

(559

)

 

NM

 

 

 

1,129

 

 

 

181

 

 

 

948

 

 

NM

 

Net (loss) income

 

$

(14,935

)

 

$

(14,467

)

 

$

(468

)

 

 

3.2

%

 

$

22,900

 

 

$

(64,713

)

 

$

87,613

 

 

NM

 

NM - Not meaningful

Revenue:

Subscription revenue

Subscription revenue of $27.2 million for the three months ended September 30, 2024 decreased $2.8 million, or 9%, from $30.1 million for the three months ended September 30, 2023. Subscription revenue of $84.0 million for the nine months ended September 30, 2024 decreased $4.0 million for the nine months ended September 30, 2023.

The comparability of our revenues between periods was impacted by the Board.org sale and the 2023 Acquisition described under “Factors Impacting the Comparability of Our Results of Operations” above. The table below presents the primary items that impacted the comparability of our subscription revenues between periods.

 

 

Change for the Three Months Ended

 

 

Change for the Nine Months Ended

 

 

 

September 30, 2024 vs September 30, 2023

 

 

September 30, 2024 vs September 30, 2023

 

(In thousands)

 

$

 

 

%

 

 

$

 

 

%

 

Revenue change driver:

 

 

 

 

 

 

 

 

 

 

 

 

Decrease from sale of business

 

 

(3,388

)

 

 

(100

)%

 

 

(6,718

)

 

 

100

%

Increase from 2023 Acquisitions

 

 

140

 

 

 

100

%

 

 

1,131

 

 

 

100

%

Decrease from discontinued products

 

 

(165

)

 

 

(61

)%

 

 

(438

)

 

 

(53

)%

Increase from organic business

 

 

594

 

 

 

2

%

 

 

2,054

 

 

 

3

%

Revenues, net (total change)

 

$

(2,819

)

 

 

(9

)%

 

$

(3,971

)

 

 

(5

)%

The decrease in subscription revenue during the three and nine month periods is largely due to the impact from the sale of Board.org on March 11, 2024. This is partially offset by organic growth combined with increased revenue from the 2023 Acquisition, which was completed on January 27, 2023.

Advisory, advertising, and other revenue

Advisory, advertising, and other revenue was $2.2 million for the three months ended September 30, 2024, as compared to $4.0 million for the three months ended September 30, 2023. The decrease of $1.8 million, or 44%, was due largely to the discontinuation of unprofitable offerings that contributed approximately $1.1 million of revenue during the three months ended September 30, 2023.

Advisory, advertising, and other revenue was $6.8 million for the nine months ended September 30, 2024, as compared to $10.4 million for the three months ended September 30, 2023. The decrease of $3.6 million, or 35%, was due largely to the discontinuation of unprofitable offerings that contributed approximately $2.4 million of revenue during the nine months ended September 30, 2023.

32


Table of Contents

 

Revenue by Geography

The below tables present our revenues split by geographic region for the periods presented:

 

 

Three Months Ended
September 30,

 

 

Change

 

(In thousands)

 

2024

 

 

2023

 

 

$

 

 

%

 

North America

 

$

23,073

 

 

$

27,025

 

 

$

(3,952

)

 

 

(14.6

)%

Europe

 

 

5,527

 

 

 

5,015

 

 

 

512

 

 

 

10.2

%

Australia

 

 

328

 

 

 

298

 

 

 

30

 

 

 

10.1

%

Asia

 

 

511

 

 

 

1,671

 

 

 

(1,160

)

 

 

(69.4

)%

Total revenues

 

$

29,439

 

 

$

34,009

 

 

$

(4,570

)

 

 

(13.4

)%

 

 

 

Nine Months Ended
September 30,

 

 

Change

 

(In thousands)

 

2024

 

 

2023

 

 

$

 

 

%

 

North America

 

$

72,134

 

 

$

79,921

 

 

$

(7,787

)

 

 

(9.7

)%

Europe

 

 

16,178

 

 

 

14,192

 

 

 

1,986

 

 

 

14.0

%

Australia

 

 

950

 

 

 

875

 

 

 

75

 

 

 

8.6

%

Asia

 

 

1,535

 

 

 

3,392

 

 

 

(1,857

)

 

 

(54.7

)%

Total revenues

 

$

90,797

 

 

$

98,380

 

 

$

(7,583

)

 

 

(7.7

)%

Revenues by geography are determined based on the region of the FiscalNote contracting entity, which may be different than the region of the customer. North America revenues decreased primarily for the reasons stated above. Asia revenues decreased primarily due to non-recurring revenues from 2023. Revenues outside of North America increased primarily due to our acquisition of Dragonfly on January 27, 2023 (included in Europe).

Cost of revenues, including amortization

Cost of revenues, including amortization was $6.2 million for the three months ended September 30, 2024, as compared to $10.4 million for the three months ended September 30, 2023. The decrease of $4.2 million, or 40%, was primarily attributable to the sale of Board.org on March 11, 2024, a decrease in amortization expense of $2.3 million, of which $1.9 million was recognized in the third quarter of 2023 related to a revision in useful lives of certain of its developed technology assets, combined with a decrease from workforce planning actions made primarily throughout the second half of 2023.

Cost of revenues, including amortization was $20.3 million for the nine months ended September 30, 2024, as compared to $28.9 million for the nine months ended September 30, 2023. The decrease of $8.5 million, or 30%, was primarily attributable to the sale of Board.org on March 11, 2024, a decrease in amortization expense of $3.0 million, of which $1.9 million was recognized in the third quarter of 2023 related to a revision in useful lives of certain of its developed technology assets, a decrease from workforce planning actions made primarily throughout the second half of 2023, and combined with decreases in data center costs of $0.9 million.

Research and development

Research and development expense was $3.3 million for the three months ended September 30, 2024 as compared to $4.5 million for the three months ended September 30, 2023. The decrease of $1.3 million, or 28%, was primarily attributable to a decrease of $1.2 million of workforce planning actions made throughout the second half of 2023 combined with a decrease attributable to the sale of Board.org on March 11, 2024.

Research and development expense was $9.9 million for the nine months ended September 30, 2024 as compared to $14.2 million for the nine months ended September 30, 2023. The decrease of $4.2 million, or 30%, was primarily attributable to a decrease of $3.7 million of workforce planning actions made throughout the second half of 2023 combined with a decrease of $0.2 million attributable to the sale of Board.org on March 11, 2024.

Sales and marketing

Sales and marketing expense was $9.1 million for the three months ended September 30, 2024 as compared to $11.2 million for the three months ended September 30, 2023. The decrease of $2.2 million, or 19%, was primarily attributable to a decrease attributable to the sale of Board.org on March 11, 2024 and a decrease of stock compensation expense of $0.5 million.

Sales and marketing expense was $27.5 million for the nine months ended September 30, 2024 as compared to $35.2 million for the nine months ended September 30, 2023. The decrease of $7.7 million, or 22%, was primarily attributable to a decrease of the workforce planning actions made throughout the second half of 2023 combined with a decrease attributable to the sale of Board.org on March 11, 2024 and a decrease of stock compensation expense of $0.5 million.

Editorial expense

Editorial expense was relatively flat at $4.6 million for the three months ended September 30, 2024 as compared to $4.5 million for the three months ended September 30, 2023.

Editorial expense was relatively flat at $13.8 million for the nine months ended September 30, 2024 as compared to $13.5 million for the nine months ended September 30, 2023.

33


Table of Contents

 

General and administrative

General and administrative expense was $10.6 million for the three months ended September 30, 2024 as compared to $14.4 million for the three months ended September 30, 2023. The decrease of $3.8 million, or 26%, was primarily attributable to a decrease of $1.7 million of stock compensation expense for vested awards and workforce planning actions made throughout the second half of 2023.

General and administrative expense was $38.0 million for the nine months ended September 30, 2024 as compared to $48.8 million for the nine months ended September 30, 2023. The decrease of $10.9 million, or 22%, was primarily attributable to a decrease of $4.2 million of stock compensation expense for vested awards, workforce planning actions made throughout the second half of 2023, and a reduction in legal and accounting costs.

Impairment of goodwill

Impairment of goodwill was $5.8 million recognized during the first quarter of 2023 related to the impairment of goodwill in the ESG reporting unit. No impairment of goodwill was recorded in the three or nine months ended September 30, 2024.

Amortization of intangibles

Amortization of intangibles was $2.4 million for the three months ended September 30, 2024 as compared to $2.9 million for the three months ended September 30, 2023.

Amortization of intangibles was $7.5 million for the nine months ended September 30, 2024 as compared to $8.6 million for the nine months ended September 30, 2023.

Transaction (gains) costs, net

Transaction gains were $0.0 million for the three months ended September 30, 2024, as compared to transaction gains of $0.6 million for the three months ended September 30, 2023. The change of $0.6 million primarily relates to contingent compensation expense gains in 2023 related to the reversing of previously recognized earnout liabilities partially offset by changes in earnout liabilities related to our 2021 Acquisitions.

Transaction gains were $0.0 million for the nine months ended September 30, 2024, as compared to transaction costs of $1.1 million for the nine months ended September 30, 2023. The change of $1.1 million relates to costs of $1.4 million related to the acquisition of Dragonfly in 2023 and non-capitalized costs related to the Business Combination, partially offset by contingent compensation gains from the reversal of previously recognized expense and earnout liabilities.

Interest expense, net

Interest expense was $5.6 million for the three months ended September 30, 2024 as compared to $8.0 million for the three months ended September 30, 2023. The decrease in interest expense of $2.4 million was primarily due to the repayment of the Senior Term Loan.

Interest expense was $18.3 million for the nine months ended September 30, 2024 as compared to $21.9 million for the nine months ended September 30, 2023. The decrease in interest expense of $3.6 million was primarily due to the repayment of the Senior Term Loan.

Change in fair value of financial instruments

Change in fair value of financial instruments was a $3.5 million loss for the three months ended September 30, 2024 as compared to a $7.2 million gain for the three months ended September 30, 2023. The change in financial instruments of $10.7 million is primarily related to the changes in the Dragonfly Seller Convertible Notes and New GPO Note partially offset by the change in the fair value adjustment of the warrant liabilities.

Change in fair value of financial instruments was a $3.2 million loss for the nine months ended September 30, 2024 as compared to a $18.9 million gain for the nine months ended September 30, 2023. The change in financial instruments of $22.1 million is primarily related to the change in the fair value adjustment of the warrant liabilities that were assumed in connection with the Business Combination combined with the changes in the Dragonfly Seller Convertible Notes, New GPO Note, and the Era Convertible Notes.

Certain Non-GAAP Measures

We present certain non-GAAP financial measures including Adjusted Gross Profit, Adjusted Gross Profit Margin and Adjusted EBITDA. Our management team assesses our performance based on these non-GAAP measures because it believes they reflect the underlying trends and indicators of our business and serve as meaningful indicators of our continuous operational performance. We believe these measures are useful for investors for the same reasons. Investors should be aware that these measures are not a substitute for GAAP financial measures or disclosures. Where applicable, we provide reconciliations of these non-GAAP measures to the corresponding most closely related GAAP measure.

34


Table of Contents

 

Adjusted Gross Profit and Adjusted Gross Profit Margin

The following table presents our calculation of Adjusted Gross Profit and Adjusted Gross Profit Margin for the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(In thousands)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Total revenues

 

$

29,439

 

 

$

34,009

 

 

$

90,797

 

 

$

98,380

 

Costs of revenue, including amortization of capitalized software development costs and acquired developed technology

 

 

(6,235

)

 

 

(10,441

)

 

 

(20,342

)

 

 

(28,863

)

Gross Profit

 

$

23,204

 

 

$

23,568

 

 

$

70,455

 

 

$

69,517

 

Gross Profit Margin

 

 

79

%

 

 

69

%

 

 

78

%

 

 

71

%

Gross Profit

 

 

23,204

 

 

 

23,568

 

 

 

70,455

 

 

 

69,517

 

Amortization of intangible assets

 

 

2,224

 

 

 

4,796

 

 

 

7,159

 

 

 

10,454

 

Adjusted Gross Profit

 

$

25,428

 

 

$

28,364

 

 

$

77,614

 

 

$

79,971

 

Adjusted Gross Profit Margin

 

 

86

%

 

 

83

%

 

 

85

%

 

 

81

%

 

EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin

The following table presents our calculation of EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin for the periods presented:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(In thousands)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net loss

 

$

(14,935

)

 

$

(14,467

)

 

$

22,900

 

 

$

(64,713

)

Income tax (benefit) provision

 

 

(621

)

 

 

(62

)

 

 

1,129

 

 

 

181

 

Depreciation and amortization

 

 

4,961

 

 

 

8,030

 

 

 

15,604

 

 

 

20,074

 

Interest expense, net

 

 

5,585

 

 

 

8,018

 

 

 

18,267

 

 

 

21,853

 

EBITDA

 

 

(5,010

)

 

 

1,519

 

 

 

57,900

 

 

 

(22,605

)

Gain on sale of business (a)

 

 

-

 

 

 

-

 

 

 

(71,599

)

 

 

-

 

Stock-based compensation

 

 

4,181

 

 

 

6,224

 

 

 

13,885

 

 

 

18,212

 

Change in fair value of financial instruments (b)

 

 

3,501

 

 

 

(7,157

)

 

 

3,174

 

 

 

(18,850

)

Other non-cash charges (c)

 

 

17

 

 

 

(704

)

 

 

93

 

 

 

5,227

 

Acquisition and disposal related costs (d)

 

 

40

 

 

 

12

 

 

 

1,138

 

 

 

1,391

 

Employee severance costs (e)

 

 

437

 

 

 

560

 

 

 

635

 

 

 

1,310

 

Non-capitalizable debt raising costs

 

 

49

 

 

 

-

 

 

 

527

 

 

 

316

 

Business Combination with DSAC (f)

 

 

-

 

 

 

81

 

 

 

-

 

 

 

415

 

Loss contingency (g)

 

 

-

 

 

 

201

 

 

 

-

 

 

 

4,091

 

Costs incurred related to the Special Committee (h)

 

 

229

 

 

 

-

 

 

 

682

 

 

 

-

 

Adjusted EBITDA

 

$

3,444

 

 

$

736

 

 

$

6,435

 

 

$

(10,493

)

Adjusted EBITDA Margin

 

 

11.7

%

 

 

2.2

%

 

 

7.1

%

 

 

(10.7

)%

(a)
Reflects the gain on disposal from the sale of Board.org on March 11, 2024.
(b)
Reflects the non-cash impact from the mark to market adjustments on our financial instruments.
(c)
Reflects the non-cash impact of the following: (i) charge of $49 in the first quarter of 2024, $31 in the second quarter of 2024, and $17 in the third quarter of 2024 related to the unrealized loss on investments; (ii) gain of $4 in the first quarter of 2024 from the change in fair value related to the contingent consideration and contingent compensation related to the 2021, 2022, and 2023 Acquisitions; (iii) impairment of goodwill of $5,837 in the first quarter of 2023, (iv) charge of $115 in the third quarter of 2023 related to the unrealized loss on investments; (v) loss from equity method investment of $34 in the first quarter of 2023, loss from equity method investment of $56 in the second quarter of 2023, and a gain from equity method investment of $147 in the third quarter of 2023, and (vi) charge of $2 in the first quarter of 2023, a charge of $2 in the second quarter of 2023, and a gain of $672 in the third quarter of 2023 from the change in fair value related to the contingent consideration and contingent compensation related to the 2021, 2022, and 2023 Acquisitions.
(d)
In 2024 reflects the costs incurred related to the sale of Board.org, principally consisting of accounting, tax, and legal fees. In 2023 reflects the costs incurred to identify, consider, and complete business combination transactions consisting of advisory, legal, and other professional and consulting costs.
(e)
Severance costs associated with workforce changes related to business realignment actions.
(f)
Includes non-capitalizable transaction costs incurred within one year of the Business Combination with DSAC.
(g)
Reflects (i) $3,474 non-cash loss contingency charge related to the settlement with GPO FN Noteholder LLC recorded in the second quarter of 2023 and (ii) accounting and legal costs incurred associated with the settlement with GPO FN Noteholder LLC totaling $168 in the first quarter of 2023, $248 in the second quarter of 2023, and $201 in the third quarter of 2023.
(h)
Reflects costs incurred related to the Special Committee.

Liquidity and Capital Resources

Historically the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt. At September 30, 2024, the Company’s cash, cash equivalents, restricted cash, and short-term investments was $33.4 million compared to $24.4 million at December 31, 2023.

The Company had a negative working capital balance of $45.8 million (excluding cash and short-term investments) at September 30, 2024 and had an accumulated deficit of $793.5 million and $816.4 million as of September 30, 2024 and December 31, 2023, respectively, and has incurred net losses of $48.7 million (excluding the gain on sale of business) for the nine months ended September 30, 2024 and $64.7 million for the nine months ended September 30, 2023, respectively. Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, acquiring new businesses and technologies, and investing in infrastructure and product development.

Our ability to maintain our minimum cash requirement, fund our future cash interest requirements under our senior term loan and fund our operating expenses and capital expenditure requirements will depend in part on general economic, financial, competitive, legislative,

35


Table of Contents

 

regulatory and other conditions that may be beyond our control. The Company has implemented various cost saving measures throughout 2023 and into 2024 and is actively seeking additional sources of capital. Volatility in the credit markets may have an adverse effect on our ability to obtain debt financing. If we raise additional funds through the issuance of equity, equity-linked or debt securities, those securities may have rights, preferences or privileges senior to the rights of our common stock, or may require us to agree to unfavorable terms, and our existing stockholders may experience significant dilution.

Our historical financing activities included borrowings under senior secured credit facilities, senior secured promissory notes, convertible debt, and preferred share issuances. Our principal debt plus paid-in kind interest outstanding as of September 30, 2024 and December 31, 2023 consisted of the following (excluding any fair value adjustments and debt discounts, as applicable):

(In thousands)

 

September 30, 2024

 

 

December 31, 2023

 

Senior Term Loan

 

$

93,365

 

 

$

158,228

 

New GPO Note

 

 

50,434

 

 

 

48,575

 

Convertible Notes

 

 

15,595

 

 

 

14,052

 

Dragonfly Seller Convertible Notes

 

 

13,641

 

 

 

12,223

 

Era Convertible Note

 

 

-

 

 

 

5,500

 

Aicel Convertible Note

 

 

1,150

 

 

 

1,156

 

PPP Loan

 

 

63

 

 

 

144

 

Total Principal plus PIK Outstanding

 

$

174,248

 

 

$

239,878

 

Senior Term Loan

In connection with the closing of the business combination with DSAC, FiscalNote entered into a $150.0 million senior credit agreement (the “Credit Agreement”) with Runway Growth Finance Corp., ORIX Growth Capital, LLC, Clover Orochi LLC, and ACM ASOF VIII SaaS FinCo LLC (together the "Senior Lenders”). The Credit Agreement also provides for an uncommitted incremental loan facility totaling $100.0 million available upon notice if the Company meets certain financial growth criteria and other customary requirements (the “New Incremental Term Facility”) (collectively the “Senior Credit Facility”). The annual interest of the Senior Term Loan consists of two components: a cash interest component of (a) the greater of (i) Prime Rate plus 5.0% per annum and (ii) 9.0% payable monthly, and (b) interest payable in kind component of 1.00% per annum, payable in kind monthly. The Senior Credit Facility will mature on July 29, 2027. Pursuant to Amendment No. 4, beginning on August 15, 2026, the Senior Term Loan must be repaid in even amounts on a monthly basis over the remaining 12 months, with the final balance due on July 15, 2027. Borrowings under our Senior Credit Facility are collateralized by substantially all assets of the borrowers and guarantors party thereto.

On March 17, 2023, the Company, entered into Amendment No. 1 (“Amendment No. 1”) to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 1 provided for the extension of an incremental term loan by one of the lenders to the borrowers under the facility in the principal amount of $6.0 million which was received by the Company on March 31, 2023, on the same terms as the existing term loans (the “Incremental Facility”).

On May 16, 2023, the Company, entered into Amendment No. 2 ("Amendment No. 2") to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 2 joined Dragonfly Eye Limited (“Dragonfly”) and Oxford Analytica Limited (“Oxford Analytica”), each a wholly owned subsidiary of the Company, as Guarantors under the Credit Agreement.

On August 3, 2023, the Company entered into Amendment No. 3 ("Amendment No. 3") to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 3 provides for: (a) the extension of the July 2023 Deferred Fee from July 29, 2023 to July 29, 2024, (b) the increase of the July 2023 Deferred Fee from $1,734 to $2,034, and (c) the revision to the minimum ARR and adjusted EBITDA covenants (as both are defined in the Credit Agreement).

In connection with the completion of the sale of Board.org on March 11, 2024, the Company also entered into Amendment No. 4 to the Credit Agreement (the “Amendment No. 4”), pursuant to which, among other things, the lenders consented to the release the liens on Board.org’s assets and permitted the consummation of the sale in exchange for the permanent retirement of $65.7 million of term loans under the Credit Agreement. The Company also made a payment of $1.3 million and $5.8 million of related prepayment and exit fees, respectively. Amendment No. 4 also requires that upon receipt of any earn-out payment pursuant to the equity purchase agreement underlying the sale of Board.org, the Company will prepay outstanding obligations under the Credit Agreement in an amount equal to 70% of the net proceeds received from such earn-out payment, together with a prepayment fee and an exit fee, equal to 5.75% of the amount of such prepayment.

In addition, Amendment No. 4 extended the commencement of amortization payments under the Credit Agreement from August 15, 2025 to August 15, 2026, with such payments to fully amortize the term loans by the maturity date of July 15, 2027. Amendment No. 4 also increased the Company’s minimum liquidity covenant to $22.5 million and modified the Company’s minimum ARR and adjusted EBITDA in order to appropriately reflect the sale of Board.org and the absence of its future contributions to the Company’s overall financial performance and position.

In connection with the completion of the sale of Aicel Technologies on October 31, 2024, the Company repaid $5.0 million of principal.

During the nine months ended September 30, 2024, we made cash interest payments totaling $11.7 million related to the Senior Term Loan.

The Senior Term Loan is senior to all other debt and has a first priority lien on substantially all of the Company’s assets. The Senior Term Loan contains customary negative covenants related to borrowing, events of default and covenants, including certain non-financial covenants and covenants limiting the Company’s ability to dispose of assets, undergo a change in control, merge with or acquire stock, and

36


Table of Contents

 

make investments, in each case subject to certain exceptions. In addition to the negative covenants, there were four financial covenants in place at September 30, 2024: a minimum cash balance requirement, minimum annual recurring revenue requirement, an adjusted EBITDA requirement (as defined in the Credit Agreement, as amended) and a capital expenditure limitation. At September 30, 2024, the Company was in compliance with all of the covenants. Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Senior Term Loan due and payable the lenders can elect to increase the interest rate by 5.0% per annum.

See Note 8 “Debt” to the condensed consolidated financial statements included elsewhere herein.

New GPO Note

On June 30, 2023 (the “Subscription Date”), the Company entered into an Exchange and Settlement Agreement (the “Exchange and Settlement Agreement”) with GPO FN Noteholder LLC (the “Investor”) pursuant to which (i) the Investor returned 5,881,723 shares of Class A Common Stock held by the Investor to the Company for cancellation, (ii) the Company issued to the Investor a subordinated convertible promissory note in an initial principal amount of $46.8 million (the “New GPO Note”), and (iii) the parties agreed to a mutual settlement and release of all claims (including, but not limited to, any claims by the Investor for additional shares or money damages resulting from the entry into the Merger Agreement, relating to or arising from the conversion of the Amended and Restated Senior Secured Subordinated Promissory Note, dated December 29, 2020, previously issued by a subsidiary of the pre-business combination FiscalNote Holdings, Inc. to the Investor. The exchange and settlement are non-cash exchanges in the condensed consolidated statement of cash flows. The before mentioned transactions closed on July 3, 2023.

The New GPO Note will mature on July 3, 2028, unless earlier redeemed or repurchased by the Company or converted in accordance with the terms thereof. The New GPO Note bears interest at a rate of 7.50% per annum payable quarterly in arrears, as follows: (i) for the first year following the date of issuance, interest will be payable in kind by adding interest to the principal amount of the New GPO Note; and (ii) for any period thereafter, interest will be payable in cash or freely tradeable shares of Class A Common Stock, at the Company’s option, with the value per share determined with reference to the trailing 30-day volume weighted average trading price prior to the interest payment date, subject to certain exceptions under which the Company will be permitted to pay PIK Interest.

The New GPO Note is subordinate to the Company’s obligations under its New Senior Term Loan which limits certain actions that the Company and the Investor may take under the New GPO Note. At any time prior to the July 3, 2028, the Investor is entitled to convert all or any portion of the principal amount of the New GPO Note and accrued interest thereon into shares of Class A Common Stock at $7.92 per share. The New GPO Note is subject to customary anti-dilution adjustments for stock splits and similar transactions and, subject to standard exceptions, weighted average anti-dilution protection. The principal amount, together with accrued interest thereon, of the New GPO Note is redeemable by the Company in whole or in part based on certain conditions as defined in the New GPO Note.

The Company elected to account for the New GPO Note using the fair value option. The New GPO Note was recorded at its June 30, 2023 acquisition date fair value of $36.6 million. The Company initially recorded a loss contingency of $11.7 million in its fiscal year 2022 financial statements representing the difference between the fair value of the shares returned by the Investor and the fair value of the New GPO Note on the date of exchange. With the execution of the Exchange and Settlement Agreement and New GPO Note, the Company recorded an additional loss on settlement with GPO of $3.5 million in the condensed consolidated statement of operations for the nine months ended September 30, 2023.

Convertible Notes

Four convertible noteholders with an aggregate principal amount (including accrued paid in kind interest) of $10.5 million as of the Closing Date elected not to convert their notes into shares of capital stock of the Company in conjunction with Closing. The convertible notes are unsecured, earn payable in kind interest of 15% per annum, payable in kind monthly, and mature in July and November of 2025. The notes that mature in July 2025 are recorded in the current maturities of long-term debt.

Dragonfly Seller Convertible Note

On January 27, 2023, we acquired Dragonfly and financed part of the purchase with the issuance of convertible notes. The Dragonfly Convertible Note is subordinate to our New Senior Credit Facility, accrues interest of 8% per annum, payable in kind or in cash, and matures in January 2028.

Era Convertible Note

On December 8, 2023 and January 5, 2024, we issued convertible notes in an aggregate principal amount of $6.3 million in connection with the Company's strategic commercial partnership with Era. During the three months ended June 30, 2024, the Company converted the Era Convertible Notes into 6,852,099 shares of Common Stock, pursuant to the terms of the convertible notes, as amended, and accordingly satisfied all obligations thereunder.

Aicel Convertible Note

On July 29, 2022, we acquired Aicel Technologies and assumed its $1.0 million convertible note. The Aicel Convertible Note is subordinate to our New Senior Credit Facility, accrues interest of 1% per annum, payable in kind monthly, and matures in July 2027. On October 31, 2024, the Company sold Aicel Technologies and the convertible note was assumed by the buyer, see Note 18, Subsequent Events for additional information.

PPP Loan

The PPP Loan requires monthly principal and interest payments of approximately $9 thousand until maturity in 2025.

37


Table of Contents

 

Capital expenditures

Capital expenditures primarily consist of purchases of capitalized software costs and property and equipment. Our capital expenditures program includes discretionary spending, which we can adjust in response to economic and other changes in our business environment to grow our business. We typically fund our capital expenditures through cash flow from operations and external financing. In the event that we are unable to obtain the necessary funding for capital expenditures, our long-term growth strategy could be significantly affected. Our total capital expenditures were $6.9 million and $6.0 million for the nine months ended September 30, 2024 and 2023, respectively.

Cash Flow Summary

The following tables summarizes our cash flows for the periods presented:

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

Net cash provided by (used in):

 

 

 

 

 

 

Operating activities

 

$

(3,950

)

 

$

(31,940

)

Investing activities

 

$

84,509

 

 

$

(18,336

)

Financing activities

 

$

(71,574

)

 

$

6,570

 

Effect of exchange rates on cash

 

$

86

 

 

$

(184

)

Net change in cash and cash equivalents

 

$

9,071

 

 

$

(43,890

)

Operating activities

Cash used in operating activities consists of net loss adjusted for certain non-cash items including depreciation and amortization, stock based compensation, changes in fair value of warrant liabilities, non-cash interest expense, and loss on debt extinguishment, as well as the effect of changes in working capital and other activities.

Cash used in operating activities in the nine months ended September 30, 2024 was $4.0 million, a decrease of $28.0 million compared to the nine months ended September 30, 2023. The primary factors affecting our net operating cash flows during this period was our net income of $22.9 million, which includes non-cash expense items totaling $26.9 million, including a gain on disposal of business of $71.6 million, non-cash and paid-in kind interest expense of $8.2 million, stock-based compensation expense of $13.9 million, a gain due to the change in fair value of financial instruments of $3.2 million, non-cash lease expense of $1.6 million, amortization and depreciation of $18.4 million, and other non-cash items of $0.6 million.

 

Cash used in operating activities in the nine months ended September 30, 2023 was $31.9 million, a decrease of $25.6 million compared to the nine months ended September 30, 2022. The primary factors affecting our net operating cash flows during this period was our net loss of $64.7 million, which includes non-cash expenses items totaling $40.7 million, including impairment of goodwill of $5.8 million, non-cash and paid-in kind interest expense of $7.0 million, stock-based compensation expense of $18.2 million, a gain due to the change in fair value of financial instruments of $18.9 million, non-cash lease expense of $2.9 million, loss on settlement with GPO of $3.5 million, and amortization and depreciation of $22.7 million, other non-cash items of $0.5 million and the effect of changes in operating assets and liabilities that resulted in cash outflows of $8.0 million.

Investing activities

Net cash provided by (used in) investing activities in the nine months ended September 30, 2024 was $84.5 million compared to $(18.3) million in the nine months ended September 30, 2023. Net cash provided by investing activities in the nine months ended September 30, 2024 primarily consisted of cash proceeds from the sale of a business of $91.4 million partially offset by cash paid of $6.8 million of capital expenditures primarily related to software development costs. Net cash used in investing activities in the nine months ended September 30, 2023 was $18.3 million, which primarily consisted of cash paid for acquisitions, net of cash acquired of $5.0 million and cash paid of $6.0 million of capital expenditures primarily related to software development costs and purchases of short-term investments of $7.4 million.

Financing activities

Net cash (used in) provided by financing activities in the nine months ended September 30, 2024 was $(71.6) million, compared to $6.6 million for the nine months ended September 30, 2023. Net cash used in financing activities during the nine months ended September 30, 2024 primarily consisted of payments of long-term debt and deferred financing costs primarily related to Amendment 4 to the Credit Agreement and the sale of Board.org of $72.8 million partially offset by the proceeds from the issuance of Era Convertible Notes of $0.8 million and proceeds from the issuance of stock options and ESPP purchases of $0.5 million. Net cash provided by financing activities in the nine months ended September 30, 2023 was $6.6 million, which primarily consisted of $6.0 million from Amendment 1 to the Credit Agreement and $0.6 million from the proceeds from the exercise of stock options.

Commitments and Contingencies

Our principal commitments consist of obligations under leases for office space. For more information regarding our lease obligations, see Note 5 “Leases” to the condensed consolidated financial statements included elsewhere herein. For more information regarding our debt service obligations, see Note 8 “Debt” to the condensed consolidated financial statements included elsewhere herein.

Off-Balance Sheet Arrangements

During the periods presented, we did not engage in any off-balance sheet financing activities or other arrangements that have or are reasonably likely to have a current or future material effect on our financial condition or results of operations.

38


Table of Contents

 

Recently Issued Accounting Pronouncements

For information regarding new accounting pronouncements, and the impact of these pronouncements on our condensed consolidated financial statements, if any, refer to Note 1 of the notes to our financial statements included in this Quarterly Report on Form 10-Q.

Critical Accounting Estimates and Policies

Our condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ from these estimates under different assumptions or conditions.

We believe that of our significant accounting policies, which are described in Note 1 “Summary of Business and Significant Accounting Policies” to our condensed consolidated financial statements, the following accounting policies and specific estimates involve a greater degree of judgment and complexity.

There were no significant and material changes in our critical accounting policies and use of estimates during the nine months ended September 30, 2024, as compared to those disclosed in "Management's Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Estimates and Accounting Policies" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on March 15, 2024.

Revenue Recognition

Subscription revenues are recurring in nature and include subscription fees from customers accessing our company’s cloud-based infrastructure, digital content, transcripts, news and analysis, images, video and podcast data. Advisory, advertising and other revenue includes revenues derived from non-recurring activities where we deliver specific deliverables for clients as well as where we provide advertising in our own publications (Roll Call and CQ) in both print and digital formats, the sale of various publications, and sponsorship revenue for events organized by the Company. Our company’s subscription arrangements are generally non-cancelable and do not contain refund-type provisions. Our company recognizes revenues upon the satisfaction of its performance obligation(s) (upon transfer of control of promised goods or services to its customers) in an amount that reflects the consideration to which it expects to be entitled to in exchange for those goods or services.

Our company’s contracts with customers may include promises to transfer multiple services. For these contracts, our company accounts for individual promises separately if they are distinct performance obligations. Determining whether services are considered distinct performance obligations may require significant judgment. Judgment is also required to determine the standalone selling price (“SSP”) for each distinct performance obligation. In instances where SSP is not directly observable, such as when our company does not sell the services separately, our company determines the SSP using available information, including market conditions and other observable inputs.

Costs Capitalized to Obtain Revenue Contracts

Costs capitalized related to new revenue contracts are amortized on a straight-line basis over four years, which, although longer than the typical initial contract period, reflects the average period of benefit, including expected contract renewals. Significant judgment is required in arriving at this average period of benefit. Therefore, we evaluate both qualitative and quantitative factors, including the estimated life cycles of our offerings and our customer attrition.

Business Combinations

Accounting for business combinations requires us to make significant estimates and assumptions, especially at the acquisition date with respect to tangible and intangible assets acquired and liabilities assumed and pre-acquisition contingencies. We use our best estimates and assumptions to accurately assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date as well as the useful lives of those acquired intangible assets.

Critical estimates in valuing certain of the intangible assets and goodwill we have acquired are:

•
future expected cash flows from subscription and content contracts, other customer contracts and acquired developed technologies, and trade names;
•
historical and expected customer attrition rates and anticipated growth in revenue from acquired customers;
•
assumptions about the period of time the acquired trade name will continue to be used in our offerings;
•
discount rates;
•
uncertain tax positions and tax-related valuation allowances assumed; and
•
fair value of earnout consideration.

Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results.

Goodwill and Intangible Assets

Significant judgment is required to estimate the fair value of our reporting units. Accordingly, we typically obtain the assistance of third-party valuation specialists for significant reporting units for purposes of determining whether there is goodwill impairment. The fair value estimates are based on available historical information and on future expectations. We typically estimate the fair value of these assets

39


Table of Contents

 

using the income method, which is based on the present value of estimated future cash flows attributable to the respective assets. The valuations used to establish and to test goodwill for impairment are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall growth rates, competitive activities, cost containment and margin progression, Company business plans and the discount rate applied to cash flows.

Goodwill is not amortized, but tested at least annually for impairment. Our ongoing annual impairment testing for goodwill occurs on October 1st. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal projections and operating plans. We believe these estimates and assumptions are reasonable and comparable to those that would be used by other marketplace participants. Unanticipated market or macroeconomic events and circumstances may occur, which could affect the accuracy or validity of the estimates and assumptions. For example, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. In addition, changes to or a failure to achieve business plans or deterioration of macroeconomic conditions could result in reduced cash flows or higher discount rates, leading to a lower valuation that would trigger an impairment of the goodwill of these businesses.

If the fair value of the reporting unit is less than its carrying value, that difference represents an impairment.

Determining the useful life of an intangible asset also requires judgment. Acquired intangible assets (customer relationships, patents and technologies, and tradenames) are expected to have determinable useful lives. Finite-lived intangible assets are amortized to expense over their estimated lives. An impairment assessment for finite-lived intangibles is only required when an event or change in circumstances indicates that the carrying amount of the asset may not be recoverable.

The most significant assumptions utilized in the determination of the estimated fair values of our reporting units are the net sales and earnings growth rates (including residual growth rates) and discount rate. The residual growth rate represents the expected rate at which the reporting units are expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit operating plans and approximates expected long-term market growth rates. The residual growth rate is dependent on overall market growth rates, the competitive environment, inflation, and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors.

Future sustained depression of our stock price may indicate that a triggering event has occurred that may require us to reassess our goodwill for impairment and may trigger future impairment charges of one or all of our reporting units. Further, changes in operating plans or adverse changes in the business or in the macroeconomic environment in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that would trigger future impairment charges of our reporting units.

Due to the decline in the Company’s stock price and market capitalization in the first quarter of 2023, and the underperformance of the Company’s ESG reporting unit compared to internal projections, the Company performed a quantitative goodwill impairment assessment as of March 31, 2023. This quantitative assessment resulted in all the goodwill in our ESG reporting unit being impaired; accordingly, a non-cash impairment charge of $5.8 million was recognized during the three months ended March 31, 2023. Prior to the quantitative goodwill impairment the Company tested the recoverability of its long-lived assets, and concluded that such assets were not impaired.

See Note 7, “Goodwill” to the condensed consolidated financial statements for additional discussion on goodwill.

Warrant Liabilities

The Company evaluates its financial instruments, including its outstanding warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company has outstanding public and private warrants, both of which do not meet the criteria for equity classification and are accounted for as liabilities. Accordingly, the Company recognizes the warrants as liabilities at fair value and adjusts the warrants to fair value at each reporting period. The warrant liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed consolidated statement of operations.

The fair value of the public warrants is estimated based on the quoted market price of such warrants. The fair value of the private warrants is estimated using a binomial option pricing model.

Debt instruments measured at fair value

The Company accounts for certain of its debt obligations at fair value. Accordingly, the Company recognizes the debt obligations upon inception at fair value. The debt obligations are subject to re-measurement at each balance sheet date, and any change in fair value is recognized in the Company’s unaudited condensed consolidated statement of operations. The Company estimates the fair value of the debt obligation using a lattice model.

Deferred Taxes and Valuation Allowance

Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are expected to be realized based on the weighting of positive and negative evidence. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the applicable tax law. We regularly review the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies.

40


Table of Contents

 

Our judgment regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed.

Incremental Borrowing Rate Used to Calculate Lease Balances

As most of our leases do not provide an implicit rate, we use our incremental borrowing rate as the discount rate to measure the operating lease assets and liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease and includes considerations of both the market, our current capital structure and exiting debt borrowings. We perform an incremental borrowing rate analysis on a quarterly basis, or upon execution of any individually material agreement, to ensure that the rates being applied to newly acquired leases are still accurate.

41


Table of Contents

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks.

We are exposed to market risks in the ordinary course of our business. These risks primarily consist of inflation risk and fluctuations in interest rates and foreign currency exchange rates. We do not enter into derivatives or other financial instruments for trading or speculative purposes.

Foreign Currency Exchange Risk

We use the U.S. Dollar ("USD") as our reporting currency. Our local subsidiaries transact generally in their local currency, considered the functional currency for that subsidiary. Our foreign currency exchange rate risk is related to translation of our assets and liabilities from the subsidiaries' functional currencies to USD. These adjustments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets. Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the Euro, British Pound Sterling and Australian Dollar. Our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations, which are primarily in the United States as well as the European Union, United Kingdom, Australia, South Korea, and India. Our results of operations and cash flows in the future may be adversely affected due to an expansion of non-U.S. dollar denominated contracts, growth of our international entities and changes in foreign exchange rates. The effect of a hypothetical 10% change in foreign currency exchange rates applicable to our business would not have a material impact on our cash denominated in foreign currency. To date, we have not engaged in any hedging strategies. As our international operations grow, we will continue to reassess our approach to manage the risk relating to fluctuations in currency rates.

Fluctuations in foreign currencies impact the amount of total assets, liabilities, revenues, operating expenses and cash flows that we report for our foreign subsidiaries upon the translation of these amounts into USD. Total revenue for the three and nine months ended September 30, 2024, was impacted by approximately 1.0% compared to the three and nine months ended September 30, 2023.

Interest Rate Risk

We are subject to market risk associated with changing interest rates within our variable rate Senior Term Loan. Our exposure to changes in interest rates is associated with the Prime Rate.

As of September 30, 2024, we had outstanding borrowings on our Senior Term Loan of $93.4 million, which bear cash interest at a floating rate based on the Prime Rate plus an applicable margin. At September 30, 2024, the interest rate on our Senior Term Loan was 13.0%. Assuming no change in the outstanding borrowings on our Senior Term Loan, we estimate that a one percentage point increase in the Prime Rate would increase our annual cash interest expense by approximately $0.9 million.

Inflation Risk

Although we do not believe inflation has had a material impact on our financial condition, results of operations or cash flows to date, a high rate of inflation in the future may have an adverse effect on our business.

Item 4. Controls and Procedures.

Limitations on Effectiveness of Disclosure Controls and Procedures

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of the disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining adequate internal controls over financial reporting and has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of September 30, 2024. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles. Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2024.

Update on Remediation of Previously Reported Material Weaknesses

Management identified three material weaknesses in internal controls in the areas of (i) information technology general controls related to administrative user access to the Company’s information systems that are relevant to the preparation of the financial statements to ensure appropriate segregation of duties and to adequately restrict access to financial applications and data; and user access provisioning and monitoring; (ii) Ineffective controls over the accounting for fair market value changes to financial instruments; and (iii) ineffective controls over the accounting for stock compensation accounting. Management is taking steps to successfully remediate these material weaknesses by implementing remediation efforts described below.

Management is committed to the remediation of the material weaknesses described above, as well as the continued improvement of our internal control over financial reporting. Our efforts resulting in successful remediation include:

42


Table of Contents

 

1.
Administrator access to financially relevant systems has been restricted to relevant system owners
2.
Enhanced design of access reviews performed across each financially relevant system
3.
Additional review procedures involving fair market value changes to financial instruments
4.
Additional review procedures surrounding the accounting for stock compensation.

 

Notwithstanding the assessment that our internal controls over financial reporting are not effective and that material weaknesses exist, we believe we have employed supplementary procedures to ensure the financial statements contained in this report fairly present in all material respects, our financial position as of September 30, 2024.

Changes in Internal Control over Financial Reporting

Other than the material weaknesses identified in prior year and material weakness remediation activities, there were no changes in our internal control over financial reporting, as identified in connection with the evaluation required by Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that occurred during the three months ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

43


Table of Contents

 

PART II—OTHER INFORMATION

From time to time, we may become involved in legal or regulatory proceedings, including intellectual property claims, commercial contract matters or employment-related disputes. Such cases may raise complex factual and legal issues, may subject us to material risks and uncertainties, could require significant management time and corporate resources to defend, could result in significant media coverage and negative publicity, and could be harmful to our reputation and our brand. We are not currently a party to any litigation or regulatory proceeding that we expect to have a material adverse effect on our business, results of operations, financial conditions or cash flows.

Item 1A. Risk Factors.

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 15, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

Other than as reported on each of our Current Reports on Form 8-K, we did not have any unregistered sales of equity securities during the three months ended September 30, 2024.

Use of Proceeds

Not applicable

Purchase of Equity Securities

We did not repurchase shares of our common stock during the three months ended September 30, 2024.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Adoption, Modification or Termination of Rule 10-b-5-1 Plans and Certain Other Trading Arrangements

During the three months ended September 30, 2024, Dominque Taylor, Senior Vice President, People and DEIBA adopted a "Rule 10-b-5-1 trading arrangement," as defined in Item 408(a) of Regulation S-K.

Securities Purchase Agreement

On November 12, 2024 (the “Issuance Date”), FiscalNote Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with EGT 10, LLC (the “Investor”), an investment vehicle managed by Era Global Technologies, LLC (“Era”), pursuant to which the Company issued a senior subordinated convertible note (the “Note”) in an aggregate principal amount of $5.5 million to the Investor (the “Principal Amount”). Era is an investment firm backed by global family offices across multiple countries and markets. Era has directly or indirectly co-invested in various ventures at which Mr. Timothy Hwang, the Company’s Chairman, Chief Executive Officer and Co-Founder, is serving as a director.

The Note matures on November 12, 2027 (the “Maturity Date”) and will bear cash interest at a rate equal to the applicable federal rate published by the Internal Revenue Service beginning on the six-month anniversary of the Issuance Date. The Note is contractually subordinated to the Company’s obligations under its senior secured indebtedness, and accordingly the Company’s right to make certain cash payments in connection therewith is limited by the terms of such subordination agreement (the “Subordination Agreement”). The Investor may convert the Note into shares (the “Underlying Shares”) of the Company’s class A common stock, par value $0.0001 per share (the “Common Stock”), beginning on the six-month anniversary of the Issuance Date (the “Initial Conversion Date”) based on the volume weighted average price of the trailing 30 trading day period prior to the conversion. In addition, the Company may elect to convert all or a portion of the Note into the Underlying Shares (the “Optional Conversion Right”) if the Underlying Shares are registered for resale under the Securities Act of 1933, as amended (the “Securities Act”).

Pursuant to the Purchase Agreement, on the Issuance Date, the Company also issued, as a success fee, 2,549,129 shares of Common Stock to the Investor (the “Success Fee Shares”). The Investor is not permitted to sell the Success Fee Shares before the six-month anniversary of the Issuance Date; provided, however, that if the Company elects to convert any portion of the Note into Underlying Shares pursuant to its Optional Conversion Right, then the Investor may sell a pro-rata portion of the Success Fee Shares.

44


Table of Contents

 

The Purchase Agreement also requires the Company to issue additional shares of Common Stock (“Additional Shares”) to the Investor if the Investor sells the Success Fee Shares and Underlying Shares within 12 months after the earlier of (i) issuance of all Underlying Shares issued pursuant to the Optional Conversion Right or (ii) the Initial Conversion Date (the “Sell-Off Period”), to the extent such sales of the Success Fee Shares and the Underlying Shares during the Sell-Off Period do not generate aggregate cash proceeds to the Investor that equal or exceed the sum of (1) the Principal Amount plus (2) $2.75 million. Any such Additional Shares would be valued based on the volume weighted average price of the trailing 30 trading day period, calculated prior to the date of any such issuance. In the event the Investor sells the Underlying Shares, Success Fee Shares and/or any Additional Shares for an amount equal to the sum of (1) the Principal Amount plus (2) $2.75 million, the Investor shall be required to return any remaining Underlying Shares, Success Fee Shares and/or Additional Shares, as applicable, and cancel any remaining amount of the Principal Amount owed by the Company.

If the Company were to complete a change of control, merger, combination or similar transaction (a “Fundamental Change”) prior to the expiration of the Sell-Off Period, the Company’s obligation to issue Additional Shares shall be terminated and the Investor will have the right to accelerate the maturity date of the Note. In addition, the Company, in lieu of its obligation to issue Additional Shares, shall be required to repurchase the Success Fee Shares then-held by the Investor for cash consideration equal to $2.75 million minus the net cash proceeds received by the Investor from any prior sales of the Success Fee Shares in the event that any of the following occur: (i) a Fundamental Change results in the Company’s shares not being listed for trading on a national stock exchange, (ii) the Company were to repay the Note prior to the Maturity Date and prior to the expiration of the Sell-Off Period, or (iii) the Company were to file for bankruptcy or experience a similar insolvency event prior to the expiration of the Sell-Off Period.

The Note provides for customary events of default including failure to pay amounts due and owing under the Notes, failure to deliver the Underlying Shares, and other customary events of default similar to those provided under the terms of the Company’s senior secured indebtedness.

The Purchase Agreement includes certain customary representations, warranties and covenants with respect to the Company and the Investor. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties therein, and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Purchase Agreement is incorporated herein by reference only to provide investors with information regarding the terms of the Purchase Agreement, and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company’s periodic reports and other filings with the SEC.

The foregoing descriptions of the Purchase Agreement and the Note do not purport to be complete and are qualified in their entirety by reference to the Purchase Agreement and the form of Note, copies of which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Quarterly Report on Form 10-Q and are incorporated herein by reference.

Registration Rights Agreement

On the Issuance Date, in connection with the Purchase Agreement, the Company also entered into a registration rights agreement with the Investor (the “Registration Rights Agreement”), requiring the Company to register for resale the Underlying Shares and Success Fee Shares by filing with the SEC a resale registration statement under the Securities Act within seven days of the Issuance Date. Additionally, the Company is required to register for resale the Additional Shares, if any, by filing with the SEC a second resale registration statement within seven days of the issuance of any Additional Shares.

The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the Registration Rights Agreement, a copy of which is filed as Exhibit 10.3 to this Quarterly Report on Form 10-Q and is incorporated herein by reference.

Unregistered Sales of Equity Securities

The Note, Underlying Shares, Success Fee Shares and Additional Shares, if any, were or will be, as applicable, issued to the Investor in a private placement pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder.

In addition, on the Issuance Date, the Company issued 650,000 shares of Common Stock to Northland Securities, Inc. (the “Brokerage Fee Shares”) to cover the brokerage costs associated with liquidating (i) any Underlying Shares issued pursuant to the Optional Conversion Right and the Success Fee Shares and (ii) the shares of Common Stock previously issued to Era in connection with the Securities Purchase Agreement, by and between the Company and EGT-East LLC, dated as of December 8, 2023, as modified from time to time. The Brokerage Fee Shares were issued in a private placement pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) promulgated thereunder. The Company is required to register for resale the Brokerage Fee Shares.

Item 6. Exhibits.

Furnish the exhibits required by Item 601 of Regulation S-K (§ 229.601 of this chapter).

Exhibit

Number

Description

Incorporation by Reference (where a report is indicated below, that document has been previously filed with the SEC and the applicable exhibit is incorporated by reference thereto)

2.1

 

Agreement and Plan of Merger, dated as of November 7, 2021, by and among Duddell Street Acquisition Corp. (renamed “FiscalNote Holdings, Inc.”), Grassroots Merger Sub, Inc. and FiscalNote Holdings, Inc. (renamed “FiscalNote Intermediate Holdco, Inc.”).

Annex A to the Proxy Statement/Prospectus filed on July 5, 2022 (File No.333-261483).

45


Table of Contents

 

2.2

 

First Amendment to Agreement and Plan of Merger, dated as of May 9, 2022, by and among Duddell Street Acquisition Corp. (renamed “FiscalNote Holdings, Inc.”), Grassroots Merger Sub, Inc. and FiscalNote Holdings, Inc. (renamed “FiscalNote Intermediate Holdco, Inc.”).

Annex A-2 to the Proxy Statement/Prospectus filed on July 5, 2022 (File No.333-261483).

3.1

 

Certificate of Incorporation of FiscalNote Holdings, Inc. (f/k/a/ Duddell Street Acquisition Corp.).

Exhibit 3.1 to the Current Report on Form 8-K filed on August 2, 2022 (File No. 001-396972)

3.2

 

Bylaws of FiscalNote Holdings, Inc. (f/k/a/ Duddell Street Acquisition Corp.).

Exhibit 3.2 to the Current Report on Form 8-K filed on August 2, 2022 (File No. 001-396972)

4.1

 

Description of Securities.

Exhibit 4.1 to the Annual Report on Form 10-K filed on March 28, 2023.

4.2

 

Warrant Agreement, dated as of October 28, 2020, by and among Duddell Street Acquisition Corp ad Continental Stock Transfer & Trust Company, as warrant agent.

Exhibit 4.1 of DSAC’s Current Report on Form 8-K filed with the SEC on November 2, 2020 (File No. 333-249207).

4.3

 

Form of Restricted Stock Agreement, dated as of March 25, 2022, pursuant to the Membership Interest Purchase Agreement, dated as of November 19, 2021, by and among FiscalNote, Inc., the unitholders listed on the Appendix 1 thereto and Legacy FiscalNote.

Exhibit 4.6 of DSAC’s Form S-4/A filed with the SEC on June 27, 2022 (File No. 333-261483).

4.4

 

Form of Warrant

Exhibit 10.2 to the Current Report on Form 8-K filed on March 20, 2023 (File No. 001-39672).

10.1

 

Securities Purchase Agreement, dated as of November 12, 2024, by and between FiscalNote Holdings, Inc. and EGT 10, LLC.

Filed with this report.

10.2

 

Form of Note

Filed with this report.

10.3

 

Registration Rights Agreement, dated as of November 12, 2024, by and between FiscalNote Holdings, Inc, and EGT 10, LLC.

Filed with this report.

31.1

 

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a).

Filed with this report.

31.2

 

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a).

Filed with this report.

32

 

Section 1350 Certifications.

Furnished with this report.

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

Submitted electronically with this report.

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

Submitted electronically with this report.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

Submitted electronically with this report.

 

* All schedules have been omitted in accordance with Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish a copy of all omitted schedules to the SEC upon its request.

+ Indicates a management contract or compensatory plan.

 

46


Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

FISCALNOTE HOLDINGS, INC.

Date: November 12, 2024

By:

/s/ Jon Slabaugh

Name: Jon Slabaugh

Title: Chief Financial Officer

Date: November 12, 2024

By:

/s/ Timothy Hwang

Name: Timothy Hwang

Title: Chief Executive Officer

47


Execution Version

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 12, 2024, by and between FISCALNOTE HOLDINGS, INC., a Delaware corporation, with headquarters located at 1201 Pennsylvania Ave NW, 6th Floor, Washington, D.C. 20004 (the “Company”), and EGT 10, LLC, a Delaware limited liability company, with its address at [****] (the “Buyer”). The Company and the Buyer are sometimes referred to in this Agreement individually as a “Party” and together as the “Parties”.

WHEREAS:

A.
The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506(b) promulgated by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act;
B.
In connection with the execution of this Agreement, the Company and the Buyer are entering into a registration rights agreement (the “Registration Rights Agreement”) obligating the Company to register the resale by the Buyer of the Conversion Shares, Success Fee Shares and Additional Shares, as applicable, under the 1933 Act;
C.
The Buyer desires to purchase from the Company, and the Company desires to issue and sell to the Buyer, upon the terms and conditions set forth in this Agreement, a Convertible Promissory Note of the Company, in the aggregate principal amount of $5,500,000 (and together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, in the form attached hereto as Exhibit A, the “Note”), convertible into shares of Class A Common Stock, $0.0001 par value per share, of the Company (the “Common Stock”), upon the terms and subject to the limitations and conditions set forth in such Note; and
D.
The Buyer wishes to purchase, upon the terms and conditions stated in this Agreement, such principal amount of the Note as is set forth immediately below its name on the signature pages hereto.

NOW THEREFORE, in consideration of the foregoing and of the agreements and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Buyer hereby agree as follows:

1.
Purchase and Sale of Note.
(a)
Purchase of Note. On the date hereof (the “Closing Date”), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase from the Company the Note, subject to the express terms of the Note and this Agreement.
(b)
Form of Payment. On the Closing Date, the Buyer shall pay the purchase price of $5,500,000 (the “Purchase Price”) by wire transfer of immediately available funds, in accordance with the Company’s written wiring instructions, against delivery of the duly executed Note in such principal amount on behalf of the Company, to the Buyer.

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

(c)
Closing. The closing of the transactions contemplated by this Agreement (the “Closing”) shall occur at 2:00 P.M., Eastern time, on the Closing Date at such location as may be agreed to by the Parties (including via exchange of electronic signatures).
2.
Issuance of Success Fee Shares/Additional Shares.
(a)
On the Closing Date, subject to Section 2(i) hereof, the Company shall issue to the Buyer, as a success fee, a number of shares of Common Stock (the “Success Fee Shares”) equal to (i) 50% of the Purchase Price, divided by (ii) the Measurement Price for the thirty (30) VWAP Trading Day period on (and including) the last trading day preceding the Closing Date, rounded to the nearest whole share.
(b)
Certain Defined Terms: As used herein:

i. “Business Day” means any day other than a Saturday, a Sunday or any day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.

ii. “Measurement Price” means the arithmetic average of the VWAPs calculated for each VWAP Trading Day in the applicable measurement period.

iii. “VWAP” means, for any VWAP Trading Day, the per share volume-weighted average price of the Common Stock as displayed under the heading “Bloomberg VWAP” on Bloomberg page “NOTE <EQUITY> AQR” (or, if such page is not available, its equivalent successor page) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such VWAP Trading Day (or, if such volume-weighted average price is unavailable, the market value of one share of Common Stock on such VWAP Trading Day, determined, using a volume-weighted average price method, by a nationally recognized independent investment banking firm selected by the Company). The VWAP for any VWAP Trading Day will be determined without regard to after-hours trading or any other trading outside of the regular trading session.

iv. “VWAP Trading Day” means a day on which trading in the Common Stock generally occurs on the principal U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then traded. If the Common Stock is not so listed or traded, then “VWAP Trading Day” means a Business Day.

(c)
The Buyer shall not be permitted to sell the Success Fee Shares before the six (6) month anniversary of the Closing Date; provided, however, if the Company issues any Conversion Shares (as defined below) pursuant to its conversion right under Section 3(b) of the Note (“Optional Conversion Right”), then the Buyer may sell a pro-rata portion of the Success Fee Shares. Any Success Fee Shares may be sold pursuant to the Buyer’s then-existing trading plan with the Broker (as defined herein).

2

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

(d)
If the Buyer sells the Success Fee Shares and all Conversion Shares within 12 months following the earlier of (i) issuance of all Conversion Shares issued pursuant to the Optional Conversion Right or (ii) the Initial Conversion Date (as defined in the Note) (the “Sell-Off Period”), the Company shall issue, subject to Section 2(i) hereof, to the Buyer a number of additional shares of Common Stock with a value equal to 150% of the Purchase Price, minus the net cash proceeds received by the Buyer (as evidenced based on documentation to be provided by the Buyer pursuant to Section 2(h) hereof) from the sale of the Success Fee Shares and the Conversion Shares (the “Additional Shares”); provided, however, if the aggregate daily trading volume for all trading days in the Sell-Off Period is less than 500% of the total number of the Success Fee Shares and Conversion Shares in the aggregate, the Company will extend the Sell-Off Period for a reasonable time period to be mutually agreed by the Buyer and the Company, to permit the Buyer to sell any remaining Success Fee Shares and/or Conversion Shares and receive any Additional Shares as required by this Section 2(d). Prior to the issuance of any Additional Shares, the Company shall provide the Buyer two (2) Business Days’ notice (which notice shall include the number of shares of Common Stock then-outstanding) of any Additional Shares to be issued and, if the issuance of the Additional Shares would otherwise not comply with Section 2(i) hereof, the Buyer shall be required to notify the Company to defer the issuance of the Additional Shares within such two (2) Business Day notice period by sending a notice of delay (the “Notice of Delay”) which shall specify the number of Additional Shares to be so deferred and the date such Additional Shares that are not so deferred shall be delivered in accordance with this Agreement; provided, however, the Company shall be obligated to issue such Additional Shares no more than 10 and no fewer than two Business Days after the Buyer sends the Notice of Delay.
(e)
In the event of a bankruptcy or similar insolvency event (“Insolvency Event”) concerning the Company prior to the conclusion of the Sell-off Period, the Company, in lieu of its obligation to issue the Additional Shares, shall be required to repurchase the Success Fee Shares then-held by the Buyer for a cash amount equal to 50% of the Purchase Price minus the net cash proceeds received by the Buyer from any prior sale of Success Fee Shares.
(f)
In the event of a Fundamental Change (as defined in the Note) prior to the expiration of the Sell-Off Period, the Company’s obligation to issue Additional Shares shall be terminated and the Buyer shall have the right to exchange the Conversion Shares and Success Fee Shares for consideration payable to the Company’s shareholders in the transaction giving rise to the Fundamental Change; provided, however, that the Buyer shall have the right to exchange any unconverted portion of the Note into an amount of cash equal to the remaining principal amount of the Note (plus any accrued interest thereon) on the date of such Fundamental Change; and provided, further, that if the Fundamental Change results in a Termination in Trading (as defined in the Note), the Buyer is entitled to require the Company to repurchase the Success Fee Shares then-held by the Buyer for a cash amount equal to 50% of the Purchase Price minus the net cash proceeds received by the Buyer from any sale of Success Fee Shares.
(g)
In the event the Company repays the Note prior to its maturity and prior to the conclusion of the Sell-off Period, the Company, in lieu of its obligation to issue the

3

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Additional Shares, shall be required to repurchase the Success Fee Shares then-held by the Buyer for a cash amount equal to 50% of the Purchase Price minus the net cash proceeds received by the Buyer from any prior sale of Success Fee Shares.
(h)
When determining the net cash proceeds received by the Buyer from any sale of Success Fee Shares and Additional Shares, as the case may be, under this Agreement, the Buyer will provide such supporting documentation as the Company reasonably requests.
(i)
Notwithstanding anything to the contrary contained herein, the Company shall not issue any shares of Common Stock pursuant to the terms of this Agreement, and the Buyer shall not have the right to any shares of Common Stock otherwise issuable pursuant to the terms of this Agreement and any such issuance shall be null and void and treated as if never made, to the extent that after giving effect to such issuance, the Buyer together with the other Attribution Parties (as defined herein) collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the number of shares of Common Stock outstanding immediately after giving effect to such issuance. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Buyer and the other Attribution Parties shall include the number of shares of Common Stock held by the Buyer and all other Attribution Parties, plus the number of shares of Common Stock issuable pursuant to the terms of this Agreement with respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including any convertible notes or convertible preferred stock or warrants) beneficially owned by the Buyer or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 2(i). For purposes of this Section 2(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act. For purposes of determining the number of outstanding shares of Common Stock the Buyer may acquire pursuant to the terms of this Agreement without exceeding the Maximum Percentage, the Buyer may rely on the number of outstanding shares of Common Stock as reflected in (i) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (ii) a more recent public announcement by the Company or (iii) any other written notice by the Company or its transfer agent setting forth the number of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives a Notice of Delay from the Buyer at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall notify the Buyer in writing of the number of shares of Common Stock then outstanding and, to the extent that such Notice of Delay would otherwise cause the Buyer’s beneficial ownership, as determined pursuant to this Section 2(i), to exceed the Maximum Percentage, the Buyer shall notify the Company of a reduced number of shares of Common Stock to be acquired pursuant to such Notice of Delay. For any reason at any time, upon one day written or oral request of the Buyer, the Company shall use commercially reasonable efforts to (within one VWAP Trading Day) confirm, orally and in writing or by electronic mail to the Buyer the number of shares of Common Stock then outstanding. In the event that the issuance of shares of Common

4

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Stock to the Buyer under this Agreement would result in the Buyer and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act), the Buyer shall notify the Company in writing to reduce the number of shares so issued by which the Buyer’s and the other Attribution Parties’ aggregate beneficial ownership would exceed the Maximum Percentage (the “Excess Shares”) and the issuance of such Excess Shares shall be deemed null and void and shall be cancelled ab initio and any number of issued Conversion Shares, Success Fee Shares and/or Additional Shares, as the case may be, will be reinstated, and the Buyer shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the Company, the Buyer may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (x) any such increase in the Maximum Percentage will not be effective until the 61st day after such notice is delivered to the Company and (y) any such increase or decrease will apply only to the Buyer and the other Attribution Parties. For purposes of clarity, it is the intent of the Company and the Buyer that the shares of Common Stock issuable pursuant to the terms of this Agreement in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Buyer for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act. The provisions of this Section 2(i) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(i) to the extent necessary to correct this Section 2(i) (or any portion of this Section 2(i)) that may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 2(i) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this Section 2(i)) may not be waived and shall apply to a successor of the Buyer to this Agreement.

For the purposes of Section 2(i),

i. “Affiliate” means, with respect to any Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.

ii. “Attribution Parties” means, collectively, the following Persons: (a) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the Closing Date, directly or indirectly managed or advised by the Buyer’s investment manager or any of its Affiliates or principals, (b) any direct or indirect Affiliates of the Buyer or any of the foregoing, (c) any Person acting or who could be deemed to be acting as a Group together with the Buyer or any of the foregoing and (d) any other Person whose beneficial ownership of the Common Stock would or could be aggregated with the Buyer and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively the Buyer and all other Attribution Parties of the Buyer to the Maximum Percentage.

iii. “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether

5

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

through the ability to exercise voting power, by contract or otherwise, and “Controlling” and “Controlled” have meanings correlative thereto.

iv. “Governmental Authority” means any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, administrative tribunal, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.

v. “Group” means a “group” as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended, and as defined in Rule 13d-5 thereunder.

vi. “Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.

 

3.
Buyer’s Representations and Warranties. The Buyer represents and warrants to the Company as of the Closing Date that:
(a)
Investment Purpose. The Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion thereof (the “Conversion Shares”), and is receiving the Success Fee Shares and any Additional Shares (collectively with the Note, the Success Fee Shares and the Conversion Shares, the “Securities”) for its own account for investment purposes and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.
(b)
Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D (an “Accredited Investor”).
(c)
Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the Securities.
(d)
Information. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities that have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company regarding its business and affairs. Notwithstanding the foregoing, the Company has not disclosed to the

6

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Buyer any material nonpublic information regarding the Company or otherwise and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by the Buyer or any of its advisors or representatives shall modify, amend or affect the Buyer’s right to rely on the Company’s representations and warranties contained in Section 3.
(e)
Governmental Review. The Buyer understands that no United States federal or state agency or any other government or governmental agency has passed upon or made any recommendation or endorsement of the Securities.
(f)
Transfer or Re-sale. The Buyer understands that: (i) the sale of the Securities has not been and is not being registered under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (A) the Securities are sold pursuant to an effective registration statement under the 1933 Act, (B) the Buyer shall have delivered to the Company an opinion of counsel (which may be the Legal Counsel Opinion (as defined below)) that shall be in form, substance and scope customary for opinions of counsel in comparable transactions to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption from such registration, and reasonably acceptable to the Company, (C) the Securities are sold or transferred to an “affiliate” (as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”)) of the Buyer that agrees to sell or otherwise transfer the Securities only in accordance with this Section 3.f and that is an Accredited Investor, (D) the Securities are sold pursuant to Rule 144, or (E) the Securities are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation S”), and the Buyer shall have delivered to the Company an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in corporate transactions, and reasonably acceptable to the Company; (ii) any sale of Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any re-sale of the Securities under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and (iii) other than as set forth in the Registration Rights Agreement, neither the Company nor any other Person is under any obligation to register such Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case).
(g)
Legends.
(i)
The Buyer understands that until such time as the Note, the Conversion Shares, Success Fee Shares or Additional Shares, as applicable, have been registered under the 1933 Act or may be sold pursuant to Rule 144, Rule 144A under the 1933 Act (“Rule 144A”) or Regulation S without any restriction as to the number of securities as of a particular date that can then be immediately sold, the Securities (in certificated or book entry form) may bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of the Securities):

7

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

“NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE [NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE] HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN FORM AND SUBSTANCE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S UNDER SAID ACT.”

The legend set forth above shall be removed and the Company shall cause the applicable shares of Common Stock to be reissued without such legend to the holder of any Security upon which it is stamped in certificated or book-entry form or (as requested by such holder) issue the applicable shares of Common Stock to such holder by electronic delivery by crediting the account of such holder’s broker with The Depository Trust Company (“DTC”), if, unless otherwise required by applicable state securities laws, (i) such Security is registered for sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144, Rule 144A or Regulation S without any restriction as to the number of securities as of a particular date that can then be immediately sold, or (ii) the Company or the Buyer provides the Legal Counsel Opinion (as contemplated by and in accordance with Section 3(f) to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be in form and substance reasonably acceptable to the Company. The Company shall be responsible for the fees of its transfer agent and all DTC fees associated with any such issuance. The Buyer agrees to sell all Securities, including those represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any.

(ii)
The Buyer understands that, until the Initial Conversion Date, the Success Fee Shares may bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of such Success Fee Shares):

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A SECURITIES PURCHASE AGREEMENT, DATED AS OF NOVEMBER 12, 2024, BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE “ISSUER”) AND THE PURCHASER NAMED THEREIN. THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE

8

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

SOLD UNTIL THE SIX (6) MONTH ANNIVERSARY OF THE ISSUANCE OF SUCH SECURITIES.”

The legend set forth above shall be removed on the number of shares of Success Fee Shares the holder is permitted to sell under Section 2(c) hereof, and the Company shall cause the applicable shares of Success Fee Shares to be reissued without such legend to the holder of any shares of Success Fee Shares upon which it is stamped in certificated or book-entry form or (as requested by such holder) issue the applicable shares of Success Fee Shares to such holder by electronic delivery by crediting the account of such holder’s broker with DTC, provided that such shares do not then bear the legend set forth in Section 3(g)(i).

(h)
Authorization; Enforcement. Each of this Agreement and the Registration Rights Agreement has been duly and validly authorized by the Buyer and has been duly executed and delivered on behalf of the Buyer, and each constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’ rights generally and except as may be limited by the exercise of judicial discretion in applying principles of equity.
(i)
Residency. The principal place of business of the Buyer is set forth immediately below the Buyer’s name on the signature pages hereto.
4.
Representations and Warranties of the Company. The Company represents and warrants to the Buyer as of the as of the Closing Date that:
(a)
Organization and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated and conducted. The Company is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes such qualification necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect. “Material Adverse Effect” means any material adverse effect on the business, operations, assets, financial condition or prospects of the Company and its subsidiaries taken as a whole, or on the transactions contemplated hereby or by the agreements or instruments to be entered into in connection herewith.
(b)
Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the Note, the Subordination Agreement and the Registration Rights Agreement (collectively, the “Transaction Documents”), and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof and thereof, (ii) the Company’s execution and delivery of the Transaction Documents and the consummation by it of the transactions contemplated thereby (including the issuance of the Note and the Success Fee Shares, as well as the issuance and reservation for issuance of the Conversion Shares

9

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

issuable upon conversion of the Note and the Additional Shares) have been duly authorized by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, its shareholders, or its debt holders is required, (iii) the Transaction Documents (together with any other instruments executed in connection herewith or therewith) have been duly executed and delivered by the Company by its authorized representative, and such authorized representative is the true and official representative with authority to sign the Transaction Documents and the other instruments documents executed in connection herewith or therewith and bind the Company accordingly, and (iv) each of the Transaction Documents will constitute, a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with their respective terms; provided, however, in the case of clauses (i) and (ii), in the event the issuance of the Conversion Shares, Success Fee Shares and/or Additional Shares (taking into account any prior issuance of Conversion Shares, Success Fee Shares and/or Additional Shares and the issuance of 650,000 shares of Common Stock to Northland Securities, Inc. as compensation for its brokerage services provided to Buyer (the “Brokerage Fee Shares”), as the case may be), would result in the issuance in excess of 19.99% of the issued and outstanding shares of the Company’s Common Stock and Class B Stock, taken as a whole, on the date hereof (the “NYSE Limit”), such issuance shall be subject to the approval of the Company’s shareholders (“Shareholder Approval”) as may be required by Section 312 of the New York Stock Exchange Listed Company Manual or the rules and regulations of any successor national securities exchange (the “Principal Market”).
(c)
Capitalization; Governing Documents. As of the Closing Date, the authorized capital stock of the Company consists of: 1,809,000,000 authorized shares, of which 1,700,000,000 are the Common Stock, 9,000,000 are Class B common stock, par value $0.0001 per share (the “Class B Stock”) and 100,000,000 are preferred stock, par value $0.0001 per share (the “Preferred Stock”). As of the November 4, 2024, 132,925,259 shares of Common Stock were issued and outstanding, 8,290,921 shares of the Class B Stock were issued and outstanding and no shares of Preferred Stock were issued and outstanding. All of such outstanding shares of capital stock of the Company, the Conversion Shares, Success Fee Shares and Additional Shares are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable. No shares of the Company’s capital stock are subject to preemptive rights or any other similar rights of the Company’s shareholders or any liens or encumbrances imposed through the Company’s actions or failure to act. As of the Closing Date, other than as set forth in the SEC Documents (as defined below) or as have been or may be granted or issued pursuant to the Company’s 2022 Long-Term Incentive Plan, its 2022 Employee Stock Purchase Plan and its 2024 Inducement Equity Incentive Plan (i) there are no outstanding options, warrants, scrip, rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or rights of any character whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of the Company’s capital stock, or arrangements by which the Company is or may become bound to issue additional shares of capital stock and (ii) there are no agreements or arrangements under which the Company is obligated to register the sale of any of its securities under the 1933 Act. The Company has furnished or made available to the Buyer true and correct copies of the Company’s Certificate of Incorporation as currently in effect (the “Certificate of Incorporation”), the

10

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Company’s By-laws, as currently in effect (the “By-laws”), and the terms of all securities convertible into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.
(d)
Issuance of Shares. Subject only to the receipt of the Shareholder Approval with respect to the issuance of any Conversion Shares, Success Fee Shares, Additional Shares and/or Brokerage Fee Shares that exceed (taking into account any prior issuance of Conversion Shares, Success Fee Shares, Additional Shares and/or Brokerage Fee Shares, as the case may be) the NYSE Limit, the Conversion Shares, the Success Fee Shares and Additional Shares are duly authorized and the Conversion Shares and Additional Shares are reserved for issuance. The Success Fee Shares are validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of the Company’s shareholders and will not impose personal liability upon the holder thereof. The Additional Shares and the Conversion Shares, if and to the extent issued upon conversion of the Note in accordance with its terms, upon issuance will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of the Company’s shareholders and will not impose personal liability upon the holder thereof.
(e)
Acknowledgment of Dilution. The Company understands and acknowledges the potentially dilutive effect of the Success Fee Shares, the Additional Shares and the Conversion Shares to the Common Stock. The Company further acknowledges that its obligations to issue the Success Fee Shares and the Additional Shares and, upon conversion of the Note, the Conversion Shares, in accordance with this Agreement, and the Note are absolute and unconditional, subject to the receipt of the Shareholder Approval with respect to the issuance of any Common Stock that exceeds the NYSE Limit, regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.
(f)
No Conflicts. The Company’s execution, delivery and performance of this Agreement and the Note and the Company’s consummation of the transactions contemplated hereby and thereby (including the issuance of the Success Fee Shares and reservation for issuance of the Conversion Shares and Additional Shares, subject only to the receipt of the Shareholder Approval with respect to the issuance of any Conversion Shares, Success Fee Shares and Additional Shares that exceed (taking into account any prior issuance of Conversion Shares, Success Fee Shares, Additional Shares and/or Brokerage Fee Shares, as the case may be) the NYSE Limit) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws, (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, note, evidence of indebtedness, indenture, patent, patent license or instrument to which the Company or any of its subsidiaries is a party or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the

11

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Company or its securities is subject) applicable to the Company or any of its subsidiaries or by which any property or asset of the Company or any of its subsidiaries is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect). The Company is not in violation of its Certificate of Incorporation, By-laws or other organizational documents and neither the Company nor any of its subsidiaries is in default (and no event has occurred that with notice or lapse of time or both could put the Company or any of its subsidiaries in default) under, and neither the Company nor any of its subsidiaries has taken any action or failed to take any action that would give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its subsidiaries is a party or by which any property or assets of the Company or any of its subsidiaries is bound or affected, except for possible defaults as would not, individually or in the aggregate, have a Material Adverse Effect. Except as specifically contemplated by this Agreement, including the potential need to obtain Shareholder Approval with respect to the issuance of shares in excess of the NYSE Limit, and as required under the 1933 Act, any applicable state securities laws, the applicable rules and regulations of the Principal Market or as has been obtained or made, the Company is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental agency, regulatory agency, self-regulatory organization or stock market or any third party in order for it to execute, deliver or perform any of its obligations under this Agreement and the Note in accordance with the terms hereof or thereof or to issue and sell the Note in accordance with the terms hereof and issue Success Fee Shares and Additional Shares and, upon conversion of the Note, the Conversion Shares.
(g)
SEC Documents; Financial Statements. Since September 30, 2023, the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “1934 Act”) (all of the foregoing filed since September 30, 2023 and all exhibits included therein and financial statements and schedules thereto and documents (other than exhibits to such documents) incorporated by reference therein, collectively, the “SEC Documents”). As of their respective filing dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under applicable law (except for such statements as have been amended or updated in subsequent filings prior the date hereof). As of their respective dates, the financial statements of the Company included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted accounting principles, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial position of the Company and its consolidated subsidiaries as of the dates thereof and the

12

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

consolidated results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). Except as set forth in the Company’s financial statements included in the SEC Documents, the Company has no liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business subsequent to June 30, 2024, and (ii) obligations under contracts and commitments incurred in the ordinary course of business, and not required under generally accepted accounting principles to be reflected in such financial statements, that, individually or in the aggregate, are not material to the Company’s financial condition or operating results. As of the date hereof, except for the transactions contemplated by the Transaction Documents, no event has occurred that would be required to be disclosed on a Current Report on Form 8-K that has not been so disclosed. The Company is subject to the reporting requirements of the 1934 Act.
(h)
Absence of Certain Changes. Since June 30, 2024, except as set forth in the SEC Documents, there has been no material adverse change and no material adverse development in the Company’s assets, liabilities, business, properties, operations, financial condition, results of operations, prospects or 1934 Act reporting status.
(i)
Absence of Litigation. There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the Company’s knowledge, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a Material Adverse Effect, other than those disclosed in the SEC Documents. The SEC Documents contain a complete list and summary description of any pending or, to the Company’s knowledge, threatened material proceeding against or affecting the Company or any of its subsidiaries. The Company and its subsidiaries are unaware of any facts or circumstances that might give rise to any of the foregoing.
(j)
Intellectual Property. The Company and each of its subsidiaries owns or possesses the requisite licenses or rights to use all patents, patent applications, patent rights, inventions, know-how, trade secrets, trademarks, trademark applications, service marks, service names, trade names and copyrights (“Intellectual Property”) necessary to enable it to conduct its business as now operated (and, as presently contemplated to be operated in the future); there is no claim or action by any Person pertaining to, or proceeding pending, or to the Company’s knowledge threatened, that challenges the right of the Company or of a subsidiary with respect to any Intellectual Property necessary to enable it to conduct its business as now operated (and, as presently contemplated to be operated in the future); to the Company’s knowledge, the Company’s and its subsidiaries’ current and intended products, services and processes do not infringe on any Intellectual Property or other rights held by any Person; and the Company is unaware of any facts or circumstances that might give rise to any of the foregoing. The Company and each of its subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of its Intellectual Property.
(k)
No Materially Adverse Contracts, Etc. Neither the Company nor any of its subsidiaries is subject to any charter, corporate or other legal restriction, or any judgment,

13

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

decree, order, rule or regulation that, in the judgment of the Company’s officers, has or is reasonably expected in the future to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries is a party to any contract or agreement that, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect.
(l)
Tax Status. The Company and each of its subsidiaries has made or filed all federal, state and foreign income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company or its subsidiaries have set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the Company’s officers know of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating to the assessment or collection of any foreign, federal, state or local tax. None of the Company’s tax returns is presently being audited by any taxing authority.
(m)
Transactions with Affiliates. Except (i) as disclosed in the SEC Documents, (ii) for arm’s length transactions pursuant to which the Company or any of its subsidiaries makes payments in the ordinary course of business upon terms no less favorable than the Company or such subsidiaries could obtain from third parties and (iii) the grant of stock options described in the SEC Documents, none of the Company’s officers, directors, or employees is presently a party to any transaction with the Company or any of its subsidiaries (other than for services as employees, officers and directors).
(n)
Disclosure. All information relating to or concerning the Company or any of its subsidiaries set forth in this Agreement and provided to the Buyer pursuant to Section 4.c hereof and otherwise in connection with the transactions contemplated hereby is true and correct in all material respects and the Company has not omitted to state any material fact necessary in order to make the statements made herein or therein, in light of the circumstances under which they were made, not misleading. No event or circumstance has occurred or exists with respect to the Company or any of its business, properties, prospects, operations or financial conditions that, under applicable law, rule or regulation, requires the Company’s public disclosure or announcement that has not been so publicly disclosed in the SEC Documents (assuming for this purpose that the Company’s reports filed under the 1934 Act are being incorporated into an effective registration statement filed by the Company under the 1933 Act).
(o)
No Integrated Offering. Neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf, has directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require registration under the 1933 Act of the issuance of the Securities to the Buyer.

14

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

(p)
No Brokers. Other than arranging for the sale of the shares of Common Stock pursuant to the Trading Plan (as defined below), the Company has taken no action that would give rise to any claim by any Person for brokerage commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.
(q)
Permits; Compliance. The Company is in possession of all material franchises, grants, authorizations, licenses, permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and operate its properties and to carry on its business as it is now being conducted (collectively, the “Company Permits”), and there is no action pending or, to the Company’s knowledge, threatened regarding suspension or cancellation of any of the Company Permits. The Company is not in conflict with, or in default or violation of, any of the Company Permits, except for any such conflicts, defaults or violations which, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. Since June 30, 2024, the Company has not received any notification with respect to possible conflicts, defaults or violations of applicable laws, except for notices relating to possible conflicts, defaults or violations, which conflicts, defaults or violations would not have a Material Adverse Effect.
(r)
Environmental Matters. The Company (i) has not violated any applicable environmental laws in any material respect, (ii) does not maintain any properties or assets that have been designated in any manner pursuant to any environmental protection statute as a hazardous materials disposal site, and (iii) has not received any notice, summons, citation or directive from the Environmental Protection Agency or any other similar governmental authority.
(s)
Title to Property. The Company and its subsidiaries have a valid leasehold interest in all real property leased by them and good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects, or such as would not have a Material Adverse Effect. Any real property and facilities held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as would not have a Material Adverse Effect.
(t)
Insurance. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the business in which the Company is engaged, including, but not limited to, directors and officers insurance coverage.
(u)
Internal Accounting Controls. Except as set forth in the SEC Documents, the Company maintains a system of internal accounting controls sufficient, in the judgment of the Company’s Board of Directors, to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s

15

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
(v)
Foreign Corrupt Practices. Neither the Company, nor any of its subsidiaries, nor any director, officer, agent, employee or other person acting on behalf of the Company or any subsidiary has, in the course of his or her actions for, or on behalf of, the Company, used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.
(w)
No Investment Company. The Company is not, and upon the issuance and sale of the Securities will not be, an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment Company”). The Company is not controlled by an Investment Company.
(x)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its subsidiaries and an unconsolidated or other off balance sheet entity that the Company is required to disclose in its 1934 Act filings and is not so disclosed, or that otherwise could be reasonably likely to have a Material Adverse Effect.
(y)
No Disqualification Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.
(z)
Manipulation of Price. The Company has not, and to the Company’s knowledge, no one acting on its behalf has: (i) taken, directly or indirectly, any action designed to cause or to result, or that could reasonably be expected to cause or result, in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities; (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities; or (iii) paid or agreed to pay to any person any compensation for soliciting another to purchase any other securities of the Company.

16

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

(aa)
Outstanding Indebtedness. The Company has no outstanding Indebtedness, except pursuant to the agreements listed on Exhibit B hereto, and Exhibit B identifies, as of the date hereof, the Indebtedness that is senior to the Note, the Indebtedness that is secured by a valid security interest and Indebtedness that is unsecured. “Indebtedness” shall mean any debt that is required to be disclosed on the Company’s balance sheet in accordance generally accepted accounting principles; provided, however, Indebtedness shall not include any unsecured debt incurred in the ordinary course of business.
5.
ADDITIONAL COVENANTS, AGREEMENTS AND ACKNOWLEDGEMENTS.
(a)
Blue Sky Laws. The Company shall, on or before the Closing Date take such action as the Company shall reasonably determine is necessary to qualify the Securities for sale to the Buyer at the Closing under applicable federal or state securities laws (or to obtain an exemption from such qualification).
(b)
Listing. The Company will, so long as the Buyer owns any of the Success Fee Shares, Conversion Shares and/or Additional Shares, promptly provide to the Buyer copies of any notices it receives from the Principal Market and any other exchanges or electronic quotation systems on which the Common Stock is then traded regarding the continued eligibility of the Common Stock for listing on such exchanges and quotation systems. At or before the Closing, the Company will have submitted to the New York Stock Exchange a Supplemental Listing Application with respect to the Success Fee Shares, Conversion Shares and/or Additional Shares. The Company will use its commercially reasonable efforts to maintain the listing of the Success Fee Shares, Conversion Shares and/or Additional Shares on the New York Stock Exchange for so long as the Common Stock is then so listed.
(c)
No Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances that would require registration of the Securities under the 1933 Act.
(d)
Support for Shareholder Approval. In the event that the issuance of the Success Fee Shares, Conversion Shares, Additional Shares and/or Brokerage Fee Shares exceed the NYSE Limit or otherwise require Shareholder Approval, the Company shall use its commercially reasonable efforts to seek the Shareholder Approval in accordance with Delaware law and the rules and regulations of the SEC and the NYSE, it being agreed and understood that the Company cannot guarantee that such Shareholder Approval will be obtained.
(e)
Disclosure of Transactions and Other Material Information. Promptly following the Closing Date, the Company shall file a Current Report on Form 8-K describing the terms of the transactions contemplated by this Agreement in the form required by the 1934 Act and attaching this Agreement (the “8-K Filing”). From and after the filing of the 8-K Filing with the SEC, the Buyer shall not be in possession of any material, nonpublic information received from the Company, any of its subsidiaries or any of their respective officers, directors, employees or agents that is not disclosed in the 8-K

17

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Filing. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the Buyer or any of its affiliates, on the other hand, shall terminate.
(f)
Legal Counsel Opinions. Upon the request of the Buyer from to time to time, the Company shall be responsible (at its cost) for promptly supplying to the Company’s transfer agent and the Buyer a customary legal opinion letter of its counsel (the “Legal Counsel Opinion”) to the effect that the resale of the Success Fee Shares, Conversion Shares and/or Additional Shares by the Buyer or its affiliates, successors and assigns has been registered or is exempt from the registration requirements of the 1933 Act pursuant to Rule 144 (provided the requirements of Rule 144 are satisfied and provided the Success Fee Shares, Conversion Shares and/or Additional Shares are not then registered under the 1933 Act for resale pursuant to an effective registration statement); provided, however, the Buyer shall be required to deliver the certificate attached hereto as Exhibit C (with such revisions as may be reasonably requested by the Company’s transfer agent) prior to the issuance of the Legal Counsel Opinion. Should the Company’s legal counsel fail for any reason to issue the Legal Counsel Opinion, the Buyer may secure another legal counsel to issue the Legal Counsel Opinion, and the Company will instruct its transfer agent to accept such opinion and will reimburse the Buyer for any reasonable and documented legal fees therefor.
(g)
Forfeiture of Shares/Cancellation of Principal. Notwithstanding anything to the contrary herein, if the Buyer sells the Conversion Shares, Success Fee Shares and/or Additional Shares for, net of brokerage fees and expenses, an amount equal to 150% of the Purchase Price, Buyer shall be required to return any remaining Conversion Shares, Success Fee Shares and/or Additional Shares to the Company and shall cooperate with the Company and deliver all documents reasonably requested to effectuate such return of the Conversion Shares, Success Fee Shares and/or Additional Shares (“Forfeiture Event”). In addition, upon a Forfeiture Event the Buyer agrees to cancel any remaining principal amount owed under the Note and shall cooperate with the Company and deliver all documents reasonably requested to effectuate such cancellation.
(h)
No Hedging. The Buyer agrees that so long as the Note is outstanding, it shall not engage in any hedging activities including any transaction by which any economic risks and/or rewards, or ownership, of the Note, the Conversion Shares, the Success Fee Shares or any Additional Shares are transferred or affected.
(i)
Use of Proceeds. The Buyer hereby acknowledges that the Company may use the proceeds from the Note for any corporate purpose.
(j)
Sales Limitation. Notwithstanding anything to the contrary herein, the Buyer agrees that it shall not sell any Conversion Shares, Success Fee Shares and/or Additional Shares on any trading day if such sales taken together would exceed 20% of the average daily trading volume for the trailing 30 day period; provided, however, this limitation shall not apply to sales made pursuant to Section 5(k).

18

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

(k)
Organized Sales. If the Company exercises its Optional Conversion Right, the disposition of the Conversion Shares and Success Fee Shares shall be governed by a trading plan (the “Trading Plan”) to be mutually agreed to by the Company and the Buyer in good faith and executed by Northland Securities, Inc. (the “Broker”) or another broker mutually acceptable to the Company and the Buyer. Notwithstanding anything to the contrary herein, if the Buyer moves any of the Success Fee Shares or Conversion Shares out of its account at the Broker, it shall forfeit its right to receive any Additional Shares pursuant to the terms of this Agreement; provided, however, the Buyer shall have the right to modify or alter the Trading Plan with the consent of the Company without forfeiting its right to receive any Additional Shares. For the avoidance of doubt, the Buyer has the right to modify or alter its Trading Plan after the Initial Conversion Date without forfeiting its right to receive any Additional Shares.
(l)
Share Cap Limit. The Buyer acknowledges that in no event shall the Company be required to issue Conversion Shares, Success Fee Shares and/or Additional Shares if such issuance, when aggregated with the issuance of the Brokerage Fee Shares and any other shares of Common Stock pursuant to this Agreement would in the aggregate result in the issuance in excess of 19.99% of the issued and outstanding Common Stock and Class B Stock, taken as a whole, on the date hereof until Shareholder Approval is obtained pursuant to this Agreement.
(m)
Expenses. Each party will bear its own legal and other expenses with respect to the transactions contemplated hereby; provided, that the Company will reimburse the Buyer for up to $50,000 of its reasonable and documented legal and other third party expenses.
6.
Transfer Agent Instructions. Upon receipt of a conversion notice in respect of the Conversion Shares, the Company shall issue instructions to the Company’s transfer agent to issue certificates or a book-entry position, registered in the name of the Buyer or its nominee, in such amounts as specified from time to time by the Buyer to the Company in accordance with the terms within 2 Business Days of receipt of a conversion notice. The Company warrants that: (i) no instruction other than the instructions referred to in this Section 6 will be given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not to transfer or delay, impair, or hinder its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for the Securities to be issued to the Buyer, including upon conversion of or otherwise pursuant to the Note, as and when required by the Note and this Agreement; (iii) it will not fail to remove (or direct its transfer agent not to remove, or impair, delay, or hinder its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any Securities, including upon conversion of or otherwise pursuant to the Note, as and when required by the Note and this Agreement; and (iv) it will provide any required corporate resolutions and issuance approvals to its transfer agent within 2 Business Days of the conversion of the Note. Nothing in this Section 6 shall affect in any way the Buyer’s obligations and agreement set forth in Section 3.g to comply with all applicable prospectus delivery requirements, if any, upon re-sale of the Securities.

19

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

7.
Governing Law; Miscellaneous.
(a)
Interpretive Provisions. With reference to this Agreement, unless otherwise specified herein:
(i)
the meanings of defined terms are equally applicable to the singular and plural forms of the defined terms;
(ii)
the words “herein,” “hereto,” “hereof” and “hereunder” and words of similar import when used in this Agreement shall refer this Agreement as a whole and not to any particular provision thereof;
(iii)
references in this Agreement to an Exhibit, Schedule, Article, Section, clause or subclause refer to the appropriate Exhibit or Schedule to, or Article, Section, clause or subclause in this Agreement;
(iv)
the term “Business Day” means any day, other than Saturday or Sunday, or any day on which the Federal Reserve Bank of New York is authorized or required by law to be closed;
(v)
the term “including” is by way of example and not limitation;
(vi)
the term “documents” includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form;
(vii)
the term “Person” means any individual or corporation, association, partnership, limited liability company, joint venture, joint stock, or other company, business trust, trust, organization, governmental authority, or other entity of any kind;
(viii)
any reference herein to any Person shall be construed to include such Person’s successors and assigns;
(ix)
the term “or” means “and/or”; and
(x)
on the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including”; the words “to” and “until” each mean “to but excluding”; and the word “through” means “to and including.”
(b)
Governing Law; Venue. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict of laws thereof. Each Party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a Party or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the

20

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

state and federal courts sitting in the City of New York, Borough of Manhattan (the “New York Courts”). Each Party hereby irrevocably submits to the non-exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each Party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
(c)
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each Party and delivered to the other Party. In the event that any signature to this Agreement is delivered by facsimile transmission or by e-mail delivery of a “.pdf’ format data file or other electronic transmission (including pdf format and any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), such signature shall create a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf’ or such other electronic transmission signature page were an original thereof.
(d)
Severability. If any provision of this Agreement is invalid, illegal or unenforceable, the balance of this Agreement shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances so long as this Agreement as so modified continues to express, without material change, the original intentions of the Company and the Buyer as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the Company or the Buyer or the practical realization of the benefits that would otherwise be conferred upon the Company or the Buyer. The Company and the Buyer will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
(e)
Entire Agreement; Amendments. This Agreement, the Note, and the instruments referenced herein contain the entire understanding of the Parties with respect

21

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement or any agreement or instrument contemplated hereby may be waived or amended other than by an instrument in writing signed by the Buyer.
(f)
Notices. Any and all notices or other communications or deliveries to be provided by the Buyer hereunder shall be in writing and delivered personally, by email attachment or sent by a nationally recognized overnight courier service, addressed to the Company, at the address set forth for the Company in set forth below, or such other email address or address as the Company may specify for such purposes by notice to the Buyer delivered in accordance with this Section 7.f. Any and all notices or other communications or deliveries to be provided by the Company hereunder, shall be in writing and delivered personally or by email attachment or sent by a nationally recognized overnight courier service addressed to the Buyer as set forth below. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via email attachment prior to 5:30 PM Eastern time on any date, (ii) the next VWAP Trading Day after the date of transmission, if such notice or communication is delivered via email attachment on a day that is not a VWAP Trading Day or later than 5:30 PM Eastern time on any VWAP Trading Day, (iii) the second VWAP Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service and (iv) upon actual receipt by the Party to whom such notice is required to be given. The addresses for such notices and communications are as follows:

If to the Company, to:

FISCALNOTE HOLDINGS, INC.
1201 Pennsylvania Ave NW,
6th Floor
Washington, D.C. 20004
Attention: Todd Aman, General Counsel & Secretary
e-mail: [****]

With a copy by e-mail only to (which copy shall not constitute notice):

POLSINELLI PC
1401 I Street, NW
Suite 80
Washington, DC
20005 Attn: Kevin Vold
e-mail: kvold@polsinelli.com

If to the Buyer:

EGT 10, LLC
[****]
 

22

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Attn: Jasper Lau
e-mail: [****]

With a copy by e-mail only to (which copy shall not constitute notice):

GUNDERSON DETTMER STOUGH VILLENEUVE FRANKLIN & HACHIGIAN, LLP
1245 Broadway
New York, NY 10001
Attn: Melissa Marks
e-mail: mmarks@gunder.com

(g)
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Parties and their successors and permitted assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the other Party.
(h)
Third Party Beneficiaries. This Agreement is intended for the benefit of the Parties and their respective successors and permitted assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.
(i)
Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the Closing notwithstanding any due diligence investigation conducted by or on behalf of the Buyer.
(j)
Publicity. The Company and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC, Principal Market or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, Principal Market (or other applicable trading market) or FINRA filings with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by the Company in connection with any such press release prior to its release and shall be provided with a copy thereof and be given a reasonable opportunity to comment thereon).
(k)
Further Assurances. The Company and the Buyer hereby agree to take such actions consistent with the terms of this Agreement as may be reasonably necessary in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(l)
Amendments; Waivers. Any provision of this Agreement may be amended or waived by a written instrument executed by both Parties. Any waiver by either Party of a breach of any provision of this Agreement shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Agreement. The failure of either Party to insist upon strict adherence to any term of this Agreement on one or more occasions shall not be considered a waiver or deprive that Party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement on any other occasion.

23

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

[Signature Page Follows]

 

24

DOCPROPERTY"SWDocID" GDSVF&H\10632331.2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

The undersigned Parties have caused this Agreement to be duly executed as of the date first above written.

FISCALNOTE HOLDINGS, INC.

By: /s/ Tim Hwang
Name: Tim Hwang
Title: Chief Executive Officer

EGT 10, LLC

By: /s/ Jasper Lau
Name: Jasper Lau
Title: CEO

 

[Signature Page to Securities Purchase Agreement]

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

EXHIBIT A

FORM OF NOTE

[Refer to Exhibit [ ] to the Quarterly Report on Form 10-Q Filed on November 12, 2024]

 

Exhibit A

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

EXHIBIT B

Outstanding Indebtedness

Intentionally omitted in reliance upon Item 601(a)(5)

 

Exhibit B

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

EXHIBIT C

Investor Certificate

[STOCKHOLDER LETTERHEAD]

[Date]

FiscalNote Holdings, Inc.

1201 Pennsylvania Avenue NW, 6th Floor Washington, DC 20004 Attention: Senior Vice President, General Counsel & Secretary Polsinelli PC

1401 I Street NW, Suite 800 Washington, DC 20005 Attention: Kevin Vold

Re: Legend Removal Representation Letter

Ladies and Gentlemen:

The undersigned stockholder (the “Stockholder”) of FiscalNote Holdings, Inc., a Delaware corporation (the “Company”), owns the number of shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), set forth under the Stockholder’s name on the signature page hereof (the “Shares”) and is delivering this letter to the Company in connection with the Stockholder’s request to remove the transfer restriction legends under the Securities Act of 1933, as amended (the “Securities Act”), from certificates or book-entry notations issued in the Stockholder’s name with respect to the Shares. In order to induce the Company to provide an instruction letter to the Company’s transfer agent, Continental Stock Transfer & Trust Company (the “Transfer Agent”), and to enable the Transfer Agent to remove the restrictive legends borne by the Shares, the Stockholder hereby represents, warrants and agrees, as follows:

1)
The Stockholder is sophisticated in financial matters and is familiar with the registration requirements under the Securities Act. If the Stockholder is an investment fund, the Stockholder’s chief compliance officer (or the chief compliance officer of the general partner, manager or other entity that manages the Stockholder) has reviewed this letter and is aware that the Stockholder will be executing and delivering this letter to the Company and undertaking the obligations set forth herein.
2)
The Stockholder will only sell or transfer the Shares pursuant to and in a manner contemplated by the Company’s Registration Statement on Form [S-3/S-1] (File No. 333-[•]) and the prospectus, if any, included therein (as amended from time to time, the “Registration Statement”) or pursuant to a valid exemption from the Securities Act.
3)
The Stockholder will not sell or transfer the Shares pursuant to the Registration Statement if at any time the Stockholder has received notice from the Company indicating that the Registration Statement is unavailable for the offer and sale of the

Exhibit C-1

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Shares, unless the Stockholder provides the Company with advance notice of such sale or transfer and an opinion of counsel that the proposed sale or transfer is in compliance with the Securities Act.
4)
Any applicable prospectus delivery requirements of the Securities Act will be satisfied in connection with a sale or transfer of the Shares.
5)
The Stockholder will comply with all applicable securities laws and regulations in connection with a sale or transfer of the Shares.
6)
There are no applicable contractual restrictions that would prohibit the sale or transfer of the Shares.

The Stockholder will provide the Company with any update to the Stockholder’s contact information set forth on the signature page hereof for purposes of any notification to be delivered to the Stockholder relating hereto. The Stockholder hereby acknowledges and agrees that each of the Company and Polsinelli PC, or the Company’s then current outside counsel (collectively, the “Authorized Recipients”), and may each rely upon the completeness and accuracy of this representation letter.

[Signature Page Follows]

Exhibit C-2

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


 

Yours truly,

Name of Stockholder:

Signature:

Name of Signatory (of Entity):

Title of Signatory:

Exhibit C-3

DOCPROPERTY "CUS_DocIDChunk0" 99398190.10


Execution Version

NEITHER THIS SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE NOR THE SECURITIES INTO WHICH THIS SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OR OTHER JURISDICTION AND HAS BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE SECURITIES LAWS.

ALL INDEBTEDNESS EVIDENCED BY THIS SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE IS SUBORDINATE TO OTHER INDEBTEDNESS PURSUANT TO, AND TO THE EXTENT PROVIDED IN, AND IS OTHERWISE SUBJECT TO THE TERMS OF, THE SUBORDINATION AGREEMENT, DATED AS OF __________, 2024 (THE “SUBORDINATION AGREEMENT”), AS THE SAME MAY BE AMENDED, RESTATED, SUPPLEMENTED OR OTHERWISE MODIFIED FROM TIME TO TIME, BY AND AMONG THE HOLDER (AS DEFINED BELOW), THE COMPANY (AS DEFINED BELOW) AND RUNWAY GROWTH FINANCE CORP. (TOGETHER WITH ITS PERMITTED SUCCESSORS AND ASSIGNS), AS ADMINISTRATIVE AGENT FOR THE SENIOR LENDERS (AS DEFINED IN THE SUBORDINATION AGREEMENT) FROM TIME TO TIME PARTY TO THE SENIOR LOAN AGREEMENT (AS DEFINED IN THE SUBORDINATION AGREEMENT), AND HOLDER, BY ITS ACCEPTANCE HEREOF, ACKNOWLEDGES AND AGREES TO BE BOUND BY THE PROVISIONS OF THE SUBORDINATION AGREEMENT.

Issue Date: __________, 2024

Principal Amount: $__________

SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE DUE __________, 2027

THIS SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE is issued by FiscalNote Holdings, Inc., a Delaware corporation (the “Company”), having its principal place of business at 1201 Pennsylvania Avenue, NW, 6th Floor, Washington, District of Columbia, 20004 (this note, as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms hereof and of the Subordination Agreement, the “Note” and “Notes” refers to this Note along with any portion(s) of this Note transferred to a transferee).

FOR VALUE RECEIVED, the Company promises to pay to __________ or its registered assigns (the “Holder”), or shall have paid pursuant to the terms hereunder, the principal sum of $__________on or prior to __________, 2027 (the “Maturity Date”), or such earlier date as this Note is required or permitted to be repaid as provided hereunder, and to pay Interest (as defined below) to the Holder on the aggregate unconverted and then-outstanding principal amount of this

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

Note in accordance with the provisions hereof. This Note was issued pursuant to the Securities Purchase Agreement, dated __________, 2024 by and between the Company and the Holder (as amended, restated, supplemented or otherwise modified from time to time, the “Securities Purchase Agreement”).

Section 1. Definitions. For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized terms not otherwise defined herein shall have the meanings set forth in the Securities Purchase Agreement and (b) the following terms shall have the following meanings:

“Affiliate” means, with respect to any Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.

“AFR” means the applicable federal rate published by the Internal Revenue Service for mid-term loans shown in Table 1 at https://www.irs.gov/applicable-federal-rates (or, if such page is not available, its equivalent successor page).

“Attribution Parties” means, collectively, the following Persons: (a) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issue Date, directly or indirectly managed or advised by the Holder’s investment manager or any of its Affiliates or principals, (b) any direct or indirect Affiliates of the Holder or any of the foregoing, (c) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (d) any other Person whose beneficial ownership of the Common Stock would or could be aggregated with the Holder’s and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties of the Holder to the Maximum Percentage.

“Bankruptcy Law” means Title 11, United States Code, or any similar U.S. federal or state or non-U.S. law for the relief of debtors.

“Business Day” means any day other than a Saturday, a Sunday or any day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.

“Close of Business” means 5:00 p.m., Eastern time.

“Common Stock” means the Class A Common Stock, par value $0.0001 per share, of the Company.

“Company” has the meaning set forth in the Recitals.

“Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise, and “Controlling” and “Controlled” have meanings correlative thereto.

2

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

“Conversion Date” means, as applicable, the Holder Conversion Date or the Company Conversion Date.

“Conversion Price” with respect to each VWAP Trading Day within the 30 VWAP Trading Days immediately preceding a Conversion Date (excluding the Conversion Date), the arithmetic average of the VWAPs for such VWAP Trading Days.

“Conversion Rate” means 100% and may be adjusted pursuant to Section 4(a) hereof.

“Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of this Note in accordance with the terms hereof and the Securities Purchase Agreement.

“Eligible Market” means of The New York Stock Exchange, NYSE MKT LLC, The NASDAQ Global Select Market, The NASDAQ Global Market or The NASDAQ Capital Market (or any of their respective successors).

“Event of Default” has the meaning set forth in Section 7(a).

“Excess Shares” has the meaning set forth in Section 3(f).

“Exchange Act” means the U.S. Securities and Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Excluded Holder” means Tim Hwang, Gerald Yao and Duddell Street Holdings Limited and their respective Affiliates.

“Freely Tradeable” means each of the following conditions with respect to the issuance of Common Stock pursuant to the terms of this Note, provided that the Holder may, in its sole and absolute discretion, waive in writing any such condition:

(a) shares of Common Stock that are duly authorized and listed and eligible for trading on an Eligible Market; and

(b) shares of Common Stock that are eligible to be sold by the holder thereof (i) without any volume or manner of sale restrictions under the Securities Act pursuant to Rule 144 thereunder or (ii) pursuant to a then-effective resale registration statement and available prospectus filed with the SEC.

“Fundamental Change” means and will be deemed to have occurred at such time as:

(a) any “person” or “group” (as those terms are used in Sections 13(d) and 14(d) of the Exchange Act), other than the Excluded Holder (such exception to apply solely with respect to clause (i) below), files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect “beneficial owner” (as that term is used in Rule 13d-3 under the Exchange Act) of more than (i) 50% of the total outstanding voting power of the Voting Stock; (ii) 50% of the outstanding shares of Voting Stock calculated as if any shares of Voting Stock held by such

3

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

“person” or “group” were not outstanding; or (iii) a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Voting Stock or other equity securities of the Company sufficient to allow such “person” or “group” to effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of Voting Stock without approval of the stockholders of the Company;

(b) the consummation of a single transaction or series of related transactions for a sale, transfer, lease, conveyance or other disposition, in one or a series of related transactions, of all or substantially all of the consolidated property or assets of the Company and its Subsidiaries, taken as a whole, to any “person” or “group” (as those terms are used in Sections 13(d) and 14(d) of the Exchange Act), other than the Company or one or more of the Company’s direct or indirect Subsidiaries (for the avoidance of doubt a merger or consolidation of the Company with or into another Person is not subject to this clause (b));

(c) any transaction or series of related transactions is consummated in connection with which (whether by means of merger, exchange, liquidation, tender offer, consolidation, combination, reclassification, recapitalization, acquisition or otherwise) all of the Common Stock and the Company’s Class B Common Stock, par value $0.0001 per share, are exchanged for, converted into, acquired for or constitutes solely the right to receive other securities, other property, assets or cash, but excluding the consummation of any merger, exchange, tender offer, consolidation or acquisition of the Company with or by another Person pursuant to which the Persons that “beneficially owned,” directly or indirectly, the shares of the Voting Stock immediately prior to such transaction “beneficially own,” directly or indirectly, immediately after such transaction, shares of the surviving, continuing or acquiring corporation’s voting stock representing at least 50% of the total outstanding voting power of all outstanding classes of voting stock of the surviving, continuing or acquiring corporation in substantially the same proportion relative to each other as such ownership immediately prior to such transaction;

(d) the adoption of a plan relating to the Company’s liquidation or dissolution; or

(e) a Termination in Trading.

“Fundamental Change Notice” has the meaning set forth in Section 5(d).

“Fundamental Change Notice Date” has the meaning set forth in Section 5(d).

“Fundamental Change Repurchase” has the meaning set forth in Section 5(c).

“Fundamental Change Repurchase Price” has the meaning set forth in Section 5(c).

“Governmental Authority” means any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, administrative tribunal, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.

4

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

“Group” means a “group” as that term is used in Section 13(d) of the Exchange Act and as defined in Rule 13d-5 thereunder.

“Holder” has the meaning set forth in the Recitals.

“Initial Conversion Date” means the date that is six months after the Issue Date.

“Interest” has the meaning set forth in Section 2(a).

“Interest Accrual Start Date” means the date that is six months after the Issue Date.

“Interest Rate” has the meaning set forth in Section 2(a).

“Issue Date” means the date of the first issuance of this Note, regardless of any transfers of this Note and regardless of the number of instruments that may be issued to evidence this Note.

“Loan Parties” has the meaning set forth in the Subordination Agreement.

“Maturity Date” has the meaning set forth in the Recitals.

“Maximum Percentage” has the meaning set forth in Section 3(f).

“Maximum Rate” has the meaning set forth in Section 9(g).

“New York Courts” has the meaning set forth in Section 9(d).

“Note” has the meaning set forth in the Recitals.

“Notice of Conversion” has the meaning set forth in Section 3(a).

“NYSE Limit” has the meaning set forth in the Securities Purchase Agreement.

“Optional Redemption Date” has the meaning set forth in Section 5(b).

“Optional Redemption Notice” has the meaning set forth in Section 5(b).

“Parties” means, collectively, the Company and the Holder.

“Party” means each of the Company and the Holder.

“Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.

“Redemption Price” has the meaning set forth in Section 5(a).

“Reported Outstanding Share Number” has the meaning set forth in Section 3(f).

“SEC” means the U.S. Securities and Exchange Commission.

5

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

“Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Securities Purchase Agreement” has the meaning set forth in the Recitals.

“Senior Loans” has the meaning set forth in the Subordination Agreement.

“Standard Settlement Period” means the standard settlement period, expressed in a number of VWAP Trading Days, on the principal securities exchange or securities market on which the Common Stock is then traded as in effect on the date of delivery of the applicable Notice of Conversion.

“Stockholder Approval” means the approval of holders of the Common Stock pursuant to Rule 312 of the NYSE Listed Company Manual (or its successor) or any other U.S. national securities exchange on which the Common Stock is then listed.

“Subordination Agreement” has the meaning set forth in Section 6.

“Subsidiary” of a Person means a corporation, partnership, joint venture, limited liability company or other business entity (a) of which a majority of the shares of securities or other equity interests having ordinary voting power for the election of directors, managers or other governing body (other than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially owned or (b) the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person and, in the case of this clause (b), that is treated as a consolidated subsidiary for accounting purposes. Unless otherwise specified, all references herein to a “Subsidiary” or to “Subsidiaries” shall refer to a Subsidiary or Subsidiaries of the Company.

“Termination in Trading” means the date (if ever) on which the Common Stock (or other common equity into which this Note is then convertible) is not listed for trading on any Eligible Market.

“Transaction Documents” means, collectively, this Note, the Securities Purchase Agreement and the Subordination Agreement.

“Voting Stock” means all classes of the Company’s common stock entitled to vote generally in the election of directors.

“VWAP” means, for any VWAP Trading Day, the per share volume-weighted average price of the Common Stock as displayed under the heading “Bloomberg VWAP” on Bloomberg page “NOTE <EQUITY> AQR” (or, if such page is not available, its equivalent successor page) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such VWAP Trading Day (or, if such volume- weighted average price is unavailable, the market value of one share of Common Stock on such VWAP Trading Day, determined, using a volume-weighted average price method, by a nationally recognized independent investment banking firm selected by the Company). The Daily VWAP will be determined without regard to after-hours trading or any other trading outside of the regular trading session.

6

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

“VWAP Trading Day” means any day on which trading in the Common Stock generally occurs on the principal U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then traded. If the Common Stock is not so listed or traded, then “VWAP Trading Day” means a Business Day.

Section 2. Interest; Amounts Outstanding.

(a) Interest Accrual Start Date; Interest Rate. The principal amount of this Note shall not bear interest until the Interest Accrual Start Date. Beginning on the Interest Accrual Start Date, the principal amount of this Note will bear simple interest (“Interest”) at a rate equal to the AFR for the month in which the Interest Accrual Start Date occurs (the “Interest Rate”). The Interest Rate shall apply from the Interest Accrual Start Date until this Note is repaid, converted, or otherwise terminated in full.

(b) Interest Calculations. Interest on this Note shall be calculated on the basis of a 360-day year and the actual number of days elapsed from and after the Interest Accrual Start Date.

(c) Amounts Outstanding. If the Company has caused this Note (or any portion thereof) to be repaid as provided herein, whether a repurchase, redemption or payment at maturity in accordance with the terms hereof, then (i) this Note (or portion thereof) will be deemed, as of the date of such payment, to cease to be outstanding, and (ii) the rights of the Holder of this Note (or such portion thereof), as such, and the obligations of the Company will terminate with respect to this Note (or such portion thereof).

(d) Note to Be Converted. If this Note (or any portion thereof) is converted pursuant to Section 3, then (i) this Note (or portion thereof) will be deemed, as of the date of such conversion, to cease to be outstanding, and (ii) the rights of the Holder of this Note (or such portion thereof), as such, and the obligations of the Company will terminate with respect to this Note (or such portion thereof), other than, for the avoidance of doubt, delivery of the Conversion Shares.

(e) Cessation of Accrual of Interest. Interest will cease to accrue on this Note (or portion thereof) to, but not including, the date that this Note (or portion thereof) is deemed, pursuant to this Section 2, to cease to be outstanding, unless there occurs a default in the payment on this Note (or such portion thereof).

(f) Cancellation of Note. Upon a Forfeiture Event (as defined in the Securities Purchase Agreement) any remaining principal amount owed under this Note shall be cancelled and this Note shall be deemed to cease to be outstanding.

(g) Maturity Date Repayment. On the Maturity Date, if any portion of this Note remains outstanding, the Company shall pay to the Holder an amount in cash representing the outstanding principal amount and any accrued and unpaid Interest on such principal amount.

Section 3. Conversion.

7

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

(a) Voluntary Conversion by Holder. From and after the Initial Conversion Date, the Holder may, at its option, require the Company to convert all, or any portion thereof in increments of at least the lesser of (i) $50,000 in aggregate principal amount and (ii) an aggregate principal amount that is then convertible into a number of shares equal to the maximum number of shares that Holder may sell pursuant to Section 4(i) of the Securities Purchase Agreement, of the then-outstanding principal amount of this Note plus accrued and unpaid Interest thereon into Conversion Shares. The Holder may request a voluntary conversion under this Section 3(a) by delivering to the Company a notice of conversion, the form of which is attached hereto as Annex A (the “Notice of Conversion”), specifying therein the principal amount of this Note to be converted and the date on which such conversion shall be effected (which date shall be a Business Day of the Holder’s choosing that is no more than 10 and no fewer than two Business Days after the Holder sends the Notice of Conversion) (such date, the “Holder Conversion Date”).

(b) Voluntary Conversion by the Company. From and after the Issue Date and at any time prior to the earlier to occur of (i) any Event of Default set forth under Section 7(a)(iv), (ii) a Fundamental Change, and (iii) a public announcement of a sale of the Company or a sale of FiscalNote, Inc., and subject to the limitations of Section 3(f) hereof the Company may, at its option, convert all, or a portion, of the then-outstanding principal amount of this Note plus accrued and unpaid Interest thereon into Conversion Shares; provided, that the Conversion Shares issued to the Holder upon such conversion are registered for resale pursuant to an effective registration statement under the Securities Act and such Conversion Shares, when issued to the Holder, would be Freely Tradeable. The Company shall notify the Holder of a voluntary conversion under this Section 3(b) by delivering to the Holder a Notice of Conversion, specifying therein the principal amount of this Note to be converted and the date on which such conversion shall be effected (which date shall be a Business Day of the Company’s choosing that is no more than 10 and no fewer than two Business Days after the Company sends the Notice of Conversion) (such date, the “Company Conversion Date”). If Conversion Shares are issued pursuant to this Section 3(b), the Company and Holder shall enter into a Trading Plan (as defined in the Securities Purchase Agreement) to be mutually agreed to by the Company and the Holder in good faith.

(c) The Holder and the Company shall maintain records showing the principal amount and Interest converted and the dates of such conversions, or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Note upon conversion.

(d) Mechanics of Conversion.

(i) Conversion Shares Issuable Upon Conversion of Principal Amount. The number of Conversion Shares issuable upon a conversion hereunder shall be determined by the quotient obtained by dividing (x) the product of (A) the applicable Conversion Rate multiplied by (B) the then-outstanding principal amount of this Note to be converted, plus all accrued and unpaid Interest thereon to, but not including, the Conversion Date, as indicated in the applicable Notice of Conversion, by (y) the Conversion Price.

8

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

(ii) Delivery of Conversion Shares Upon Conversion. The Company shall deliver, or cause to be delivered, to the Holder the Conversion Shares no later than the earlier of (x) two VWAP Trading Days and (y) the number of VWAP Trading Days comprising the Standard Settlement Period, in each case, following a Conversion Date. The Holder shall establish and maintain an account with the Company’s transfer agent to facilitate the transfer of Conversion Shares to the Holder.

(iii) Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note. As to any fraction of a share to which the Holder would otherwise be entitled upon a voluntary conversion under this Section 3, the number of shares issuable to the Holder shall be rounded down to the nearest whole number.

(iv) Taxes and Expenses. The Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any Conversion Shares upon conversion in a name other than that of the Holder of this Note so converted, and the Company shall not be required to issue or deliver any such Conversion Shares to a Person other than the Holder of this Note so converted until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid.

(e) Reserve and Status of Common Stock Issued Upon Conversion. At all times from and after the Issue Date, when any portion of this Note is outstanding, the Company will reserve, out of its authorized but unissued and unreserved shares of Common Stock, a number of shares of Common Stock sufficient to permit the conversion of the then-outstanding principal amount of this Note, plus all accrued and unpaid Interest thereon; provided, however, that prior to Stockholder Approval, the Company shall not be required to comply with this section for shares in excess of the NYSE Limit.

(f) Beneficial Ownership. Notwithstanding anything to the contrary contained herein, the Company shall not issue any shares of Common Stock pursuant to the terms of this Note, and the Holder shall not have the right to any shares of Common Stock otherwise issuable pursuant to the terms of this Note, and any such issuance shall be null and void and treated as if never made, to the extent that after giving effect to such issuance, the Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the number of shares of Common Stock outstanding immediately after giving effect to such issuance. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable pursuant to the terms of this Note or the Securities Purchase Agreement with respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable (i) pursuant to the terms of the remaining, nonconverted portion of this Note beneficially owned by the Holder or any of the other Attribution Parties and (ii) upon exercise or conversion of the

9

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

unexercised or nonconverted portion of any other securities of the Company (including any convertible notes or convertible preferred stock or warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 3(f). For purposes of this Section 3(f), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act. For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire pursuant to the terms of this Note without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (i) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (ii) a more recent public announcement by the Company or (iii) any other written notice by the Company or its transfer agent setting forth the number of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives a Notice of Conversion from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Notice of Conversion would otherwise cause the Holder’s beneficial ownership, as determined pursuant to this Section 3(f), to exceed the Maximum Percentage, the Holder shall notify the Company of a reduced number of shares of Common Stock to be purchased pursuant to such Notice of Conversion. For any reason at any time, upon the written or oral request of the Holder, the Company shall use commercially reasonable efforts to (within one VWAP Trading Day) confirm, orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In the event that the issuance of shares of Common Stock to the Holder upon conversion of this Note would result in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act), the Holder shall notify the Company in writing to reduce the number of shares so issued by which the Holder’s and the other Attribution Parties’ aggregate beneficial ownership would exceed the Maximum Percentage (the “Excess Shares”) and the issuance of such Excess Shares shall be deemed null and void and shall be cancelled ab initio and any portion of this Note so converted will be reinstated, and the Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (x) any such increase in the Maximum Percentage will not be effective until the 61st day after such notice is delivered to the Company and (y) any such increase or decrease will apply only to the Holder and the other Attribution Parties. For purposes of clarity, it is the intent of the Company and the Holder that the shares of Common Stock issuable pursuant to the terms of this Note in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act. The provisions of this Section 3(f) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 3(f) to the extent necessary to correct this Section 3(f) (or any portion of this Section 3(f)) that may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 3(f) or to make changes or

10

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this Section 3(f) may not be waived and shall apply to a successor holder of this Note.

(g) Share Cap Limit. Notwithstanding anything to the contrary contained herein, unless and until the Company shall have obtained Stockholder Approval, in no event shall the Company be required to issue any Conversion Shares if and to the extent such issuance, when aggregated with the issuance of the Brokerage Fee Shares, Success Fee Shares and/or any Additional Shares (each as defined in the Securities Purchase Agreement) would in the aggregate result in the issuance in excess of 19.99% of the issued and outstanding Common Stock and Class B Stock, taken as a whole, as of the date of the Securities Purchase Agreement.

Section 4. Certain Adjustments. The Conversion Rate shall be automatically increased by 10 percentage points if, following the Initial Conversion Date, the Company fails to timely file any document or report that the Company is required to file under the Exchange Act to remain current in its public reporting pursuant to Rule 144(i) under the Securities Act (such failure, a “Filing Failure”). The Conversion Rate shall be automatically increased by an additional 10 percentage points for each 30 calendar day period in which such Filing Failure is not cured. Notwithstanding the foregoing, in no event will the Conversion Rate be increased by more than 30 percentage points.

Section 5. Optional Redemption; Fundamental Change Repurchase.

(a) Optional Redemption at Election of Company. The Company shall have the right, at its election, to redeem all of this Note, at any time and from time to time following the Issue Date, for a cash purchase price equal to the principal amount of this Note, plus any accrued and unpaid Interest on such principal amount (the “Redemption Price”). Notwithstanding anything to the contrary in this Section 5, until the Redemption Price is paid in full, the principal amount of this Note pursuant to the Optional Redemption Notice may be converted, in whole or in part, by the Holder into Common Stock pursuant to Section 3.

(b) Optional Redemption Procedures. In connection with any optional redemption pursuant to Section 5(a), the Company shall deliver a notice to the Holder (an “Optional Redemption Notice”) of its election to redeem all of the then-outstanding principal amount of this Note for cash at the Redemption Price. Such Optional Redemption Notice shall set out the principal amount of this Note to be redeemed, any accrued and unpaid Interest thereon and the date fixed for redemption (the “Optional Redemption Date”). Any optional redemption of any principal amount of this Note may, at the Company’s discretion, be subject to one or more conditions precedent. The Optional Redemption Date of any optional redemption that is subject to satisfaction of one or more conditions precedent may, in the Company’s discretion, be delayed until such time as any or all such conditions shall be satisfied (or waived by the Company in its sole discretion), or such optional redemption may not occur and any related Optional Redemption Notice may be modified or rescinded in the event that any or all such conditions shall not have been satisfied (or waived by the Company in its sole discretion) by the Optional

11

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

Redemption Date, or by the Optional Redemption Date so delayed, in either case by providing notice to the Holder.

(c) Fundamental Change Conversion or Repurchase. If a Fundamental Change occurs at any time prior to the Maturity Date, the Holder shall have the right to elect to either (i) convert this Note into Conversion Shares in accordance with Section 3 (a “Fundamental Change Conversion”), or (ii) require the Company to repurchase this Note (a “Fundamental Change Repurchase”) at a repurchase price equal to the principal amount hereof, plus accrued and unpaid Interest, if any, hereon to, but excluding, the Fundamental Change Note Termination Date (the “Fundamental Change Repurchase Price”). The effective date of any Fundamental Change Conversion or Fundamental Change Repurchase (such date, as applicable, the “Fundamental Change Note Termination Date”) shall be specified by the Company in the Fundamental Change Notice.

(d) Fundamental Change Notice. Prior to the date on which the Company anticipates consummating a Fundamental Change (or, if later, promptly after the Company discovers that a Fundamental Change may occur), a written notice shall be sent by or on behalf of the Company to the Holder, which notice shall contain the date on which the Fundamental Change is anticipated to be effected (or, if applicable, the date on which a Schedule TO or other schedule, form or report disclosing a Fundamental Change was filed) (the “Fundamental Change Notice” and the date such notice is delivered to the Holder, the “Fundamental Change Notice Date”). The Fundamental Change Notice shall specify:

(i) the events causing the Fundamental Change;

(ii) the date of the Fundamental Change;

(iii) the Fundamental Change Note Termination Date;

(iv) the Fundamental Change Repurchase Price;

(v) the number of Conversion Shares into which this Note is convertible pursuant to a Fundamental Change Conversion (or, if the exact number of Conversion Shares is not determinable as of the Fundamental Change Notice Date, an estimate of the number of such Conversion Shares);

(vi) the procedures that the Holder must follow in connection with a Fundamental Change Conversion or a Fundamental Change Repurchase; provided, that, no failure of the Company to give the foregoing notices and no defect therein shall affect the validity of the proceedings for the conversion or repurchase of this Note pursuant to this Section 5; and provided, further that if an anticipated Fundamental Change related to a Fundamental Change Note Termination Date set forth in a Fundamental Change Notice has not occurred as of such Fundamental Change Note Termination Date, the Company may, with notice to the Holder, delay the Fundamental Change Note Termination Date specified within such Fundamental Change Notice until the related Fundamental Change has occurred.

12

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

(e) Withdrawal of Fundamental Change Notice. A Fundamental Change Notice may be withdrawn (in whole or in part) by means of a written notice of withdrawal delivered by the Company to the Holder at any time prior to the Close of Business on the Business Day immediately preceding the Fundamental Change Note Termination Date, specifying the:

(a) principal amount of this Note with respect to which such notice of withdrawal is being submitted; and

(b) principal amount, if any, of this Note that remains subject to the original Fundamental Change Notice.

Section 6. Subordination. Notwithstanding anything to the contrary herein, the payment of the obligations evidenced by this Note, and the exercise of the rights of the Holder hereunder are each expressly subject and subordinated to Senior Loans in accordance with the terms of that certain Subordination Agreement, dated as of the date hereof (as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, the “Subordination Agreement”), by and among the Holder, the administrative agent under the Senior Loans, the Loan Parties and each other borrower under the Senior Loans.

Section 7. Events of Default.

(a) Events of Default. Any of the following shall constitute an “Event of Default”:

(i) a default in the payment when due on the Maturity Date of the principal of this Note and any accrued and unpaid Interest thereon, or otherwise when due pursuant to the terms of this Note;

(ii) a default in the Company’s obligation to convert this Note in accordance with Section 3 upon the exercise of the conversion right with respect thereto, if such default is not cured within five Business Days after its occurrence; it being expressly agreed and acknowledged that the Company’s obligation to issue any Conversion Shares upon any conversion of this Note is limited by the provisions of Section 3(f) and Section 3(g) hereof;

(iii) other than as specifically set forth in another clause of this Section 7(a), a default in any of the Company’s obligations or agreements under this Note where such default is not cured or waived in writing by the Holder within 45 days after the occurrence of such default;

(iv) a default by the Company or any of its Subsidiaries with respect to any one or more mortgages, agreements or other instruments under which there is outstanding, or by which there is secured or evidenced, any indebtedness for money borrowed of at least $10,000,000 (or its foreign currency equivalent) in the aggregate of the Company or any of its Subsidiaries, whether such indebtedness exists as of the Issue Date or is thereafter created, where such default (A) constitutes a failure to pay the principal of or interest on such indebtedness when due and

13

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

payable at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, in each case after the expiration of any applicable grace period; or (B) results in such indebtedness becoming, or being declared, due and payable before its stated maturity;

(v) the Company or any of its Subsidiaries, pursuant to or within the meaning of any Bankruptcy Law, either:

(A) commences a voluntary case or proceeding;

(B) consents to the entry of an order for relief against it in an involuntary case or proceeding;

(C) consents to the appointment of a custodian of it or for any substantial part of its property;

(D) makes a general assignment for the benefit of its creditors;

(E) takes any comparable action under any foreign Bankruptcy Law; or

(F) generally is not paying its debts as they become due;

(vi) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that either:

(A) is for relief against the Company or any of its Subsidiaries in an involuntary case or proceeding;

(B) appoints a custodian of the Company or any of its Subsidiaries, or for any substantial part of the property of the Company or any of its Subsidiaries;

(C) orders the winding up or liquidation of the Company or any of its Subsidiaries; or

(D) grants any similar relief under any foreign Bankruptcy Law, and, in each case under this Section 7(a)(v)(D), such order or decree remains unstayed and in effect for at least 60 days;

(vii) a final judgment or judgments for the payment of money (to the extent not paid or fully covered by insurance maintained in accordance with the requirements of the Credit Agreement and as to which the relevant insurance company has not denied coverage) aggregating in excess of $3,000,000 are rendered against the Company or any of its Subsidiaries and which judgments are not, within sixty (60) days after the entry, assessment or issuance thereof, bonded, discharged or stayed pending appeal, or are not discharged within sixty (60) days after the expiration of such stay; and

14

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

(viii) a default in any of the Company’s obligations under Sections 8(a) or 8(b) of this Note where such default is not cured or waived in writing by the Holder within ninety (90) days after the occurrence of such default.

(b) Remedies Upon Event of Default. If any Event of Default occurs, the outstanding principal amount of this Note, plus accrued and unpaid Interest, if any, and all other amounts owing in respect thereof through the date of the Event of Default, shall become, at the election of the Holder, immediately due and payable in cash. Upon the payment in full of all amounts due to the Holder, the Holder shall promptly surrender this Note to or as directed by the Company. Such election by the Holder may be rescinded and annulled by the Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of this Note until such time, if any, as the Holder receives full payment pursuant to this Section 7(b). No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.

Section 8. Reporting. So long as amounts due under this Note remain outstanding, the Company shall furnish to the Holder:

(a) if the Company is subject to the reporting requirements of Section 13(a) or 15(d) of the Exchange Act, all Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K that the Company is required to file with the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act within fifteen (15) calendar days after the date that the Company is required to file the same (after giving effect to all applicable grace periods under the Exchange Act); provided, however, that the Company need not send to the Holder any material for which the Company has received, or is seeking in good faith and has not been denied, confidential treatment by the SEC, and any report that the Company files with the SEC through the EDGAR system (or any successor thereto) will be deemed to be sent to the Holder at the time such report is so filed via the EDGAR system (or such successor); and

(b) if the Company is not subject to the reporting requirements of Section 13(a) or 15(d) of the Exchange Act, at any time when the Conversion Shares issuable upon conversion of the Note are “restricted securities” (as defined in Rule 144), the information required to be delivered pursuant to Rule 144(c)(2) under the Securities Act.

Section 9. Miscellaneous.

(a) Interpretive Provisions. With reference to this Note, unless otherwise specified herein:

(i) the meanings of defined terms are equally applicable to the singular and plural forms of the defined terms;

(ii) the words “herein,” “hereto,” “hereof” and “hereunder” and words of similar import when used in this Note shall refer this Note as a whole and not to any particular provision thereof;

15

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

(iii) references in this Note to an Exhibit, Schedule, Article, Section, clause or subclause refer to the appropriate Exhibit or Schedule to, or Article, Section, clause or subclause in this Note;

(iv) the term “including” is by way of example and not limitation;

(v) the term “documents” includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form;

(vi) any reference herein to any Person shall be construed to include such Person’s successors and assigns;

(vii) the term “or” means “and/or”; and

(viii) on the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including”; the words “to” and “until” each mean “to but excluding”; and the word “through” means “to and including.”

(b) Notices. Any and all notices or other communications or deliveries to be provided by the Holder hereunder shall be in writing and delivered personally, by email attachment or sent by a nationally recognized overnight courier service, addressed to the Company, at the address set forth for the Company in the Securities Purchase Agreement, or such other email address or address as the Company may specify for such purposes by notice to the Holder delivered in accordance with this Section 9(b). Any and all notices or other communications or deliveries to be provided by the Company hereunder, including an Optional Redemption Notice or Fundamental Change Notice, shall be in writing and delivered personally or by email attachment or sent by a nationally recognized overnight courier service addressed to the Holder at the email address or address of the Holder appearing on the books of the Company, or if no such email attachment or address appears on the books of the Company, at the principal place of business of the Holder, as set forth in the Securities Purchase Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via email attachment to the email address set forth in the Securities Purchase Agreement prior to 5:30 PM Eastern time on any date, (ii) the next VWAP Trading Day after the date of transmission, if such notice or communication is delivered via email attachment to the email address set forth in the Securities Purchase Agreement on a day that is not a VWAP Trading Day or later than 5:30 PM Eastern time on any VWAP Trading Day, (iii) the second VWAP Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service and (iv) upon actual receipt by the Party to whom such notice is required to be given.

(c) Lost or Mutilated Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or

16

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

destroyed Note, a new Note for the principal amount of the Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Note.

(d) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict of laws thereof. Each Party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a Party or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the “New York Courts”). Each Party hereby irrevocably submits to the non-exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each Party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY.

(e) Amendments; Waivers. Any provision of this Note may be amended or waived, and consent to any departure by the Company of the terms of this Note may be granted, by a written instrument executed by the Company and the Holder. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that Party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion.

(f) Severability. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances so long as this Note as so modified continues to express,

17

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

without material change, the original intentions of the Company and the Holder as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the Company or the Holder or the practical realization of the benefits that would otherwise be conferred upon the Company or the Holder. The Company and the Holder will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

(g) Usury. Notwithstanding any provision to the contrary contained herein, it is expressly agreed and provided that the total liability of the Company under the this Note (or any other Transaction Document) for payments in the nature of Interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of Interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under such documents exceed the Maximum Rate. The Parties agree that if the maximum contract rate of interest allowed by law and applicable to such documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to such documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to the Holder with respect to indebtedness evidenced by this Note and the other Transaction Documents, such excess will be applied by the Holder to the unpaid principal balance of this Note or be refunded to the Company, the manner of handling such excess to be at the Holder’s election.

(h) Remedies; Other Obligations. The remedies provided in this Note are cumulative and the exclusive remedies for any failure by the Company to comply with the terms of this Note. Amounts set forth or provided for herein with respect to payments, conversion, redemption and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof).

(i) Transfer Restrictions. The transfer, assignment or participation of any amount of this Note effected by the Holder is subject to the Company’s prior written consent, and the Company reserves the right to refuse to transfer, assign or grant a participation in this Note. Each of the following shall be deemed a transfer that shall require the Company’s prior written consent: (i) the Holder merges with or into or consolidates with another entity under circumstances where the owners of the Holder immediately prior to such merger or consolidation do not own after such merger or consolidation equity interests representing at least 50% of the voting power of the Holder or the surviving or resulting entity, as the case may be; (ii) equity interests representing 50% or more of the voting power of the Holder are otherwise transferred to an unrelated third party; and (iii) the Holder is liquidated, or sells or otherwise disposes of all or substantially all of its assets.

18

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

(j) Headings. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof.

(k) Execution. In the event that any signature to this Note is delivered by facsimile transmission or by e-mail delivery of a “.pdf’ format data file or other electronic transmission (including pdf format and any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), such signature shall create a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf’ or such other electronic transmission signature page were an original thereof.

(l) Further Assurances. The Company and the Holder hereby agree to take such actions consistent with the terms of this Note as may be reasonably necessary, including, if necessary, any amendments hereto in accordance with Section 9(e) in order to ensure that the Conversion Shares are Freely Tradeable upon issuance pursuant to the then applicable guidance of the SEC without changing the economic terms set forth in this Note.

[Signature Page Follows]

 

19

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

IN WITNESS WHEREOF, the Parties have caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.

FISCALNOTE HOLDINGS, INC.

By:

Name:


Title:

EGT 10 LLC

By:

Name:


Title:

 

Signature Page to Note

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


 

ANNEX A

NOTICE OF CONVERSION

The undersigned hereby elects to convert, in whole or in part, the Senior Subordinated Convertible Promissory Note due __________, 2027 (the “Note”) of FiscalNote Holdings, Inc., a Delaware corporation (the “Company”), into shares of Class A Common Stock, par value $0.0001 per share, of the Company (the “Common Stock”) according to the conditions contained in the Note, as of the date written below. Capitalized terms used herein and not otherwise defined have the meanings assigned to them in the Note.

Conversion Information:

Holder:

Conversion Date:

Principal Amount of the Note:

Number of Shares of Common Stock to Be Issued:

Signature:

Name:

Address for Delivery of Common Stock Certificates:

Or

DWAC Instructions:

Broker No:

Account No:

Annex A

DOCPROPERTY "CUS_DocIDChunk0" 99401006.8


Execution Version

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is dated as of November 12, 2024, by and among FiscalNote Holdings, Inc., a Delaware corporation (the “Company”), and the several signatories hereto (each, including its successors and assigns, a “Holder” and collectively, the “Holders”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of November 12, 2024, between the Company and each Holder (the “Purchase Agreement”).

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each of the Holders agree as follows:

1.
Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” has the meaning set forth in Section 6(c).

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act of 1933, as amended.

“Agreement” has the meaning set forth in the Preamble.

“Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

“Commission” means the Securities and Exchange Commission.

“Common Stock” means the Company’s Class A common stock, par value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

“Company” has the meaning set forth in the Preamble.

“Effective Date” means the date that the Registration Statement filed pursuant to Section 2(a) is first declared effective by the Commission.

“Effectiveness Deadline” means, with respect to the Initial Registration Statement, Subsequent Registration Statement or the New Registration Statement, the sixtieth (60th) calendar day following the Initial Filing Deadline or Subsequent Filing Deadline, as the case may be; provided, however, that if the Company is notified by the Commission that the Initial Registration Statement, Subsequent Registration Statement or the New Registration Statement will not be reviewed or is no longer subject to further review and comments, the Effectiveness Deadline as to such Registration Statement shall be no later than the third (3rd) Trading Day following the date

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

on which the Company is so notified if such date precedes the dates otherwise required above; provided, further, that if the Effectiveness Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall be extended to the next Business Day on which the Commission is open for business.

“Effectiveness Period” has the meaning set forth in Section 2(b).

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“FINRA” means the Financial Industry Regulatory Authority.

“Holder” or “Holders” has the meaning set forth in the Preamble.

“Indemnified Party” has the meaning set forth in Section 5(c).

“Indemnifying Party” has the meaning set forth in Section 5(c).

“Initial Filing Deadline” means, with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), the seventh (7th) calendar day following the closing date of the transactions contemplated by the Purchase Agreement, provided, however, that if the Initial Filing Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Initial Filing Deadline shall be extended to the next Business Day on which the Commission is open for business.

“Initial Registrable Securities” means all of (i) the Initial Shares and (ii) any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing, provided, that the Holder has completed and delivered to the Company a Selling Stockholder Questionnaire; and provided, further, that with respect to a particular Holder, such Holder’s Initial Shares shall cease to be Initial Registrable Securities upon the earliest to occur of the following: (A) a sale pursuant to a Registration Statement or Rule 144 under the Securities Act (in which case, only such security sold by the Holder shall cease to be a Initial Registrable Security); or (B) becoming eligible for resale by the Holder under Rule 144 without the requirement for the Company to be in compliance with the current public information required thereunder and without volume or manner-of-sale restrictions.

“Initial Registration Statement” has the meaning set forth in Section 2(a).

“Initial Shares” means the Success Fee Shares (as defined in the Purchase Agreement) and shares of Common Stock which may be issued upon conversion of the Subordinated Convertible Notes issued to a Holder pursuant to the Purchase Agreement.

“Losses” has the meaning set forth in Section 5(a).

“New Registration Statement” has the meaning set forth in Section 2(a).

2

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Principal Market” means the Trading Market on which the Common Stock are primarily listed on and quoted for trading, which, as of the date hereof, shall be the New York Stock Exchange.

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened.

“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430B promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

“Purchase Agreement” has the meaning set forth in the Recitals.

“Registrable Securities” means collectively, the Initial Registrable Securities and the Subsequent Registrable Securities.

“Registration Statements” means any one or more registration statements of the Company filed under the Securities Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including without limitation the Initial Registration Statement, Subsequent Registration Statement, the New Registration Statement and any Remainder Registration Statements), amendments and supplements to such Registration Statements, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such Registration Statements.

“Remainder Registration Statement” has the meaning set forth in Section 2(a).

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

“Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

3

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

“SEC Guidance” means (i) any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff; provided, that any such oral guidance, comments, requirements or requests are reduced to writing by the Commission and (ii) the Securities Act.

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Selling Stockholder Questionnaire” means a questionnaire substantially in the form attached as Exhibit A hereto or such other form of questionnaire as may reasonably be adopted by the Company from time to time for use with respect to any Holder.

“Subordinated Convertible Notes” means the Company’s subordinated convertible notes due 2027 issued to the Holders pursuant to the terms of the Purchase Agreement.

“Subsequent Filing Deadline” means, with respect to any Subsequent Registration Statement required to be filed pursuant to Section 2(a), the seventh (7th) calendar day following the issuance of any Additional Shares (as defined in the Purchase Agreement), provided, however, that if the Subsequent Filing Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Subsequent Filing Deadline shall be extended to the next Business Day on which the Commission is open for business.

“Subsequent Registrable Securities” means all of (i) the Subsequent Shares and (ii) any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing, provided, that the Holder has completed and delivered to the Company a Selling Stockholder Questionnaire; and provided, further, that with respect to a particular Holder, such Holder’s Subsequent Shares shall cease to be Subsequent Registrable Securities upon the earliest to occur of the following: (A) a sale pursuant to a Registration Statement or Rule 144 under the Securities Act (in which case, only such security sold by the Holder shall cease to be a Subsequent Registrable Security); or (B) becoming eligible for resale by the Holder under Rule 144 without the requirement for the Company to be in compliance with the current public information required thereunder and without volume or manner-of-sale restrictions.

“Subsequent Registration Statement” has the meaning set forth in Section 2(a).

“Subsequent Shares” means the shares of Common Stock which may be issued pursuant to the terms of the Purchase Agreement as Additional Shares.

“Trading Day” means a day on which the Principal Market is open for business.

“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).

2.
Registration.

4

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

(a)
On or prior to the Initial Filing Deadline, the Company shall prepare and shall use commercially reasonable efforts to file with the Commission a Registration Statement covering the resale of all of the Initial Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of the Initial Registrable Securities, by such other means of distribution of Initial Registrable Securities as the Holders may reasonably specify (the “Initial Registration Statement”). The Initial Registration Statement shall be on Form S-3 (except if the Company is then ineligible to register for resale the Initial Registrable Securities on Form S-3, in which case such registration shall be on such other form available to register for resale the Initial Registrable Securities as a secondary offering) subject to the provisions of Section 2(d) and shall contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement) the “Plan of Distribution” section substantially in the form attached hereto as Annex A (which may be modified to respond to comments, if any, provided by the Commission). On or prior to the Subsequent Filing Deadline, the Company shall prepare and shall use commercially reasonable efforts to file with the Commission a Registration Statement covering the resale of all of the Subsequent Registrable Securities not then registered on an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of the Subsequent Registrable Securities, by such other means of distribution of Subsequent Registrable Securities as the Holders may reasonably specify (the “Subsequent Registration Statement”). The Subsequent Registration Statement shall be on Form S-3 (except if the Company is then ineligible to register for resale the Subsequent Registrable Securities on Form S-3, in which case such registration shall be on such other form available to register for resale the Subsequent Registrable Securities as a secondary offering) subject to the provisions of Section 2(d) and shall contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement) the “Plan of Distribution” section substantially in the form attached hereto as Annex A (which may be modified to respond to comments, if any, provided by the Commission). Notwithstanding the registration obligations set forth in this Section 2, in the event the Commission informs the Company that any of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i) inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement or the Subsequent Registration Statement, as the case may be, as required by the Commission and/or (ii) withdraw the Initial Registration Statement or the Subsequent Registration Statement, as the case may be, and file a new registration statement (a “New Registration Statement”), in either case, covering the maximum number of Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, permitted to be registered by the Commission, on Form S-3 or, if the Company is ineligible to register the Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, on Form S-3, such other form available to register for resale the Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, as a secondary offering; provided, however, that prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, in accordance with the SEC Guidance. Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, permitted

5

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Initial Registrable Securities or Subsequent Registrable Securities, as the case may be), unless otherwise directed in writing by a Holder as to its Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, the number of Initial Registrable Securities or Subsequent Registrable Securities, as the case may be, to be registered on such Registration Statement will first be reduced by Registrable Securities not acquired pursuant to the Purchase Agreement (whether pursuant to registration rights or otherwise), as the case may be, and second by Registrable Securities represented by shares of Common Stock applied to the Holders on a pro rata basis based on the total number of Registrable Securities held by such Holders, subject to a determination by the Commission that certain Holders must be reduced first based on the number of Registrable Securities held by such Holders. In the event the Company amends the Initial Registration Statement, Subsequent Registration Statement or files a New Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended, Subsequent Registration Statement, as amended, or the New Registration Statement (the “Remainder Registration Statements”). No Holder shall be named as an “underwriter” in any Registration Statement without such Holder’s prior written consent.
(b)
The Company shall use its commercially reasonable efforts to cause each Registration Statement to be declared effective by the Commission as soon as practicable and, with respect to the Initial Registration Statement, Subsequent Registration Statement or the New Registration Statement, as applicable, no later than the Effectiveness Deadline (including filing with the Commission a request for acceleration of effectiveness in accordance with Rule 461 promulgated under the Securities Act), and shall use its commercially reasonable efforts to keep each Registration Statement continuously effective under the Securities Act until the earlier of (i) such time as all of the Registrable Securities covered by such Registration Statement have been sold by the Holders or (ii) the expiration of two years from the Effective Date of such Registration Statement (the “Effectiveness Period”). The Company shall request effectiveness of a Registration Statement as of 4:00 P.M. New York City time on a Trading Day. The Company shall promptly notify the Holders via e-mail of the effectiveness of a Registration Statement or any post-effective amendment thereto on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which date of confirmation shall initially be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 A.M. New York City time on the first Trading Day after the Effective Date, file a final Prospectus with the Commission, as required by Rule 424(b) and shall provide the Holders with copies of the final Prospectus to be used in connection with the sale or other disposition of the securities covered thereby. The Company shall promptly inform each Holder in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holder is required to deliver a Prospectus in connection with any disposition of Registrable Securities.
(c)
Each Holder agrees to furnish to the Company a completed Selling Stockholder Questionnaire. At least four (4) Trading Days prior to the first anticipated filing date of a

6

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

Registration Statement for any registration under this Agreement, the Company will notify each Holder of any information the Company requires from that Holder other than the information contained in the Selling Stockholder Questionnaire, if any, which shall be completed and delivered to the Company promptly upon request and, in any event, within two (2) Trading Days prior to the applicable anticipated filing date. Each Holder further agrees that it shall not be entitled to be named as a selling securityholder in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company a completed Selling Stockholder Questionnaire and all such further responsive information requested by the Company as described in the previous sentence. If a Holder of Registrable Securities returns a request for further information after the three (3) Trading Day aforementioned deadline, the Company shall use its commercially reasonable efforts to take such actions as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable Securities identified in such request for further information. Each Holder acknowledges and agrees that the information in the request for further information as described in this Section 2(c) will be used by the Company in the preparation of the Registration Statement and hereby consents to the inclusion of such information in the Registration Statement.
(d)
In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form reasonably acceptable to the Holders and (ii) undertake to register the Registrable Securities on Form S-3 promptly after such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.
3.
Registration Procedures

In connection with the Company’s registration obligations hereunder, the Company shall:

(a)
Not less than two (2) Trading Days prior to the filing of each Registration Statement, any related Prospectus or any amendment or supplement thereto (except for Annual Reports on Form 10-K, and Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and any similar or successor reports), (i) furnish to each Holder copies of such Registration Statement, Prospectus or amendment or supplement thereto, as proposed to be filed, which documents will be subject to the review of such Holder (it being acknowledged and agreed that if a Holder does not object to or comment on the aforementioned documents within such two (2) Trading Day period, then the Holder shall be deemed to have consented to and approved the use of such documents) and (ii) use commercially reasonable efforts to cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file any Registration Statement or amendment or supplement thereto in a form to which a Holder reasonably objects in good faith, provided that, the Company is notified of such objection in writing within the two (2) Trading Day period described above.

7

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

(b)
(i) Prepare and file with the Commission such amendments (including post-effective amendments) and supplements, to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period; (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424; (iii) respond as promptly as reasonably practicable to any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably possible, provide the Holders true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that pertains to the Holders as “Selling Stockholders” but not any comments that would result in the disclosure to the Holders of material and non-public information concerning the Company; and (iv) comply with the provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement until such time as all of such Registrable Securities shall have been disposed of (subject to the terms of this Agreement) in accordance with the intended methods of disposition by the Holders thereof as set forth in such Registration Statement as so amended or in such Prospectus as so supplemented; provided, however, that each Holder shall be responsible for the delivery of the Prospectus to the Persons to whom such Holder sells any of the Initial Shares or Subsequent Shares (including in accordance with Rule 172 under the Securities Act), and each Holder agrees to dispose of Registrable Securities in compliance with the “Plan of Distribution” described in the Registration Statement and otherwise in compliance with applicable federal and state securities laws.
(c)
Notify the Holders (which notice, in the case of clauses (iii) through (vi) hereof, shall be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably practicable (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person): (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed; (B) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on any Registration Statement (in which case the Company shall provide to each of the Holders true and complete copies of all comments that pertain to the Holders as a “Selling Stockholder” or to the “Plan of Distribution” and all written responses thereto, but not information that the Company believes would constitute material and non-public information); and (C) with respect to each Registration Statement or any post-effective amendment, when the same has become effective; (ii) of any request by the Commission or any other Federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information that pertains to the Holders as “Selling Stockholders” or the “Plan of Distribution”; (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; (v) of the occurrence of any event or passage of time that makes the financial statements included or incorporated by reference in a Registration Statement ineligible for inclusion or incorporation by reference therein or any statement made in such Registration Statement or Prospectus or any document incorporated or

8

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that, upon the advice of legal counsel, the Company’s board of directors reasonably believes would require additional disclosure by the Company in the Registration Statement of material information that the Company has a bona fide purpose for keeping confidential, and the non-disclosure of which would be expected, and that, in the reasonable determination of the Company’s board directors, upon the advice of legal counsel, to cause the Registration Statement to fail to comply with applicable disclosure requirements, provided that, any and all such information shall remain confidential to each Holder until such information otherwise becomes public, unless disclosure by a Holder is required by law; provided, further, that notwithstanding each Holder’s agreement to keep such information confidential, each such Holder makes no acknowledgement that any such information is material, non-public information; and provided, further, that the Company shall not, when so advising Holder of such events, provide Subscriber with any material, nonpublic information regarding the Issuer other than to the extent that providing notice to Subscriber of the occurrence of the events listed in above constitutes material, nonpublic information regarding the Issuer.
(d)
Use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, as soon as practicable.
(e)
If requested by a Holder, furnish to such Holder, without charge, at least one conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided, that the Company shall have no obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system.
(f)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify, or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of, such Registrable Securities for the resale by the Holder under the securities or “Blue Sky” laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.

9

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

(g)
Cooperate with such Holder to facilitate the timely preparation and delivery of book entry statements representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may reasonably request.
(h)
Following the occurrence of any event contemplated by Section 3(c)(v), as promptly as reasonably practicable, prepare a supplement or amendment, including a post-effective amendment, to the affected Registration Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(c) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is reasonably practicable. The Company shall be entitled to exercise its right under this Section 3(h) to suspend the availability of a Registration Statement and Prospectus for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.
(i)
As long as any Holder shall own Registrable Securities, the Company shall, at all times while it shall be a reporting company under the Exchange Act, file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.
(j)
The Company may require each selling Holder to furnish to the Company a certified statement as to (i) the number of shares of Common Stock beneficially owned by such Holder and any Affiliate thereof, (ii) any FINRA affiliations, (iii) any natural persons who have the power to vote or dispose of the Common Stock and (iv) any other information as may be requested by the Commission, FINRA or any state securities commission.
(k)
The Company shall cooperate with any registered broker through which a Holder proposes to resell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110 as requested by any such Holder and the Company shall pay the filing fee required for the first such filing within two (2) Business Days of the request therefor.
4.
Registration Expenses. All fees and expenses incident to the Company’s performance of or compliance with its obligations under this Agreement (excluding any underwriting discounts and selling commissions and all legal fees and expenses of legal counsel for any Holder) shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,

10

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

fees and expenses (A) with respect to filings required to be made with any Trading Market on which the Common Stock are then listed for trading, (B) with respect to compliance with applicable state securities or “Blue Sky” laws (including, without limitation, fees and disbursements of counsel for the Company in connection with “Blue Sky” qualifications or exemptions of the Registrable Securities and determination of the eligibility of the Registrable Securities for investment under the laws of such jurisdictions as requested by the Holders) and (C) if not previously paid by the Company in connection with Section 3(j) above, with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant to the FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission in connection with such sale), (ii) printing expenses (including, without limitation, expenses of printing prospectuses if the printing of prospectuses is reasonably requested by the Holders of a majority of the Registrable Securities included in the Registration Statement), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any underwriting, broker or similar fees or commissions of any Holder or, except to the extent provided for in the Purchase Agreement, any legal fees or other costs of any Holder.
5.
Indemnification.
(a)
Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify, defend and hold harmless each Holder, the officers, directors, agents, partners, members, managers, stockholders, Affiliates, investment advisers and employees of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, partners, members, managers, stockholders, agents, investment advisers and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (A) such untrue statements, alleged untrue statements, omissions or alleged omissions are based solely upon information regarding such Holder furnished in writing to the Company by such

11

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in the Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto (it being understood that each Holder has approved Annex A hereto for this purpose) or (B) in the case of an occurrence of an event of the type specified in Section 3(c)(iii)-(vi), related to the use by a Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated and defined in Section 6(d) below, to the extent that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected or (C) to the extent that any such Losses arise out of the Holder’s (or any other indemnified Person’s) failure to send or give a copy of the Prospectus or supplement (as then amended or supplemented), if required, pursuant to Rule 172 under the Securities Act (or any successor rule) to the Persons asserting an untrue statement or alleged untrue statement or alleged untrue statement or omission or alleged omission at or prior to the written confirmation of the sale of Registrable Securities to such Person if such statement or omission was corrected in such Prospectus or supplement. The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an Indemnified Party (as defined in Section 5(c)) and shall survive the transfer of the Registrable Securities by the Holders.
(b)
Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or are based solely upon any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent that such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, (ii) to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or such form of Prospectus or in any amendment or supplement thereto or (iii) in the case of an occurrence of an event of the type specified in Section 3(c)(iii)-(vi), to the extent related to the use by such Holder of an outdated or defective Prospectus after a duly authorized representative of the Company has notified such Holder in writing to its chief executive officer or chief financial officer that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the gross proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

12

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

(c)
Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.

An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Indemnified Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest exists if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and such counsel shall be at the expense of the Indemnifying Party); provided, that the Indemnifying Party shall not be liable for the fees and expenses of more than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

Subject to the terms of this Agreement, all fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section 5) shall be paid to the Indemnified Party, as incurred, within twenty (20) Trading Days of written notice thereof to the Indemnifying Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally judicially determined to not be entitled to indemnification hereunder. The failure to deliver written notice to the Indemnifying Party within a reasonable time of the commencement of any such action shall not relieve such Indemnifying Party of any liability to the Indemnified Party under this Section 5, except to the extent that the Indemnifying Party is materially and adversely prejudiced in its ability to defend such action.

(d)
Contribution. If a claim for indemnification under Section 5(a) or (b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then

13

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section 5 was available to such party in accordance with its terms.

The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), (A) no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the gross proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission and (B) no contribution will be made under circumstances where the maker of such contribution would not have been required to indemnify the Indemnified Party under the fault standards set forth in this Section 5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

The indemnity and contribution agreements contained in this Section 5 are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or limitation of the indemnification provisions under the Purchase Agreement.

6.
Miscellaneous.
(a)
Remedies. In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate.
(b)
Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption

14

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

therefrom is available) in connection with sales of Registrable Securities pursuant to the Registration Statement and shall sell the Registrable Securities only in accordance with a method of distribution described in the Registration Statement.
(c)
Discontinued Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(c)(iii)-(vi), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is reasonably practicable.
(d)
No Inconsistent Agreements. Neither the Company nor any of its subsidiaries has entered, as of the date hereof, nor shall the Company or any of its subsidiaries, on or after the date hereof, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof.
(e)
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, or waived unless the same shall be in writing and signed by the Company and Holders holding no less than a majority of the then outstanding Registrable Securities, provided that any party may give a waiver as to itself. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders and that does not directly or indirectly affect the rights of other Holders may be given by Holders of all of the Registrable Securities to which such waiver or consent relates; provided, however, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the immediately preceding sentence.
(f)
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement.
(g)
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may not assign its rights (except by merger or in connection with another entity acquiring all or substantially all of the Company’s assets) or obligations hereunder without the prior written consent of all the Holders of the then outstanding Registrable Securities. Each Holder may assign its respective rights hereunder in the manner and to the Persons as permitted under the Purchase Agreement; provided in each case that (i) the Holder agrees in writing with the transferee or assignee to assign such rights and related obligations under this Agreement, and the transferee or assignee agrees in writing for the transferee or assignee to assume such obligations and, with respect to such transferred or assigned Registrable Securities, to be bound by the terms and conditions of the Purchase Agreement with respect to any ongoing obligations thereunder, and a copy of such agreement is furnished to the Company within a

15

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

reasonable time after such assignment, (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being transferred or assigned, (iii) at or before the time the Company received the written notice contemplated by clause (ii) of this sentence, the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein and (iv) the transferee is an “accredited investor,” as that term is defined in Rule 501 of Regulation D.
(h)
Execution and Counterparts. This Agreement may be executed in two or more counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
(i)
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Purchase Agreement.
(j)
Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.
(k)
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their good faith reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.
(l)
Headings. The headings in this Agreement are for convenience only and shall not limit or otherwise affect the meaning hereof.
(m)
Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder under this Agreement are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. The decision of each Holder to purchase or otherwise acquire Registrable Securities pursuant to the applicable Purchase Agreement has been made by such Holder independently of any other Holder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any

16

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

other kind of entity, or create a presumption that the Holders are in any way acting in concert as a group with respect to such obligations or the transactions contemplated by this Agreement. Each Holder acknowledges that no other Holder has acted as agent for such Holder in connection with making its investment hereunder and that no Holder will be acting as agent of such Holder in connection with monitoring its investment in the securities or enforcing its rights under the Purchase Agreement. Each Holder shall be entitled to protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any Proceeding for such purpose.
(n)
Interpretive Provisions. With reference to this Agreement, unless otherwise specified herein:
(i)
the meanings of defined terms are equally applicable to the singular and plural forms of the defined terms;
(ii)
the words “herein,” “hereto,” “hereof” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision thereof;
(iii)
references in this Agreement to an Exhibit, Schedule, Article, Section, clause or subclause refer to the appropriate Exhibit or Schedule to, or Article, Section, clause or subclause in this Agreement;
(iv)
the term “including” is by way of example and not limitation;
(v)
the term “documents” includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form;
(vi)
any reference herein to any Person shall be construed to include such Person’s successors and assigns;
(vii)
the term “or” means “and/or”; and
(viii)
on the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including”; the words “to” and “until” each mean “to but excluding”; and the word “through” means “to and including.”

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

17

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

FISCALNOTE HOLDINGS, INC.

By: /s/ Tim Hwang
Name: Tim Hwang
Title: Chief Executive Officer

Signature Page to Registration Rights Agreement

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

EGT 10, LLC

By: /s/ Jasper Lau
Name:
Jasper Lau
Title:
CEO

ADDRESS FOR NOTICE c/o:

Street: [****]
City/State/Zip:
[****]
Attention: Jasper Lau
Tel:
Fax:

Email:
[****]

 

Signature Page to Registration Rights Agreement

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

ANNEX A

PLAN OF DISTRIBUTION

We are registering shares of Class A Common Stock to permit the resale of these shares of Class A Common Stock by the selling stockholder from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholder of the shares of Class A Common Stock. We will, or will procure to, bear all fees and expenses incident to our obligation to register the shares of Class A Common Stock.

The selling stockholder may sell all or a portion of the shares of Class A Common Stock beneficially owned by it and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. If the shares of Class A Common Stock are sold through underwriters, the selling stockholder will be responsible for underwriting discounts. If the shares of Class A Common Stock are sold through broker-dealers, we have agreed to reimburse the selling stockholder for commissions or agent’s commissions or pay such commissions or agent’s commissions directly. The shares of Class A Common Stock may be sold on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale, in the over-the-counter market or in transactions otherwise than on these exchanges or systems or in the over-the-counter market and in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions. The selling stockholder may use any one or more of the following methods when selling shares:

•

ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

•

block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

•

purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

•

an over-the-counter distribution in accordance with the rules of the applicable exchange;

•

privately negotiated transactions;

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

•

settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;

•

to or through underwriters or broker-dealers;

•

through trading plans entered into by the selling stockholder, including any trading plans pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of its shares on the basis of parameters described in such trading plans;

•

distribution to employees, members, partners or stockholders of the selling stockholder;

•

in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents;

•

in privately negotiated transactions;

•

through the writing or settlement of options, whether such options are listed on an options exchange or otherwise;

•

a combination of any such methods of sale; or

•

any other method permitted pursuant to applicable law.

The selling stockholder also may resell all or a portion of the shares of Class A Common Stock in open market transactions in reliance upon Rule 144 under the Securities Act as permitted by that rule, or Section 4(a)(1) under the Securities Act, if available, rather than under this prospectus, provided that they meet the criteria and conform to the requirements of those provisions.

2

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

Broker-dealers engaged by the selling stockholder may arrange for other broker-dealers to participate in sales. If the selling stockholder effects such transactions by selling shares of Class A Common Stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling stockholder or commissions from purchasers of the shares of Class A Common Stock for whom they may act as agent or to whom they may sell as principal. Such commissions will be in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction will not be in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2121.01.

If at the time of any offering made under this prospectus a member of FINRA participating in the offering has a “conflict of interest” as defined in FINRA Rule 5121 (“Rule 5121”), that offering will be conducted in accordance with the relevant provisions of Rule 5121.

The selling stockholder may, from time to time, pledge or grant a security interest in some or all of the shares of Class A Common Stock owned by it and, if it defaults in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Shares from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholder also may transfer and donate the shares of Class A Common Stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of Class A Common Stock from time to time under the prospectus or an amendment to the registration statement or supplement to the prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of selling stockholders to include the transferee or other successors in interest as selling stockholders under the prospectus, as appropriate.

The selling stockholder and any broker-dealer or agents participating in the distribution of the shares of Class A Common Stock may be deemed to be “underwriters” within the meaning of Section 2(11) of the Securities Act in connection with such sales. In such event, any commissions paid, or any discounts or concessions allowed to, any such broker-dealer or agent and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Any selling stockholder who is an “underwriter” within the meaning of Section 2(11) of the Securities Act will be subject to the applicable prospectus delivery requirements of the Securities Act including Rule 172 thereunder and may be subject to certain statutory liabilities of, including but not limited to, Sections 11, 12 and 17 of the Securities Act and Rule 10b-5 under the Exchange Act.

The selling stockholder has informed the Company that it is not a registered broker-dealer and does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the shares of Class A Common Stock. Upon the Company being notified in writing by the selling stockholder that any material arrangement has been entered into with a

3

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

broker-dealer for the sale of the Class A Common Stock through a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, a supplement to this prospectus will be filed, if required, pursuant to Rule 424(b) under the Securities Act, disclosing (i) the name of the selling stockholder and of the participating broker-dealer(s), (ii) the number of shares involved, (iii) the price at which such shares of Class A Common Stock were sold, (iv) the commissions paid or discounts or concessions allowed to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated by reference in this prospectus, and (vi) other facts material to the transaction. In no event shall any broker-dealer receive fees, commissions and markups, which, in the aggregate, would exceed eight percent (8.0%).

Under the securities laws of some U.S. states, the shares of Class A Common Stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some U.S. states the shares of Class A Common Stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with.

There can be no assurance that the selling stockholder will sell any or all of the shares of Class A Common Stock registered pursuant to the registration statement, of which this prospectus forms a part.

The selling stockholder and any other person participating in such distribution will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including, without limitation, to the extent applicable, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of Class A Common Stock by the selling stockholder and any other participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged in the distribution of the shares of Class A Common Stock to engage in market-making activities with respect to the Class A Common Stock. All of the foregoing may affect the marketability of the Class A Common Stock and the ability of any person or entity to engage in market-making activities with respect to the shares of Class A Common Stock.

In addition, we will make copies of this prospectus available to the selling stockholder for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholder may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.

We will pay all expenses of the registration of the shares of Class A Common Stock pursuant to the Registration Rights Agreement, including, without limitation, SEC filing fees and expenses of compliance with state securities or “blue sky” laws; provided, however, that the selling stockholder will pay all underwriting discounts, if any, and any related legal expenses incurred by it; provided, further we have agreed to reimburse the selling stockholder for commissions or agent’s commissions or pay such commissions or agent’s commissions directly. We will indemnify the selling stockholder against certain liabilities, including some liabilities under the Securities Act, in accordance with the Registration Rights Agreement, or the selling stockholder

4

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

will be entitled to contribution. We may be indemnified by the selling stockholder against civil liabilities, including liabilities under the Securities Act, that may arise from any written information furnished to us by the selling stockholder specifically for use in this prospectus, in accordance with the related Registration Rights Agreement, or we may be entitled to contribution.

5

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

 

 

Exhibit A

SELLING STOCKHOLDER QUESTIONNAIRE

The undersigned holder of shares of the convertible note due 2027 of FiscalNote Holdings, Inc. (the “Company”) of the Company issued pursuant to a certain Securities Purchase Agreement by and among the Company and the Purchaser named therein, dated as of November 12, 2024 (the “Agreement”), understands that the Company intends to file with the Securities and Exchange Commission a registration statement on either, in the Company’s discretion, Form S-3 or Form S-1 (the “Resale Registration Statement”) for the registration and the resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities in accordance with the terms of the Agreement. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement, dated November 12, 2024, by and the Holders named therein (the “RRA”).

In order to sell or otherwise dispose of any Registrable Securities pursuant to the Resale Registration Statement, a holder of Registrable Securities generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as so supplemented, the “Prospectus”), deliver the Prospectus to purchasers of Registrable Securities (including pursuant to Rule 172 under the Securities Act) and be bound by the provisions of the Agreement (including certain indemnification provisions, as described below). Holders must complete and deliver this Notice and Questionnaire in order to be named as selling stockholders in the Prospectus. Holders of Registrable Securities who do not complete, execute and return this Notice and Questionnaire within three (3) Trading Days following the date of the Agreement (1) will not be named as selling stockholders in the Resale Registration Statement or the Prospectus and (2) may not use the Prospectus for resales of Registrable Securities.

Certain legal consequences arise from being named as a selling stockholder in the Resale Registration Statement and the Prospectus. Holders of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not named as a selling stockholder in the Resale Registration Statement and the Prospectus.

NOTICE

The undersigned holder (the “Selling Stockholder”) of Registrable Securities hereby gives notice to the Company of its intention to sell or otherwise dispose of Registrable Securities owned by it and listed below in Item (3), unless otherwise specified in Item (3), pursuant to the Resale Registration Statement. The undersigned, by signing and returning this Notice and Questionnaire, understands and agrees that it will be bound by the terms and conditions of this Notice and Questionnaire and the Agreement.

The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate and complete:

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

QUESTIONNAIRE

(1)
Name.
(a)
Full Legal Name of Selling Stockholder:
(b)
Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:
(c)
Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the questionnaire):
(2)
Address for Notices to Selling Stockholder:

Telephone:

Fax:

Contact Person:

E-mail address of Contact Person:

(3)
Beneficial Ownership of Registrable Securities Issuable Pursuant to the Purchase Agreement:
(a)
Type and Number of Registrable Securities beneficially owned and issued pursuant to the Agreement:
(b)
Number of shares of Common Stock to be registered pursuant to this Notice for resale:
(4)
Broker-Dealer Status:
(a)
Are you a broker-dealer?

Yes ☐ No ☐

(b)
If “yes” to Section 4(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?

Yes ☐ No ☐

2

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

Note: If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

(c)
Are you an affiliate of a broker-dealer?

Yes ☐ No ☐

Note: If yes, provide a narrative explanation below:

(d)
If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

Yes ☐ No ☐

Note: If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement

(5)
Beneficial Ownership of Other Securities of the Company Owned by the Selling Stockholder.

Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities listed above in Item 3.

Type and amount of other securities beneficially owned:

(6)
Relationships with the Company:

Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

State any exceptions here:

(7)
Plan of Distribution:

The undersigned has reviewed the form of Plan of Distribution attached as Annex A to the RRA, and hereby confirms that, except as set forth below, the information

3

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

contained therein regarding the undersigned and its plan of distribution is correct and complete.

State any exceptions here:

***********

The undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof and prior to the effective date of any applicable Resale Registration Statement. All notices hereunder and pursuant to the Agreement shall be made in writing, by hand delivery, confirmed or facsimile transmission, first-class mail or air courier guaranteeing overnight delivery at the address set forth below. In the absence of any such notification, the Company shall be entitled to continue to rely on the accuracy of the information in this Notice and Questionnaire.

By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items (1) through (7) above and the inclusion of such information in the Resale Registration Statement and the Prospectus. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of any such Registration Statement and the Prospectus.

By signing below, the undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with the provisions of the Exchange Act and the rules and regulations thereunder, particularly Regulation M in connection with any offering of Registrable Securities pursuant to the Resale Registration Statement. The undersigned also acknowledges that it understands that the answers to this Questionnaire are furnished for use in connection with Registration Statements filed pursuant to the Registration Rights Agreement and any amendments or supplements thereto filed with the Commission pursuant to the Securities Act.

The undersigned hereby acknowledges and is advised of the following Question 239.10 of the Securities Act Rules Compliance and Disclosure Interpretations regarding short selling:

“An Issuer filed a Form S-3 registration statement for a secondary offering of common stock which is not yet effective. One of the selling stockholders wanted to do a short sale of common stock “against the box” and cover the short sale with registered shares after the effective date. The issuer was advised that the short sale could not be made before the registration statement become effective, because the shares underlying the short sale are deemed to be sold at the time such sale is made. There would, therefore, be a violation of Section 5 if the shares were effectively sold prior to the effective date.”

By returning this Questionnaire, the undersigned will be deemed to be aware of the foregoing interpretation.

I confirm that, to the best of my knowledge and belief, the foregoing statements (including without limitation the answers to this Questionnaire) are correct.

4

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


 

IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Questionnaire to be executed and delivered either in person or by its duly authorized agent.

Dated: Beneficial Owner:

By:
Name:
Title:

PLEASE EMAIL A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY PDF, TO:

Polsinelli PC
Shashi Khiani
1401 Eye “I” Street, N.W., Suite 800
Washington, DC 20005
Tel: (202) 626-8312
Email: skhiani@polsinelli.com

5

DOCPROPERTY "CUS_DocIDChunk0" 99403809.7


EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Timothy Hwang, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 of FiscalNote Holdings, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 


 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

 

 

 

 

 

 

November 12, 2024

/s/ Timothy Hwang

 

Timothy Hwang
Chief Executive Officer
(Principal Executive Officer)


 

 

 


 

 

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jon Slabaugh, certify that:

1.

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 of FiscalNote Holdings, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles

 

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.


 

 

 

 

 

 

 

November 12, 2024

/s/ Jon Slabaugh

 

Jon Slabaugh
Chief Financial Officer
(Principal Financial Officer)


 

 

 


EXHIBIT 32

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of FiscalNote Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Timothy Hwang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

 

November 12, 2024

/s/ Timothy Hwang

 

Timothy Hwang
Chief Executive Officer
(Principal Executive Officer)


 

 

In connection with the Quarterly Report of FiscalNote Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jon Slabaugh, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

 

November 12, 2024

/s/ Jon Slabaugh

 

Jon Slabaugh

Chief Financial Officer
(Principal Financial Officer)